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UvrA is an essential component of the Escherichla coli nucleotide excision repair (NER) 
apparatus. Previous studies indicated that the N-terminal region of UvrA interacts with 
UvrB. UvrB shares a region of sequence and structural homology with Mfd, a 
transcription-repair coupling factor. UvrB and Mfd are believed to interact with UvrA via 
this homology region. Mfd recognises stalled transcription complexes and recruits the 
nucleotide excision repair apparatus via its interaction with UvrA. 
In this work the UvrA-UvrB and the UvrA-Mfd interactions have been studied. A bacterial 
two-hybrid system was used to monitor interactions between the N-terminal domain of 
UvrA and regions of UvrB or Mfd. Single amino acid substitutions within UvrA that 
disrupt this interaction have been identified. A second screen, based on UV sensitivity, has 
been used to identify a further series of uvrA mutations that affect a wide range of UvrA 
functions. 
The UvrA mutants identified in these screens have been purified and characterised to 
determine their nucleotide hydrolysis rates, DNA binding, protein-protein interaction and 
overall repair capability. UvrAG173 and UvrAD205 have been identified as potential residues 
involved in the UvrA-UvrB interaction. 
As part of the repair studies site-specific methyltransferase induced labelling (SMILing) of 
DNA has been used as a novel method of introducing a single site-specific modification 
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Chapter 1- Introduction 
DNA is continuously damaged by numerous endogenous and exogenous mutagens 
(reviewed in (Friedberg et al., 2006)). A wide variety of DNA lesions have now been 
identified. Damaged DNA can have mutagenic and cytotoxic consequences. Certain types 
of DNA damage act as roadblocks for DNA polymerase and RNA polymerase (RNAP), 
preventing DNA replication and transcription respectively (Donahue et al., 1994) (Pages 
and Fuchs, 2003). If even single base mismatches are not repaired the downstream 
consequences can be serious with daughter cells potentially inheriting the incorrect DNA 
sequence. For an individual cell and its progeny to survive it is therefore essential that the 
damage is efficiently repaired. Organisms recognise and repair the different types of DNA 
damage using a range of repair pathways (Table 1.1) (reviewed in (Scharer, 2003)). 
Mutagens and DNA damage 
Endogenous mutagens 
Alkylating agents 
Many DNA adducts are caused by alkylating agents that modify DNA bases. Alkylating 
agents are electrophilic and react with the nucleophilic centres of base residues to 
introduce alkyl groups. The alkylating agents that cause the damage can be mono or 
bifunctional. Monofunctional alkylating agents include S-adenosylmethionine (AdoMet). 
Alkylating agents covalently attach alkyl groups to DNA bases at one of a variety of 
positions (Figure 1.1). Adenine N3, guanine N7 and guanine 06 are the most reactive sites 
and upon exposure to alkylating agents form products such as N7-methylguanine, 
N3-methyladenine and 06-methylguanine. The downstream consequences of these three 
alkylation products are all different. 06-methylguanine can lead to transition mutations as 
it is able to base pair with thymine (instead of cytosine) (Snow et al., 1984). 
N7-methylguanine base pairs with cytosine as normal and therefore is not as harmful to the 
cell as 06-methylguanine. N3-methyladenine is cytotoxic as it prevents DNA replication 
(Fronza and Gold, 2004). Alkylating agents can also indirectly cause depurination and. 
depyrimidination as the glycosidic bond of the nucleotide that has been modified is 
weakened and therefore more susceptible to hydrolysis (reviewed in (Loeb and Preston, 
1986)). 
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Lesion Principle cause Principle Effect if not Reference 
repair repaired 
pathway 
CPD UV irradiation NER Cytotoxic (Franklin and 
Haseltine, 
1984) 
6-4 photoproduct UV irradiation NER Cytotoxic (Franklin and 
Haseltine, 
1984) 
Double strand break Ionizing HR or Cytotoxic (Karagiannis 
irradiation NHEJ and El-Osta, 
2004) 
Thymine glycol Ionizing NER or cytotoxic (Weinfeld et 




Ionizing BER cytotoxic (D'Ham et al., 
irradiation 1999) 
O -meth 1 anine Alkylating agents DR Transition (Kleibl, 2002) 
N -meth 1 anine Al latin agents DR Limited (Kleibl, 2002) 
N -meth ]adenine Al latin agents DR Cytotoxic (Kleibl, 2002) 
Intrastrand Cross-linking NER Cytotoxic (Van Houten, 
cross-link reagents 1990) 
Interstrand Cross-linking NER Cytotoxic (Van Houten, 
cross-link reagents 1990 
8-hydroxyguanine Free radicals DR Transversion (Boiteux and 
Radicella, 
1999) 
Uracil (from Deamination BER Transition (Krokan et al., 
cytosine) 1997) 
Hypoxanthine Deamination BER Transition (Krokan et al., 
(from adenine) 1997) 
Depurination Spontaneous BER Transition or (Lindahl, 1993) 
transversion 
Depyrimidination Spontaneous BER Transition or (Lindahl, 1993) 
transversion 
Table 1.1 Types of DNA damage. 
Different types of damage are listed alongside the principle cause of the damage, the main repair pathway 
and the effect that they would have on the cell if left uncorrected. The principle repair pathways are 
represented by: NER, nucleotide excision repair; BER, base excision repair, NHEJ, non-homologous end 
joining; HR, homologous recombination; and DR, direct reversal. 
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Figure 1.1 Alkylation sites. 
The alkylation sites on the four DNA bases are shown in blue and red. The atoms highlighted in red are most 
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Oxidative damage 
Oxidative damage is caused by a variety of radical species that include hydroxyl radicals 
(-OH), superoxide radicals ("02) and hydrogen peroxide (H2O2). Radical species are 
produced as by-products of cellular processes such as the electron transport chain and can 
be formed as a result of ionizing radiation (reviewed in (Friedberg et al., 2006)). The 
attack of DNA by radical species can cause strand breakage, base loss and base 
modification. Guanine is converted to 8-hydroxyguanine by the attack of a hydroxyl 
radical. 8-hydroxyguanine base pairs with adenine instead of cytosine and therefore 
introduces a transversion mutation if not repaired. Thymine glycols that are also a result of 
oxidative damage are cytotoxic as they prevent transcription and replication. 
Deamination 
Deamination occurs spontaneously in DNA due to changes in temperature and pH 
(Lindahl, 1993). Cytosine and 5-methylcytosine undergo deamination to form uracil and 
thymine respectively. If left in the deaminated form transition mutations will occur upon 
replication as both uracil and thymine base pair with adenine instead of guanine. However 
uracil is not a standard component of DNA and is therefore recognised as a DNA lesion 
that can be repaired (Poole et al., 2001). Thymine is a standard DNA base and therefore it 
is more difficult to identify which base in the GT base pair is incorrect. 
Deamination of purine residues accounts for approximately 2% of all deamination 
reactions (Karran and Lindahl, 1980). Adenine and guanine are deaminated to form 
hypoxanthine and xanthine respectively. Hypoxanthine base pairs with cytosine potentially 
introducing a transition mutation. Xanthine also base pairs with cytosine but because it 
derives from guanine is not as mutagenic. Overall, deamination events primarily involve 
cytidine residues and it has been estimated that in a human cell 100 to 500 cytidine bases 
are deaminated every day (Frederico et al., 1990). 
Depurination and depyrimidination 
The formation of abasic sites occurs spontaneously within DNA as well as being a 
secondary consequence in some alkylation reactions. Abasic sites are formed when the 
glycosidic bond linking the sugar and base is hydrolysed separating the base from the 
5 
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DNA molecule. If left uncorrected the loss of a base is likely to lead to replication errors 
resulting in both transition and transversion mutations. Within a human cell it has been 
estimated that 2000 to 10000 abasic sites are formed every day (Lindahl and Nyberg, 
1972) (Nakamura et al., 1998). In approximately 95% of these cases this is due to the loss 
of a pyrimidine base (Lindahl, 1993). 
Replication errors 
Mismatches can be introduced during DNA replication and are caused by DNA 
polymerase incorporating the incorrect base or tautomer (Strazewski, 1988). For DNA 
polymerases with proof reading activity (such as DNA polymerase I and DNA polymerase 
III) approximately one error is introduced every 106 to 107 bases (reviewed in (Kunkel, 
1992)). If left uncorrected an incorrect tautomer can lead to transition mutations whereas 
an incorrect base can lead to either transition or transversion mutations (Strazewski, 1988). 
Exogenous mutagens 
Exogenous precursors to alkylating agents 
Several known chemicals that have no direct effect on the DNA molecule are precursors of 
DNA alkylating agents. These chemicals can be modified within cells to form mutagens. 
Within liver cells aflatoxin B1, a peanut mould toxin, is converted to 
aflatoxin BI-8,9, -epoxide that covalently attaches to the N7 position of guanine (Essigmann 
et aL, 1977). Benzo[a]pyrene, found in cigarette smoke, is converted through a series of 
reactions to 7,8-diol-9,10-epoxide that will covalently bind the N2 position of guanine 
(Phillips, 1983). 
Cross-linking reagents 
Cross-linking reagents have two reactive centres that can each react with the DNA 
molecule. Cross-linking reagents include some bifunctional alkylating agents, mitomycin, 
cis-platinum based products (e. g. cis-diaminedichloroplatinum) and psoralens. If the two 
reactive centres interact with the same DNA strand then an intrastrand cross-link is 
established. If they react with opposite strands then interstrand cross-links are formed 
(reviewed in (Friedberg et al., 2006)). Interstrand cross-links prevent strand separation of 
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the DNA molecule preventing DNA replication and thus cell division. Cross-linking 
reagents have therefore been used as chemotherapy tools to treat cancer (Scharer, 2005). 
Psoralens are tricyclic planner molecules that intercalate between DNA bases. Upon 
exposure to 320 nm to 410 nm ultraviolet (UV) light the psoralen molecules are activated 
and can react with the C5-C6 double bond of pyrimidine bases. Psoralens can be activated 
at either end and thus can form interstrand cross-links by reacting with a pyrimidine on 
either strand. The formation of a psoralen induced interstrand cross-link between two 
pyrimidine bases causes a predicted 47° helical distortion (Pearlman et al., 1985). 
Angelicin, a psoralen related compound, also intercalates between the bases and is 
activated upon exposure to UV light (Friedberg et al., 2006). However, angelicin is not a 
cross-linking reagent as it can only form monoadducts due to its steric positioning within 
the DNA. 
Ultraviolet irradiation 
UV light is an exogenous mutagen that can directly lead to the introduction of 
photoproducts within DNA molecules. Solar UV light is made up of UVA (320 to 400 
nm), UVB (280 to 320 nm) and UVC (100 to 280 nm) wavelengths. UVA and UVB light 
reach the biosphere more frequently than UVC. Despite this, most DNA repair 
experiments on UV irradiated DNA have been carried out on DNA that has been irradiated 
using a 254 nm (UVC) wavelength. Studies have shown that the DNA lesions introduced 
using this monochromatic wavelength are the same as lesions introduced by solar UV and 
are therefore physiologically relevant (Slieman and Nicholson, 2000). 
UV irradiation can cause pyrimidine residues within DNA to become photoexcited. A 
DNA photoproduct is formed if a photoexcited pyrimidine reacts with an adjacent 
pyrimidine base. UV irradiated DNA contains a variety of photoproducts of which the 
cyclobutane pyrimidine dimer (CPD) is the most common (Douki and Cadet, 2001). A 
CPD consists of a cyclobutane ring formed due to the saturation of the C5-C6 double bond 
of adjacent pyrimidines (Figure 1.2A). TT CPDs are observed more frequently than TC, 
CT and CC CPDs (written 5' to 3') (Douki and Cadet, 2001). The covalent bonds formed 
between the pyrimidines cause a distortion within the DNA backbone that has been 
reported to be between 7° and 30° (Husain et al., 1988) (Pearlman et al., 1985) (Wang and 
Taylor, 1991). A less abundant but significant photoproduct caused by UV irradiation is 
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Figure 1.2 UV photoproducts. 
Photoproducts are formed as a result of UV irradiation. The two major types of photoproducts are the (A) 
cyclobutane pyrimidine dimer and (B) the 6-4 photoproduct. Thymine thymine photoproducts are shown. 
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the pyrimidine-pyrimidone (6-4) photoproduct in which a single covalent bond is formed 
between the C6 and the C4 position of adjacent pyrimidine bases (Figure 1.2B). On 
exposure to less than 6.4 kJ/m2 UVB or UVC light, TC 6-4 photoproducts were observed 
more frequently then TT and CC 6-4 photoproducts (Douki and Cadet, 2001). CT 6-4 
photoproducts were not detected. The formation of the covalent bond between the adjacent 
pyrimidines causes a 47° distortion in the DNA backbone, greater than the distortion 
caused by the CPD (Warren et al., 1998). UV irradiation can also cause the formation of 
several other photoproducts including thymine glycols as well as causing single and 
double strand breaks (reviewed in (Friedberg et al., 2006)). Lesions arising from UV 
irradiation can have both cytotoxic and mutagenic effects. The helical distortions caused 
by the photoproducts stall both DNA polymerase and RNAP preventing the cell from 
replicating and expressing required proteins (Selby and Sancar, 1990). During DNA 
synthesis UV induced lesions can be bypassed by DNA polymerase V (Tang et al., 2000). 
However this can result in permanent transition or transversion mutations being 
introduced. 
Ionizing radiation 
Ionizing radiation is an environmental and man made mutagen. It acts on DNA both 
directly (35%) and indirectly (65%) to cause a variety of lesions (Ward, 1988). Within the 
cell, ionizing radiation can create free radicals such as -OH and H202 that go on to damage 
the DNA. On exposure to ionizing radiation the C5-C6 double bond of pyrimidine bases are 
often attacked forming modifications such as thymine glycols and 5-hydroxycytosine. 
Ionizing radiation affects the deoxyribose sugar less frequently. Despite this, sugar 
modifications can be more harmful to the cell as there is a chance that the DNA strand will 
be broken. Both the 5' and 3' termini of strand breaks are often damaged eliminating the 
possibility of a straight forward ligation reaction as a form of repair (Renner et al., 1982). 
Unlike other mutagens, ionizing radiation often introduces DNA lesions in clusters 
(Sutherland et al., 2000). This subsequently increases the frequency of double strand 
breaks occurring within the DNA molecule as a single strand break in each strand could 
occur within a few nucleotides of each other. 
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Repair Pathways 
The vast majority of lesions within a DNA molecule are repaired before the cell suffers 
any detrimental consequences. There are several repair mechanisms available to a cell: 
mismatch repair (MMR), base excision repair (BER), nucleotide excision repair (NER), 
direct reversal (DR), double strand break repair by homologous recombination (HR) and 
non-homologous end joining (NHEJ). Transcription-coupled repair (TCR) links certain 
repair pathways to transcription. Each repair mechanism acts in different ways to 
regenerate the original DNA sequence. 
Direct reversal 
Certain DNA lesions can be repaired using enzymes that directly restore the DNA to its 
original state (Figure 1.3). The process is unique amongst repair pathways as only one 
enzyme is involved in the entire restoration process. Two classes of lesions are known to 
be repaired in this manner: some photoproducts and certain alkylation products which are 
restored by the action of specific photolyases and alkyltransferases respectively. 
Direct reversal of photoproducts 
CPD photolyases recognise and directly repair CPDs by converting the CPD back to its 
original pyrimidine-pyrimidine sequence using energy from light. All photolyases contain 
two chromophores: a catalytic and a light harvesting cofactor (Kim and Sancar, 1993). In 
all reported cases the catalytic cofactor is FADH-. The light harvesting cofactor is either a 
methenyltetrahydrofolate or an 8-hydroxy-5-deazariboflavin (Yasui et al., 1994). CPD 
photolyases fall into two categories (class I and class II) depending on their amino acid 
sequence (Yasui et al., 1994). Class I CPD photolyases are further subcategorised into the 
folate or deazaflavin class depending on the light harvesting cofactor that they contain. In 
general, class I photolyases have been found in prokaryotes and type II photolyases have 
been found in lower eukaryotes (Todo, 1999). No DNA photolyases have been reported in 
placental mammals. 
In a light-independent reaction Escherichia coli DNA photolyase recognises and binds 
thymine dimers 104-fold more efficiently than undamaged DNA (Kim and Sancar, 1991). 
Footprinting studies revealed that the CPD photolyase binds either side of the lesion on 
both the damaged and undamaged DNA strands (Husain et al., 1987). It is proposed that 
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06-methylguanine Cyclobutane pyrimidine dimer 
Figure 1.3 Direct reversal. 
(A) 06-methylguanine, which is introduced by alkylating agents, is directly restored to guanine by 
06-alkylguanine transferase. This reaction irreversibly inactivates 06-alkylguanine transferase. (B) 
Pyrimidine dimers introduced by UV irradiation can be repaired by DNA photolyase that is activated upon 
exposure to long wavelength UV light (reviewed in (Friedberg et at, 2006)). 
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the CPD is then flipped out of the helix to position it to readily accept an electron 
(Christine et al., 2002). To carry out the photoreactivation reaction a photon of light needs 
to be absorbed by one of the cofactors. The light harvesting cofactor absorbs a photon of 
light within the 300 to 500 nm range and then transfers an electron to FADH- (Kim and 
Sancar, 1993). The catalytic cofactor can also weakly absorb a photon of light without the 
assistance of the light harvesting cofactor. An electron is then transferred from the excited 
FADH- to the cyclobutane ring (Weber, 2005). The C5-C5 bond breaks followed by the 
C6-C6 bond and the transfer of the electron back to the cofactor (Kim and Sancar, 1991). 
The original DNA sequence is restored. As well as CPD photolyases there are also some 
6-4 photolyases that restore 6-4 photoproducts to the original pyrimidine bases (Kim et al., 
1994). 
Direct reversal of alkylation damage 
Alkyltransferases are found in almost all species and remove alkyl groups from modified 
DNA bases. C-Ada, OGT (both E. coli) and hAGT (human) are examples of 
06-alkylguanine alkyltransferases that recognise and bind 06-alkylguanine before flipping 
the base from the helical structure (Daniels et al., 2004). This flipping reaction positions 
the base in close proximity to an active cysteine residue within the 06-alkylguanine 
alkyltransferase (Daniels et al., 2004). The active cysteine residue then makes a 
nucleophilic attack resulting in the transfer of the alkyl group onto the enzyme restoring 
the base to guanine (Lindahl et al., 1982). The enzyme is degraded after repairing only one 
lesion as the transfer of the alkyl group onto the cysteine residue renders the enzyme 
inactive. Other enzymes are used to directly repair other types of alkylation damage. These 
include N-Ada that repairs methylphosphotriesters and A1kB that repairs 
N'-methyladenine and N3-methylcytosine (reviewed in (Mishina et al., 2006)). 
Double strand break repair 
Homologous recombination 
In prokaryotes HR seems to be the most prevalent double strand break repair mechanism 
underpinning replication (Figure 1.4). The recombination process uses several enzymes 
including RecBCD, RecA, RuvAB and RuvC. Upon formation of a double strand break 
the DNA is unwound by the motors of RecB and RecD. RecBCD has both a 5' to 3' and a 
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Figure 1.4 Homologous recombination. 
(1) Upon exposure to mutagens double strand breaks can be introduced into the DNA. (2) The RecBCD 
complex recognises the damaged DNA and uses its exonuclease activity to produce 3' overhangs. (3 - 5) The 
recombinase RecA recognises and binds the terminal regions and instigates the strand probing with a 
homologous DNA molecule. DNA polymerase can then synthesise the complementary region of DNA. 
RuvAB can recognise Holliday junctions and cause branch migration. (6) The resolvase RuvC releases two 
undamaged homologous DNA strands (reviewed in (Friedberg et aL, 2006)). The pink filled circles indicate 
newly synthesised DNA. 
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3' to 5' exonuclease activity (Dillingham et al., 2003). Initially the 3' to 5' exonuclease 
activity creates a 5' overhang (Dixon and Kowalczykowski, 1993). When a Chi sequence 
is encountered the relative activity of the two exonucleases changes resulting in a final 
DNA molecule with a 3' overhang (Ponticelli et al., 1985). RecBC then loads RecA, a 
recombinase, onto the 3' overhangs (Churchill et al., 1999). RecA mediates homology 
recognition with an undamaged double stranded homologous DNA molecule (Rao and 
Radding, 1993). RecA then promotes strand invasion and strand exchange between the two 
DNA molecules. The homologous DNA molecule acts as a template for DNA polymerase 
to synthesise the missing bases of the damaged DNA. RuvAB stimulates branch migration 
of the two Holliday junctions (Shinagawa and Iwasaki, 1996). RuvC resolves the Holliday 
junction by nicking the DNA to generate two intact DNA molecules (Dunderdale et al., 
1991). 
In eukaryotes HR is also used as a method of repairing double strand breaks. The proteins 
and mechanism involved have yet to be determined in detail. The Mrel1 complex is 
similar to RecBCD in that it is able to carry out some of the biochemical activities of 
RecBCD (Haber, 1998). Recombination mediators load Rad51 onto the single strand ends. 
Rad51 then requires accessory proteins, like Rad54, for recombination to occur (Baumann 
and West, 1998). The resolvase has yet to be determined although Rad5lC has been 
proposed to fill this role (Liu et al., 2004). 
Non-homologous end joining 
NHEJ is the principle method of double strand break repair in mammals (Sonoda et al., 
2006). NHEJ also happens in prokaryotes but occurs less frequently than HR (reviewed in 
(Lieber et al., 2003)). There are several steps involved in NHEJ: the binding of proteins to 
the DNA ends that stops nucleolytic degradation; the positioning and preparation of the 
DNA ends using the DNA bound proteins; and finally the ligation of the ends to 
reconstitute the DNA molecule (reviewed in (Lieber et al., 2003)). 
In mammals a Ku complex binds double strand break ends. The Ku complex consists of 
Ku70 and Ku80 that form a ring like structure through which the DNA can pass (Walker et 
al., 2001). Ku proteins interact with a DNA protein kinase that interacts with the DNA 
protein kinase bound to the other section of DNA (reviewed in (Friedberg et al., 2006)). 
This protein-protein interaction positions the DNA ends ready for ligation. In most cases 
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the DNA termini need modification before ligation can occur (Chappell et al., 2002). A 
variety of proteins join the complex, modify the ends and ligate the strands to generate an 
intact DNA molecule. 
Mismatch repair 
DNA polymerases are not infallible and can introduce mismatches, insertions or deletions 
during DNA synthesis. These errors are recognised and repaired by the MMR machinery 
within the cell. The MMR proteins have to recognise a mismatch, identify which of the 
two DNA strands are incorrect and then correct the error (Figure 1.5). 
Prokaryotic mismatch repair 
In E. coli MMR there are three main proteins involved in damage recognition: MutS, 
MutL and MutH. Initially an ADP bound dimer of MutS recognises and asymmetrically 
binds the mismatched base, insertion or deletion (Obmolova et al., 2000). The binding 
affinity of MutS to these sites is only approximately 4 to 20-fold more efficient than its 
binding affinity to matched DNA (Schofield et al., 2001). Common mismatches (GT) are 
recognised and bound more efficiently than rare mismatches (CC) (Su et al., 1988). ATP 
replaces the ADP molecule bound to MutS. The ATP bound MutS forms a clamp that 
slides along the DNA and recruits a MutL dimer (Acharya et al., 2003) (Selmane et al., 
2003). MutL recruits MutH to MutS that then activates the endonuclease activity of MutH. 
The activated MutH acts as an endonuclease and cleaves only the unmethylated (newly 
synthesised) strand 5' of a GATC sequence (Welsh et al., 1987). The incision can occur 
more than 1 kb away from the mismatch in either the 3' or 5' direction. MutL loads 
helicase II (UvrD) onto the nicked site which unwinds the two strands. Excision of the 
daughter strand is carried out either by a 3' to 5' exonuclease (Exol or ExoX) or a 5' to 3' 
exonuclease (RecJ or ExoVII) that degrades the DNA past the mismatch (Cooper et al., 
1993). The parent strand is protected by SSB proteins. DNA polymerase III synthesises a 
new section of DNA and DNA ligase seals the join (Figure 1.5). 
Eukaryotic mismatch repair 
The eukaryotic MMR process is similar but not identical to the prokaryotic mechanism. 
There are several MutS homologues that recognise different types of errors. MSH2 and 
MSH6 dimerize to form MutSa that is mainly responsible for recognising mismatches and 
15 




































Figure 1.5 Mismatch repair. 
(1) An incorrect base can be incorporated into DNA during DNA replication. (2) MutS binds the mismatch 
as a dimer and undergoes a conformational change to form a clamp that can bind MutL. MutL recruits MutH 
which cleaves the unmethylated DNA strand 5' of a GATC sequence. (3) MutL loads helicase II onto the 
nick and an exonuclease degrades the unmethylated strand past the mismatch. (4) DNA polymerase 
synthesises a new section of DNA. (5) DNA ligase seals the gap to generate an undamaged DNA molecule. 
(6) The DNA is then methylated. MMR is reviewed in Friedberg et al. (Friedberg et al., 2006)). M indicates 
a methylated adenine residue within a GATC sequence, the black filled circle represents an incorrect base 
and the pink filled circles indicate newly synthesised DNA. 
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loops of less than 3 bases whilst MSH2 and MSH3 dimerize to form MutSI that is 
responsible for recognising large loops (reviewed in (Kunkel and Erie, 2005)). The MutS 
homologues interact with one of several MutL homologues (Plotz et al., 2003). Eukaryotes 
do not have a MutH homologue and the mechanism by which strand discrimination takes 
place is not understood. One possibility is that the discrimination is linked to the 
replication machinery as PCNA, that has a role in DNA replication, interacts with the 
MutS and MutL homologues (Pavlov et al., 2003). 
Base excision repair 
In both prokaryotes and eukaryotes several base modifications and base deletions (abasic 
sites) can be repaired by the BER pathway (Figure 1.6) (reviewed in (Friedberg et al., 
2006)). The initial step in BER of modified bases is the generation of an abasic site 
(Huffman et al., 2005). This is achieved by the actions of one of several DNA glycosylases 
which hydrolyse the N-glycosidic bond between the modified base and the deoxyribose 
sugar (reviewed in (Krokan et al., 1997)). The abasic site is recognised by an AP 
endonuclease (endonuclease III or endonuclease IV in E. coli) that hydrolyses the 5' 
phosphodiester bond (Levin and Demple, 1990). DNA polymerase uses the exposed 3' end 
of the DNA as a primer and introduces a single nucleotide where the damage had been. A 
deoxyribosephosphodiesterase (that can be part of DNA polymerase) nicks the DNA 3' of 
the damaged site releasing the sugar phosphate (Garcia-Diaz et al., 2005). DNA ligase 
then ligates the 3' OH group of the introduced nucleotide to the 5' phosphate group of the 
original DNA. Some DNA glycosylases (such as hOGGI) have an associated AP lyase 
activity that cleaves the DNA 3' of the damaged site as part of the initial step (van der 
Kemp et al., 2004). When AP endonuclease cleaves the DNA 5' of the damaged site the 
sugar phosphate is therefore released (Wyatt et al., 1999). DNA polymerase then 
introduces a single nucleotide that is sealed in place by DNA ligase. An alternative BER 
pathway occurs when DNA polymerase introduces more than one nucleotide, displacing 
the abasic site and undamaged nucleotides in the process (Klungland and Lindahl, 1997). 
The displaced nucleotides are excised by an endonuclease (e. g. FEN-I) enabling DNA 
ligase to seal the join. 
Different lesions, predominantly caused by alkylation or oxidation, are recognised by 
different DNA glycosylases (reviewed in (Friedberg et al., 2006)). Some DNA 
17 














Deoxyribose- (4a) (4b) DNA polymerase 
5' 
5' ' 





5 DNA ligase 
5' 
M=3' 
Figure 1.6 Base excision repair. 
BER corrects base modifications and abasic sites. (1) DNA glycosylase hydrolyses the N-glycosidic bond 
between the modified base (black box) and the deoxyribose sugar to leave an abasic site. There are then two 
possible routes. (2a) An AP endonuclease hydrolyses the phosphodiester bond 5' of the damaged site. (3a) 
DNA polymerase introduces a single nucleotide displacing the sugar phosphate of the abasic site. (4a) A 
deoxyribosephosphodiesterase cleaves the DNA 3' of the damaged site removing the sugar phosphate. 
Alternatively (2b) the DNA glycosylase from step 1 has an associated AP lyase activity that cleaves the 
phosphodiester bond 3' to the site of damage. (3b) An AP endonuclease cleaves the DNA 5' of the site of 
damage resulting in the loss of the sugar phosphate. (4b) DNA polymerise introduces a new nucleotide. (5) 
DNA ligase seals the gap to restore the DNA (reviewed in (Friedberg et al., 2006)). The pink box indicates 
the introduced base. 
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glycosylases such as T4 endonuclease V (T4EV) specifically recognise pyrimidine dimers 
(Demple and Linn, 1980). T4EV cleaves the N-glycosidic bond of the 5' pyrimidine of a 
dimer. T4EV then uses its associated AP lyase activity to hydrolyse the phosphodiester 
bond connecting the two nucleotides (McMillan et al., 1981). Pyrimidine dimer DNA 
glycosylases are the only known type of DNA glycosylases that do not release the 
modified base into solution, presumably because the pyrimidine is still bound to the other 
pyrimidine through the cyclobutane ring. 
Nucleotide excision repair 
NER involves DNA damage recognition, dual incision 3' and 5' from the lesion, excision 
of the damage containing oligonucleotide fragment and finally DNA polymerisation and 
ligation to yield an undamaged DNA molecule (Figure 1.7). The NER apparatus can detect 
and repair a wide range of lesions including pyrimidine dimers and psoralen cross-links 
(Hanawalt et al., 2003). 
Overview of prokaryotic nucleotide excision repair 
Six proteins are involved in NER in prokaryotes: UvrA, UvrB, UvrC, UvrD (helicase II), 
DNA polymerase I and DNA ligase. A model for the mechanism of NER proposes that a 
UvrA dimer acts as the initial damage recognition subunit and in complex with UvrB scans 
the DNA for damage (Sancar and Hearst, 1993). Once UvrA has located a damaged site it 
loads UvrB onto the DNA and dissociates (DellaVecchia et al., 2004). UvrC recognises 
and binds the DNA bound UvrB complex and incises the DNA three to five 
phosphodiester bonds 3' and eight phosphodiester bonds 5' of the lesion (Sancar and Rupp, 
1983) (Verhoeven et al., 2000). UvrD unwinds the damage containing oligonucleotide 
form the DNA and displaces UvrC in the process (Caron et al., 1985) (Husain et al., 1985). 
DNA polymerase I synthesises a replacement section of DNA and releases UvrB from the 
undamaged stand (Caron et al., 1985) (Husain et al., 1985). DNA ligase then seals the 
nick. NER in E. coli is discussed in greater detail below. 
Overview of eukaryotic nucleotide excision repair 
The overall reaction mechanism of eukaryotic NER is similar to prokaryotic NER with 
damage recognition, incision, excision, synthesis and ligation steps. The scheme is more 
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Figure 1.7 Nucleotide excision repair. 
In E. cols bulky DNA adducts such as pyrimidine dimers are often repaired by the NER pathway. (1) DNA is 
damaged. (2) A dimer of UvrA (A) bound to one or two molecules of UvrB (B) recognises and binds the 
damaged site. (3) UvrA loads UvrB onto the DNA and is released. (4) The DNA bends and (5) UvrC (C) is 
recruited. (6) UvrC incises the DNA first 3' and then 5' of the lesion. (7) UvrD (D) binds and (8) unwinds the 
DNA releasing the oligonucleotide and UvrC in the process whilst leaving UvrB on the DNA. (9) DNA 
polymerase (P) binds and (10) synthesises a new section of DNA displacing UvrB in the process. (11) The 
polymerase is released and (12) ligase (L) binds and (13) seals the gap. The DNA is now restored to its 
original undamaged state. The UvrA cycle consists of (14) dimerization, (15) UvrB binding, (2) DNA 
binding, (3) UvrB loading and DNA release. The pink filled circles indicate newly synthesised DNA. 
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complicated as over 20 proteins are now known to be associated with this pathway (Costa 
et al., 2003). Six protein complexes are involved in the damage recognition and incision 
steps of human NER: XPC. HR23B, TFIIH, XPA, RPA, XPG and XPF. ERCC1 (Riedl et 
al., 2003). 
There is some controversy as to which is the main damage recognition component in 
eukaryotic NER. RPA, XPA and XPC have all been linked with the initial damage 
recognition step of NER (Hermanson-Miller and Turchi, 2002) (Tapias et al., 2004). It is 
now believed that XPC is the main initial damage recognition unit (Tapias et al., 2004) 
although if the lesion is sufficiently distorting XPC is not always required (Mu and Sancar, 
1997). Recognition of UV-damaged DNA has been proposed to be stimulated by UV-DDB 
(Wakasugi et al., 2002). TFIIH recognises the XPC bound DNA complex and binds 
(Yokoi et al., 2000). XPB and XPD, two subunits of TFIIH, have helicase activity and 
locally unwind the DNA at the lesion (Tapias et al., 2004). XPA, XPG, RPA and XPF are 
recruited. RPA stimulates the nuclease activity of both XPG and XPF (Moggs et al., 
1996). XPG cleaves the DNA three to nine phosphodiester bonds 3' and XPF cleaves the 
DNA 15 to 25 phosphodiester bonds 5' of the lesion (Matsunaga et al., 1995). The incised 
fragment is between 24 and 32 nucleotides long depending on the lesion and DNA 
sequence involved. The damage-containing oligonucleotide and the repair proteins (except 
the RPA complex) are released without additional factors being present. DNA polymerase 
S or DNA polymerase s, RFC and PCNA bind. DNA polymerase synthesises a new DNA 
region that is then sealed by DNA ligase. Humans unable to repair specific lesions due to 
defects in NER can suffer from Xeroderma pigmentosum (Lehmann, 2003). Symptoms of 
Xeroderma pigmentosum include sensitivity to sunlight and predisposition to skin 
carcinomas. 
Transcription-coupled repair 
TCR is the process by which damage located within the template strand of transcribed 
genes is repaired up to 10 times faster than damaged located within the rest of the genome 
(Mellon et al., 1987) (Mellon and Hanawalt, 1989) (Terleth et al., 1989). This increase in 
repair rate is achieved by a transcription repair-coupling factor (TRCF) that links repair to 
transcription (Figure 1.8). The TRCF is Mfd in E. coil (Selby and Sancar, 1993), Rad26 in 
S. cerevisiae (van Gool et al., 1994) and CSB in humans (Venema et al., 1990). 
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Figure 1.8 Transcription-coupled repair model. 
(1) An elongating RNAP complex is stalled by a lesion within the DNA. The stalled elongation complex is 
recognised and bound by Mfd (M). (2) Mfd displaces the stalled elongation complex and recruits the NER 
proteins to the lesion. (3) NER then proceeds. The pink filled circles indicate newly synthesised DNA. 
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Overview of prokaryotic transcription-coupled repair 
Mfd is the TRCF in prokaryotes (Selby and Sancar, 1993). During RNA synthesis RNAP 
translocates along the DNA. RNAP will stall if a bulky lesion is present within the 
template strand of the gene that it is transcribing (Donahue et al., 1994). The stalled 
RNAP-DNA complex is recognised by Mfd (Selby and Sancar, 1993). Mfd is believed to 
have two main functions: firstly it causes the displacement of the stalled RNAP from the 
DNA and secondly it recruits the initial NER proteins to the lesion (Selby and Sancar, 
1993). TCR in E. coli is discussed in detail below. 
Overview of eukaryotic transcription-coupled repair 
Mammalian cells lacking the CSA and CSB proteins are deficient in TCR (Venema et al., 
1990). XPC, the main damage recognition factor in NER is not required in TCR (Venema 
et al., 1991). Instead RNAP II acts as the damage sensor by stalling at sites of damage. 
However just as in prokaryotic TCR the stalled RNAP II blocks repair of the lesion and 
therefore must be displaced. CSB has been proposed to recognise and interact with the 
stalled elongation complexes (Tremeau-Bravard et al., 2004). The CSB protein has been 
proposed to be involved in the displacement or remodelling of the stalled elongation 
complex (Svejstrup, 2002). However unlike Mfd, CSB is unable to displace the stalled 
complex (Selby and Sancar, 1997) (Selby and Sancar, 1993). TFIIH, part of the 
transcription and NER machinery, has been shown to interact with CSB (Tantin, 1998). 
There is relatively little information about how the pathway then leads into NER. Humans 
deficient in TCR suffer from Cockayne syndrome (Lehmann, 2003). Patients suffering 
from this syndrome are not sensitive to UV light but do suffer from neurological disorders. 
Nucleotide excision repair in Escherichia coli 
NER was first detected in E. coli (Boyce and Howard-Flanders, 1964) (Setlow and Carrier, 
1964). UV sensitive strains were found to have defects in or were deficient in one of three 
genes: uvrA, uvrB or uvrC (Howard-Flanders et al., 1966). Strains deficient in more than 
one of these genes were no more UV sensitive than strains carrying a single uvr gene 
defect (Howard-Flanders et al., 1966). Complementation assays indicated that the gene 
products of uvrA, uvrB, and uvrC are required for NER activity (Seeberg et al., 1976). 
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Furthermore Mg2+ and ATP are also essential for NER (Seeberg et al., 1976) (Sancar and 
Rupp, 1983) (Yeung et al., 1983). 
The nucleotide excision repair proteins 
There are six essential proteins for NER in E. coli: UvrA, UvrB, UvrC, UvrD (helicase II), 
DNA polymerase I and DNA ligase. UvrA, UvrB and UvrC are required for the damage 
recognition and incision steps of NER and are described in detail below. Cho, a UvrC 
homologue that is able to carry out the 3' incision reaction, is also discussed. 
UvrA 
UvrA is a 940 amino acid, 104 kDa protein (Husain et al., 1986). UvrA is essential for 
NER and has been shown to interact with other UvrA molecules, UvrB, DNA and ATP 
(Mazur and Grossman, 1991) (Yeung et al., 1986a) (Claassen and Grossman, 1991) 
(Seeberg and Steinum, 1982). It has also been shown to interact with the TRCF, Mfd 
(Selby and Sancar, 1995a). Primary sequence analysis of UvrA (Figure 1.9) revealed that 
there are two Walker A and Walker B motifs. Further analysis revealed that UvrA is a 
member of the ABC transporter family although it only possesses the ABC ATPase 
domain and not the transmembrane domain common to these proteins (Linton and Higgins, 
1998). Sequence analysis of UvrA also revealed two zinc finger motifs, a helix-turn-helix 
motif and a glycine rich region near its C-terminus (Doolittle et al., 1986). 
The uvrA gene is under the control of the SOS response. Under normal cellular conditions 
estimates for the number of UvrA molecules within the cell range from as few as 25 to as 
many as 1000 (Husain et al., 1986), (Seeberg and Steinum, 1982), (Crowley and Hanawalt, 
1998) (Lin et al., 1997). Upon induction of the SOS response the concentration of UvrA 
within the cell is stimulated between 1.5 and 6-fold (Seeberg and Steinum, 1982) (Crowley 
and Hanawalt, 1998). This increase in UvrA concentration presumably enhances the cells 
chances of survival by increasing the frequency of repair reactions. 
UvrB 
UvrB is a 673 amino acid, 76 kDa protein (Figure 1.9) (Caron and Grossman, 1988). UvrB 
is a key protein in NER as it interacts with UvrA, UvrC, UvrD, DNA polymerase, DNA 
and ATP (reviewed in (Van Houten et al., 2005)). Of the three NER proteins required for 
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Figure 1.9 Sequence motifs of UvrA, UvrB, UvrC and Mfd. 
The primary structure of UvrA, UvrB, UvrC and Mfd are shown. Black boxes represent the structure 
indicated above each motif. The coloured boxes indicate the following domains. UvrA - green, the predicted 
UvrB interaction domain (UvrA, 
_230); purple, the predicted 
UvrA dimerization domain (UvrA, 0); and red, 
the damage recognition and stabilisation domain (UvrA 940). UvrB - dark blue, domain la; purple, domain 
lb; aqua, domain 2; orange, domain 3; yellow, domain 4; and red the ß-hairpin (Theis et al., 1999). UvrC - 
orange, UvrB interaction domain; and green, a region required for DNA binding. Mfd - dark blue, domain 
la; purple, domain lb; aqua, domain 2; orange, domain 3; pink, domain 4; yellow, domain 5; green, domain 
6; and red, domain 7 (Deaconescu et al., 2006). 
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recognition and incision of damaged DNA only UvrB has been crystallised (Figure 1.10) 
(Theis et al., 1999) (Machius et al., 1999) (Truglio et al., 2004) (Eryilmaz et al., 2006). 
The structure of UvrB from Thermus thermophilus (Machius et al., 1999), Bacillus 
caldotenax (Theis et al., 1999) and Bacillus subtilis (Eryilmaz et al., 2006) have been 
determined. In in vitro excision assays substituting E. coli UvrB with B. caldotenax UvrB 
had no effect on the outcome of the assay (Theis et al., 1999). Thus the crystal structures 
of B. caldotenax UvrB is relevant in studying the E. coli UvrB protein. 
UvrB consists of five domains: la, 1b, 2,3 and 4 (Figure 1.9 and Figure 1.10) (Theis et al., 
1999). Domains 1a and 3 contain classical superfamily 2 helicase motifs to which ATP 
binds (Machius et al., 1999) (Theis et al., 1999) (Eryilmaz et al., 2006). This region shares 
structual similiarity to many helicases despite UvrB not being a true helicase (Theis et al., 
1999). Domains 1 a, 1 b, 3 and a ß-hairpin that extends from domain 1a have all been linked 
with DNA binding (Theis et al., 1999). In the original T. thermophilus and B. caldotenax 
UvrB crystal structures, domains 2 and 4 were both disordered (Machius et al., 1999) 
(Theis et al., 1999). Domain 4 was crystallised from E. coli and consists of a 
helix-loop-helix structure that shares sequence homology to a region of UvrC that is 
believed to interact with this region of UvrB (Sohi et al., 2000). A mutated form of 
B. caldotenax UvrB, UvrBYAO96, was crystallised to reveal an intact domain 2 that has been 
implicated in the interaction that UvrB makes with UvrA (Truglio et al., 2004). 
Like uvrA, uvrB is also under the control of the SOS response. Under normal cellular 
conditions estimates for the number of UvrB molecules within the cell range from as few 
as 140 to as many as 400 (Sancar et al., 1981a) (Lin et al., 1997) (Crowley and Hanawalt, 
1998). Upon induction of the SOS response the concentration of UvrB within the cell is 
stimulated between 5 and 6-fold (Schendel et al., 1982) (Lin et al., 1997) (Crowley and 
Hanawalt, 1998). 
UvrC 
UvrC is a 610 amino acid, 66 kDa protein (Sancar et al., 1981b). Primary sequence 
analysis of UvrC (Figure 1.9) revealed that its N-terminal domain (NTD) shares homology 
to the GIY-YIG superfamily of intron encoded homing endonucleases (Verhoeven et al., 
2000). The NTD of UvrC has been crystallised in both B. caldotenax (UvrC1-098) and 
Thermotoga martima (UvrC1_097) (Truglio et al., 2005). The UvrC C-terminus shares 
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Domain 3 
Figure 1.10 Crystal structure of UvrB. 
The crystal structure of B. caldotenax UvrBYAO46 is shown (protein data bank number I D9X). The domains 
are coloured as follows: dark blue, domain la; purple, domain lb; aqua, domain 2; orange, domain 3 the 
ß-hairpin is shown in red. Domain 4 is not shown. The diagram is adapted from (Truglio et al., 2004). 
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homology with ERCC 1, the eukaryotic NER protein responsible for the 5' incision reaction 
(Doolittle et al., 1986) (Verhoeven et al., 2000). UvrC201.240 is homologous to the 
C-terminus of UvrB and UvrC is though to interact with UvrB through this region 
(Moolenaar et al., 1998b) (Verhoeven et al., 2000) (Sohi et al., 2000). Unlike uvrA and 
uvrB, the uvrC gene is not under the control of the SOS response. It is estimated that 
within a cell there are 10 molecules of UvrC (Yoakum and Grossman, 1981). 
Cho 
Recently a second nuclease, Cho, has been identified that can play a role in NER 
(Moolenaar et al., 2002). Cho stands for UvrC homologue and is encoded by the ydgQ 
gene (Moolenaar et al., 2002). Deletion of the ydgQ gene does not render wild-type cells 
UV sensitive but does further increase the UV sensitivity of EuvrC cells (Moolenaar et al., 
2002). Unlike uvrC, ydgQ expression is stimulated by the SOS response. Cho shares 
homology with the NTD of UvrC (responsible for the 3' incision reaction) and is a 
UvrA-UvrB dependent endonuclease that incises the DNA nine phosphodiester bonds 3' of 
the lesion (Moolenaar et al., 2002). It is unable to initiate a 5' incision event. It is believed 
that Cho interacts with a different region of UvrB than UvrC does since unlike UvrC it is 
able to incise DNA in the presence of a UvrB C-terminal truncation termed UvrB* 
(Moolenaar et al., 2002). Cho differs from UvrC in its preferences for lesions and the 3' 
incision reaction occurs faster than UvrC on DNA with a cholesterol or menthol group 
attached (Moolenaar et al., 2002). 
The process of nucleotide excision repair 
Dimerization, nucleotide binding and nucleotide hydrolysis activity of UvrA 
The first step in NER is the dimerization of UvrA (Ka = 10 nM in the absence of ATP) 
(Mazur and Grossman, 1991). Other members of the ABC transporter family including 
Rad50 and MutS, two other DNA repair enzymes, dimerize in a head to head orientation 
(Hopfner et al., 2000) (Obmolova et al., 2000). Truncation studies and gel filtration 
chromatography have indicated that UvrA dimerizes in a head-to-head orientation 
involving the N-terminal 605 amino acids (Claassen and Grossman, 1991) (Myles and 
Sancar, 1991). UvrA truncations that only contain the N-terminal 230,470 or 560 amino 
acids are unable to dimerize indicating that a key UvrA dimerization component lies 
28 
Chapter 1- Introduction 
within UvrA561-605 (Claassen and Grossman, 1991). In ABC ATPase domains the ATP 
binding site is formed at the dimer interface with a Walker A motif from one monomer and 
a Walker B motif from the other generating the ATP binding site (Hopfner and Tainer, 
2003). The UvrA monomer contains two Walker A and Walker B motifs on each molecule 
(Doolittle et al., 1986). Therefore a potential four ATP molecules could bind at any one 
time if the dimer interface allowed. However results of nucleotide binding studies showed 
that 0.57 molecules of ADP bound per UvrA monomer indicating that only one, not four, 
ATP molecule would bind per UvrA dimer at any one time (Myles et al., 1991). Gel 
filtration and sedimentation velocity assays indicated that ATP binding stimulates 
dimerization (Ka =1 nM) presumably by stabilizing the dimer, whilst ATP hydrolysis 
promotes dissociation (Mazur and Grossman, 1991) (Orren and Sancar, 1989) (Oh et al., 
1989) (Thiagalingam and Grossman, 1991). 
UvrA has ATPase activity with reported Km values between 30 gm and 230 gM (Seeberg 
and Steinum, 1982), (Caron and Grossman, 1988) (Oh et al., 1989) (Thiagalingam and 
Grossman, 1991) (Wang and Grossman, 1993) (Wang et al., 1994) (Myles and Sancar, 
1991). The reported kcal values were also different (17 min 1 to 125 min 1) although this 
may be due to varying buffer conditions and differences in activity of each separate UvrA 
preparation (Seeberg and Steinum, 1982) (Thomas et al., 1985) (Caron and Grossman, 
1988) (Wang and Grossman, 1993) (Oh et al., 1989). UvrA was also able to hydrolyse 
GTP (Km = 910 pM, and keat = 114 min") (Caron and Grossman, 1988). The nucleotide 
hydrolysis activity of UvrA was inhibited by the addition of excess ATPyS, ADP and 
GTPyS presumably by preventing ATP or GTP from binding (Seeberg and Steinum, 1982) 
(Caron and Grossman, 1988). 
Single amino acid mutations within the UvrA ABC ATPase motifs (UvrAKAO37 or 
UvrAKA646) indicated that the N and C-terminal ATP binding sites had different roles in 
NER (Myles et al., 1991) (Thiagalingam and Grossman, 1991). The two sites act 
cooperatively as the combined keat values for each individual site were much lower than 
the kcat of the whole protein (Thiagalingam and Grossman, 1991). A mutant in which both 
Walker A motifs had been mutated (UvrAKA037+KA646) was unable to hydrolyse ATP 
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UvrA-UvrB complex formation 
For successful NER a UvrA-UvrB complex must form. On the basis of centrifuge studies 
the UvrA-UvrB complex was thought to consist of two molecules of UvrA and one 
molecule of UvrB (Orren and Sancar, 1989). However recent AFM (atomic force 
microscopy) evidence suggests that two molecules of UvrB may be present (Verhoeven et 
al., 2002). 
For successful loading of UvrB onto DNA, ATP hydrolysis by UvrB is required. UvrB is 
unable to hydrolyse ATP by itself (Oh et al., 1989). UvrB will only hydrolyse ATP when it 
is part of a UvrA-UvrB complex (Caron and Grossman, 1988). As mentioned above UvrA 
has ATPase activity by itself. However upon complex formation with an ATPase deficient 
mutant of UvrB (UvrBK, e o45) the ATPase activity decreased indicating that UvrB has an 
inhibitory effect on the ATPase activity of UvrA (Claassen and Grossman, 1991). 
Interestingly the ATPase activity of reactions containing wild-type UvrA and wild-type 
UvrB was stimulated when the UvrA concentration was low and inhibited when the UvrA 
concentration was high (Claassen and Grossman, 1991). This is presumably due to the 
initial dimerization state of UvrA. A UvrA monomer has less ATPase activity than a 
UvrA-UvrB complex which in turn has less ATPase activity than a UvrA dimer. At low 
UvrA concentrations the majority of the UvrA molecules will be in their monomeric form 
and thus the addition of UvrB will drive the formation of UvrA-UvrB through the high 
ATPase intermediate UvrA2 resulting in the detected stimulation of ATPase activity. At 
high UvrA concentrations the majority of the UvrA molecules will be in their dimeric form 
and thus the addition of UvrB will drive the formation of the UvrA-UvrB complex that has 
lower ATPase activity than the UvrA dimer resulting in the detected inhibition of ATPase 
activity. 
The N-terminal 230 amino acids of UvrA are proposed to interact with UvrB as UvrB was 
able to stimulate the ATPase activity of UvrA1.230 (Claassen and Grossman, 1991). UvrB 
residues 115-252 and 547-673 (approximately corresponding to domains 2 and 4) 
interacted with UvrA bound to an affinity column (Hsu et al., 1995). It is not known if 
these two regions of UvrB interact with the same molecule of UvrA or if they interact with 
different molecules within the UvrA dimer. 
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DNA binding in nucleotide excision repair 
For successful NER the UvrA-UvrB complex must recognise and bind damaged DNA. 
Although in vivo damage recognition is believed to be carried out by the UvrA-UvrB 
complex UvrA can bind DNA by itself. Several regions of UvrA have been implicated in 
DNA binding and damage recognition. Mutation studies of the C-terminal zinc finger 
motif of UvrA indicated that it has a role in DNA binding, either directly or indirectly 
whilst mutations of the N-terminal zinc finger had no effect on the DNA binding 
properties of UvrA (Wang et al., 1994). The C-terminal 40 amino acids of UvrA are also 
involved in DNA binding as the loss of the residues results in a UvrA protein with a 
reduced affinity for DNA (Claassen and Grossman, 1991). UvrA with mutations within its 
helix-turn-helix motif are unable to distinguish between damaged and undamaged DNA 
(Wang and Grossman, 1993). Footprinting studies on different types of damage (e. g. a 
pyrimidine dimer or a cisplatin adduct) have indicated that UvrA protects a 37 to 38 bp 
region (Moolenaar et al., 1994) (Visse et al., 1992). 
The UvrA-UvrB complex is able to distinguish undamaged from damaged DNA 103-fold 
more efficiently than UvrA alone (DellaVecchia et al., 2004). Upon addition of UvrB to 
UvrA and DNA a 19 to 23 bp footprint is detected compared to the 37 to 38 bp UvrA 
footprint (Moolenaar et al., 1994) (Van Houten et al., 1987) (Visse et al., 1991) (Snowden 
and Van Houten, 1991). Experiments revealed that both the UvrA-UvrB and the UvrB 
footprints were of a similar size (Moolenaar et al., 1994). AFM data indicated that upon 
addition of UvrB to a mixture of UvrA and damaged DNA the contour length of the DNA 
shortened by a length equivalent to approximately 72 bp (Verhoeven et al., 2001). The 
authors predicted that the shortening was due to wrapping of the DNA around the UvrB 
molecule. Further studies indicated that only the DNA 3' of the lesion (with respect to the 
damaged strand) was involved in this wrapping (Verhoeven et al., 2001). 
When damage is located UvrA loads UvrB onto the damaged DNA. One proposed 
mechanism for damage recognition and UvrB loading is the padlock model (Theis et al., 
2000). In the padlock model UvrA is proposed to cause the movement of the ß-hairpin of 
UvrB away from domain lb (Theis et al., 2000). This UvrA-UvrB conformation can 
translocate for short distances along the undamaged strand. During this process 
consecutive nucleotides are flipped out of the DNA helix into a conserved pocket behind 
the UvrB ß-hairpin (Truglio et al., 2006). If no damage is encountered the complex 
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dissociates. However if damage is encountered UvrA dissociates (Orren et al., 1992). The 
dissociation of UvrA triggers UvrB to return to its original conformation trapping the 
undamaged strand between the ß-hairpin and domain lb (Theis et al., 2000). UvrB loading 
and damage recognition is dependent on the (3-hairpin without which the DNA could not 
become trapped (Skorvaga et al., 2004). Mutations within this hairpin (UvrBY095 or 
UvrBY096) prevent UvrB from loading onto DNA (Moolenaar et al., 2001). 
Formation of an incision complex 
The next step in NER is the formation of the incision complex that consists of UvrB, UvrC 
and the DNA. UvrC can recognise and bind the stable UvrB-DNA complex (Moolenaar et 
al., 1995) (Moolenaar et al., 2000). It has been proposed that the homologous region of 
UvrB (domain 4) and UvrC (amino acids 201 to 240) interact via salt bridges between 
UvrBE653 and UvrCR230 and also between UvrBR659 and UvrCE224 (Sohi et al., 2000) 
(Goosen and Moolenaar, 2001). Mutations within these homologous regions (UvrBFL652 
and UvrCFL223) prevented the formation of a stable incision complex (Moolenaar et al., 
1997). C-terminal truncations of UvrB in which the UvrC homology region was removed 
are also unable to interact with UvrC, indicating the requirement for domain 4 of UvrB in 
the formation of the UvrC complex (Moolenaar et al., 1995) (Moolenaar et al., 1998a). 
The incision reactions 
Once UvrC has recognised and bound the UvrB-DNA complex the incision reactions can 
take place. UvrC is directly responsible for both incision reactions (Verhoeven et al., 
2000). The first incision reaction takes place three to five phosphodiester bonds 3' from the 
lesion. The precise 3' site for incision seems to depend on the lesion involved. UvrC 
incises the DNA four phosphodiester bonds 3' of pyrimidine dimers (Sancar and Rupp, 
1983), (Yeung et al., 1983) and five phosphodiester bonds 3' of psoralen adducts (Sancar 
and Rupp, 1983). The second incision reaction takes place eight phosphodiester bonds 5' 
of the lesion on all damage substrates tested to date (Sancar and Rupp, 1983) (Yeung et al., 
1983) (Moolenaar et al., 1997). 
Different regions of UvrC are proposed to be involved in the individual incision reactions. 
The 3' incision requires the N-teminal half of the UvrC protein that contains the UvrB 
homology region (Moolenaar et al., 1997) (Verhoeven et al., 2000). The interaction 
between the homologous region of UvrB and UvrC is important for the 3' incision. This 
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was shown by mutating UvrB or UvrC within this region (UvrBFL652 and UvrCFL223)" The 
3' incision activity in experiments containing these mutants was only 50% of the wild-type 
activity. However 5' incision activity remained as wild-type on damaged DNA with 
pre-nicked 3' cleavage. These mutants are deficient in forming stable UvrB-UvrC-DNA 
complexes indicating the necessity for a stable complex for 3' but not 5' incision 
(Moolenaar et al., 1997). UvrCRA042, a mutant within the GIY-YIG region, is also deficient 
in 3' incision but is able to form a stable UvrB-UvrC-DNA complex (Verhoeven et al., 
2000). This mutant may therefore be directly involved in the incision reaction. 
For 5' incision the C-terminal domain (CTD) of UvrC is required (Lin and Sancar, 1992). 
At the C-terminal end of UvrC there are two helix-hairpin-helix motifs that are important 
for DNA binding. A C-terminal truncation of UvrC (UvrCi-554) in which these two motifs 
are absent is able to incise the DNA 3' of the lesion as normal but its 5' incision activity is 
much reduced (Moolenaar et al., 1998b). It is postulated that conformational changes 
occur within UvrC after the 3' incision has been made. These changes are stabilized by the 
interactions UvrC makes with the DNA through the two helix-hairpin-helix motifs 
(Moolenaar et al., 1998b). In the C-terminal truncation the complex does not have these 
motifs and thus becomes unstable and probably dissociates before 5' incision can occur. 
Such protein-DNA interactions were shown to be important for 5' incision as removal of 
the undamaged strand 5' of the lesion (with respect to the damaged strand) causes 50% loss 
of 5' cleavage (Moolenaar et al., 2000). Further residues within the C-terminal half of 
UvrC (UvrCD399, UvrCD438, UvrCD466, UvrCH538) have been identified through mutation 
studies as being important for the 5' incision but have no effect on the 3' incision activity 
(Lin and Sancar, 1992). 
Excision, polymerisation and ligation 
On completion of incision UvrB and UvrC remain bound to the DNA (Husain et al., 1985) 
(Omen et al., 1992). UvrB is believed to be bound to the undamaged strand whilst UvrC is 
believed to be bound to the damaged strand (Orren et al., 1992). UvrD is a helicase which 
unwinds the short section of DNA containing the damaged oligonucleotide. This process 
causes the displacement of UvrC (Caron et al., 1985) (Orren et al., 1992). UvrB is only 
removed from the DNA when the polymerisation step occurs. This step requires both DNA 
polymerase and dNTPs. In the absence of dNTPs there is no DNA synthesis and UvrB 
remains bound indicating that it is the actual process of polymerization that is important 
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for UvrB displacement (Caron et al., 1985) (Husain et al., 1985) (Orren et al., 1992). The 
polymerization process uses the 3' end of the DNA as a primer and the undamaged strand 
as a template to synthesis the correct DNA sequence. Finally DNA ligase will seal the nick 
between the 3' end of the newly synthesised section and the 5' end of the original DNA to 
generate an undamaged DNA molecule. 
Transcription-coupled repair in Escherichia coli 
The main characteristic of TCR is its increased repair rate over NER (Mellon and 
Hanawalt, 1989). TCR only takes place in transcribed regions of the genome (Mellon and 
Hanawalt, 1989). Failure to repair lesions in these areas can result in severe consequences 
including the loss of protein expression and the cell becoming unviable. It is therefore an 
advantage to the cell to repair lesions located in these transcribed regions before lesions 
located within untranscribed regions of the genome. 
In vitro TCR has been detected with the combined action of the six E. coli NER proteins 
and two additional E. coli proteins: RNAP and Mfd the TRCF (Selby and Sancar, 1993). 
Mfd 
Mfd is a 1148 amino acid, 130 kDa protein. Mfd from E. coli has recently been crystallised 
in its entirety with eight domains being identified: la, lb and 2 through 7 (Figure 1.9 and 
Figure 1.11) (Deaconescu et al., 2006). A separate paper reports the structure of the 
isolated N-terminal region (domains la, lb and 2) of Mfd also from E. coli (Assenmacher 
et al., 2006). Primary sequence analysis indicated that Mfd shares a region of homology 
with UvrB (Selby and Sancar, 1993). Structural analysis indicated that this homology 
region extends to cover domains la, lb and 2 of UvrB and Mfd (Figure 1.12) 
(Assenmacher et al., 2006) (Deaconescu et al., 2006). Primary sequence analysis also 
indicated that Mfd shares a region of homology, including the superfamily 2 helicase 
motifs, to RecG, a protein involved in processing stalled replication forks, (Selby and 
Sancar, 1993). In structural analysis of this region the two Mfd translocation domains 
(domains 5 and 6) are similar to the equivalent domains in RecG (domains TD 1 and TD2) 
(Deaconescu et al., 2006; Singleton et al., 2001). However the relative orientation of 
domain 5 towards domain 6 differs from the equivalent RecG domains (Singleton et al., 
2001) (Deaconescu et al., 2006). This difference in orientation is believed to be due to the 
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Figure 1.11 Crystal structure of Mfd. 
The crystal structure of E. coli Mfd is shown (protein data bank number, 2EYQ). The domains are coloured 
as follows: dark blue, domain la; purple, domain lb; aqua, domain 2; orange, domain 3; pink, domain 4; 
yellow, domain 5; green, domain 6; red, domain 7; and grey indicates flexible linkers. The diagram is 
adapted from (Deaconescu el al., 2006). 
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Figure 1.12 The UvrA interaction domain of UvrB and Mfd. 
(A) The region of structural homology between UvrB and Mfd is shown (domains la, lb and 2). (B) The 
UvrA interaction domain of UvrB is available for binding to UvrA but the UvrA interaction domain of Mfd 
is blocked (indicated by the black line) by domain 7. The domains are coloured as follows: dark blue, domain 
I a; purple, domain I b; aqua, domain 2; red, domain 7 in Mfd or the ß-hairpin in UvrB; and grey indicates the 
remainder of the protein. 
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nucleotide binding state of the proteins (Deaconescu et al., 2006). RecG was crystallised in 
the presence of ADP whilst Mfd was crystallised in its apo form. It is predicted that the 
binding of ATP to Mfd would alter the relative orientation of the two translocation motifs. 
Within the translocation domains is a TRG motif (Translocation in RecG) (Mahdi et al., 
2003) (Chambers et al., 2003). This motif in Mfd again differs in orientation from RecG 
but is expected to resemble RecG in the translocation active arrangement. Domain 4 of 
Mfd is the RNAP interaction domain (RID), whilst the function of domain 3 is unknown 
and is absent in some TRCF proteins (Deaconescu et al., 2006). Domain 7 may have an 
indirect role in recruitment of UvrA that will be explained below (Deaconescu et al., 
2006). 
The process of transcription-coupled repair 
Damage recognition 
The first step in TCR is the recognition of damaged DNA (Figure 1.13). In TCR only 
lesions located within transcribed regions are recognised (Bohr et al., 1985) (Mellon and 
Hanawalt, 1989) (Sweder and Hanawalt, 1992) (Terleth et al., 1989) (Selby and Sancar, 
1993). It was further shown that in order for lesions to be repaired by the TCR pathway 
they had to be located within the template strand, not the coding strand (Sweder and 
Hanawalt, 1992) (Mellon et al., 1987). Lesions within the first 15 nucleotides of the 
transcription unit were not subjected to this increased repair rate (Selby and Sancar, 
1995b). Repair of lesions in promoter regions were actually inhibited compared with 
global NER rates (Selby and Sancar, 1995b). DNA up and downstream of the lesion was 
also required for successful TCR. At least 87 bp of DNA downstream (untranscibed 
region) of the lesion (Selby and Sancar, 1995b) and at least 25 bp of DNA upstream 
(transcribed region) of the RNAP complex (Park et al., 2002) was required to detect the 
increased repair rate. 
Transcription starts with RNAP bound at a promoter in the form of an initiation complex 
(a2ßß'ß). The initiation complex generally goes through several cycles of abortive 
initiation producing short RNA transcripts up to 15 nucleotides in length (reviewed in 
(Record Jr et al., 1996)). At some stage the initiation complex enters into its elongation 
form (with the loss of the a factor). This elongation complex travels along the DNA locally 
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Mff I, Y, I lýýl 17, ff= 
Figure 1.13 Transcription-coupled repair regions. 
DNA lesions were subjected to transcription-coupled NER instead of global NER if they were present either 
at or 5' of +15 in the template strand of a gene that was currently being transcribed (Selby and Sancar, 
1995b). Lesions located elsewhere were repaired by standard NER. The red circles indicate the region in 
which lesions can be repaired by TCR. 
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unwinding the region of DNA it is transcribing enabling the template and coding strand to 
take different routes through the enzyme. For RNAP to travel along the DNA the template 
strand needs to be free of bulky lesions (Tornaletti, 2005). Damage such as pyrimidine 
dimers located in the coding strand do not effect transcription (Selby and Sancar, 1990). If 
a pyrimidine dimer is encountered in the template strand RNAP will stall (Selby and 
Sancar, 1990). A stalled elongation complex indicates that there is a problem that needs to 
be addressed before transcription can pass this point. In vitro the stalled elongation 
complex actually inhibits NER presumably because it blocks the lesion from the NER 
proteins (Selby and Sancar, 1990). For the increased rate of repair associated with lesions 
located within the template strand two things must therefore happen: RNAP must 
dissociate; and repair enzymes must be recruited. Both of these events are believed to be 
controlled by Mfd. 
Recruitment of Mfd 
Stalled elongation complexes can be recognised and bound by Mfd (Selby and Sancar, 
1995a). Truncation studies indicated that Mfd379-571 (encompassing all of domain 4 and 
some of domains 3 and 5) was able to interact with the BI domain of the ß-subunit of 
stalled RNAP complexes (Park et al., 2002). The region of RNAP that Mfd interacts with 
is close to where the upstream DNA exits (Borukhov et al., 2005) (Smith and Savery, 
2005). Residues within this region of RNAPf have been mutated and are deficient in 
RNAP displacement, the first evidence of TCR mutants that are not within a TRCF (Smith 
and Savery, 2005). 
Mfd also interacts with the DNA upstream of the RNAP complex (Park et al., 2002) 
probably through interactions with domains 5 and 6. In the absence of RNAP Mfd can 
bind DNA non-specifically on its own but requires ATP to be bound (Selby and Sancar, 
1995b). 
Displacement of RNAP 
Having recognised and bound a stalled RNAP complex Mfd must then displace it. Mfd 
displaces RNAP in an ATP-dependent manner (Selby and Sancar, 1993) (Selby and 
Sancar, 1995a). Mfd uses the energy generated by ATP hydrolysis to translocate forward, 
pushing the RNAP complex forward (Park et al., 2002). During transcription RNAP can 
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often become stalled at naturally occurring stall sites and become backtracked (Tornaletti, 
2005). The motion of Mfd will enable RNAP to continue transcribing past this point. 
However if RNAP has stalled at a lesion the force generated by Mfd will cause the 
dissociation of RNAP from the DNA probably by indirectly causing the collapse of the 
transcription bubble (Park et al., 2002) (Park and Roberts, 2006). The TRG motif is 
important for RNAP dissociation as Mfd TRG mutants are unable to displace RNAP from 
DNA (Chambers et al., 2003). Interestingly Mfd can only displace stalled elongation 
complexes (Selby and Sancar, 1995a). It has no effect on initiation complexes which 
contain a sigma factor (Selby and Sancar, 1995a). The sigma factor prevents Mfd from 
binding RNAP (Park et al., 2002). If Mfd can not bind the initiation complex it explains 
why TCR is not detected within the first 15 nucleotides of a transcription unit. It also 
explains why lesions within promoter regions are protected from repair as once RNAP is 
bound it can not be displaced from the site by Mfd. 
Recruitment of UvrA and UvrB 
The increased repair rate associated with lesions repaired by the TCR pathway over lesions 
repaired by the global NER pathway is believed to be due to an increase in the recruitment 
of the NER proteins. This implies that the recruitment of UvrA to a lesion within a 
transcription unit is faster than the rate at which UvrA would normally detect a lesion. The 
repair of the lesion will enable a different molecule of RNAP to transcribe along the DNA 
to produce the desired transcript enabling the cell to function correctly. Mfd is responsible 
for recruiting the NER proteins to the lesion. There are many questions to be answered 
about the NER recruitment process including whether UvrA is only recruited once RNAP 
has dissociated or whether it binds to either RNAP or Mfd before TCR has started. 
A weak interaction between the ß subunit of RNAP and UvrA has been observed during 
cross-linking studies on damaged and undamaged DNA (Ahn and Grossman, 1996) (Lin et 
al., 1998). If such a reaction is physiologically relevant UvrA could be brought to the 
vicinity of the lesion during the natural transcription process. However it would need to 
dissociate from RNAP when RNAP is displaced in order to bind and recognise the lesion. 
An alternative theory is that UvrA is bound to Mfd before Mfd has been recruited to a 
stalled RNAP complex. A third theory is that UvrA is recruited by Mfd at some point 
during RNAP displacement. A direct interaction between Mfd1.378 (comprising domains 
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la, lb, 2 and some of domain 3) and UvrA has been observed in pull-down assays (Selby 
and Sancar, 1995a). As mentioned previously domains la, lb and 2 of Mfd share structural 
similarity to the UvrA binding region of UvrB (Assenmacher et al., 2006) (Selby and 
Sancar, 1993) (Deaconescu et al., 2006). It is therefore likely that this region of Mfd is 
involved in UvrA binding. However in the Mfd crystal structure domain 7 is blocking the 
surface of domain 2 which is believed to be specifically responsible for the interaction 
with UvrA (Figure 1.12). Domain 7 is thought to be moved through a series of 
conformational changes. These changes are proposed to be triggered either by ATP 
binding or by the interaction Mfd makes with RNAP (Deaconescu et al., 2006). The 
repositioning of domain 7 would enable UvrA to access and bind domain 2. How UvrA is 
then loaded onto the DNA, or whether this step is actually necessary, has yet to be 
determined. The binding of UvrA to Mfd will cause an increase in the local concentration 
of UvrA in the vicinity of the lesion which may be sufficient to explain the enhanced 
repair rate. It is believed that UvrA must then go on to recruit UvrB as there is no evidence 
that UvrB is recruited by Mfd and there is some evidence to suggest that UvrB and Mfd do 
not interact (Selby and Sancar, 1993). Following the recruitment of UvrA and UvrB the 
process of NER continues as in the global NER pathway with the recruitment of UvrC, 
UvrD, DNA polymerase and DNA ligase. 
To further understand the recruitment of the NER enzymes in TCR it is important to 
increase our understanding of the UvrA-UvrB and the UvrA-Mfd interactions. Currently 
there is no evidence to suggest that UvrB and Mfd can interact with UvrA simultaneously 
and some evidence to suggest that they can not (Selby and Sancar, 1993). This had led to 
the suggestion that both proteins bind to, and compete for, the same region of UvrA. This 
hypothesis is supported by structural data in which UvrB and Mfd share a region of 
homology that has been linked to the UvrA interaction (Arsenmacher et al., 2006) 
(Deaconescu et al., 2006). However there is currently no genetic data to support this 
theory. 
Aims 
The overall aim of this work was to characterise the UvrA-UvrB and the UvrA-Mfd 
interaction by analysing the residues within UvrA that are essential for these interactions. 
To do this there were several sub-aims. The first aim was to develop a system that would 
enable the UvrA-UvrB and also the UvrA-Mfd interaction to be identified. The system 
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needed to enable a genetic screen to be used that would allow the key region of UvrA to be 
mutagenised and key amino acid residues to be identified. A second screen was also used 
that would enable the identification of a wide variety of UvrA residues that would be 
deficient in a variety of UvrA functions, including its interaction with UvrB and Mfd. 
Wild-type and mutant proteins all needed to be characterised in vitro and therefore protein 
expression and purification protocols were developed to enable the purification of a large 
number of proteins. Any mutants that were identified would be characterised both in vivo 
and in vitro to understand the role of the residues that had been mutagenised. In vitro 
analysis would include nucleotide hydrolysis, DNA binding and UvrB binding assays as 
well as an overall NER incision assay. 
As part of the in vitro characterisation analysis it was important that a suitable incision 
assay could be used to check the overall effect of the mutation on the NER process. As the 
TCR process has strict template requirements with regards to DNA flanking the lesion on 
both sides an assay was developed that would enable the introduction of a single lesion 
into a defined position within an intact plasmid. This would enable the DNA to be used in 
future TCR studies. 
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Chemicals were supplied by Sigma or BDH unless stated otherwise. 
Agars and broths 
LB broth (per litre) 10 g tryptone 
5g yeast extract 
log NaCl 
pH 7.25 to 7.50 
LB agar (per litre) 10 g tryptone 
5g yeast extract 
log NaCl 
1.6% Bacto Agar 
pH 7.25 to 7.50 
M9 broth (per litre) 6g Na2HPO4 
3g KH2PO4 
1g NH4C1 
0.5 g NaCl 
2x YT (per litre) 16 g tryptone 
10 g yeast extract 
5g NaCl 
Agar and broth supplements 
Ampicillin 100 µg/ml working concentration 
Chloramphenicol 25 µg/ml working concentration 
IPTG (Apollo Scientific Ltd. )1 mM working concentration 
Kanamycin 50 µg/ml working concentration 
Tetracycline 25 µg/ml working concentration 
X-gal (Apollo Scientific Ltd. ) 80 µg/ml working concentration 
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Solutions 
Standard buffers 
5x TBE 446 mM Tris-HC1 
445 mM Orthoboric acid 
10 mm EDTA (pH 8.0) 




5.71 % v/v Glacial acetic acid 
50 mm EDTA (pH 8.0) 
lo mm Tris-HC1(pH 8.0) 
1 mm EDTA (pH 8.0) 
6x DNA loading dye 30% v/v Glycerol 
lx TBE 
373 µM Bromophenol blue (Pharmacia Biotech) 
464 µM Xylene cyanol (Bio-Rad) 
(50 ng/µ1 RNase (Sigma) was added for alkaline lysis 
minipreped DNA) 
STEB stop buffer 0.1 M Tris-HC1 (pH 8.0) 
0.1 M EDTA (pH 8.0) 
1.17 M Sucrose 
597 µM Bromophenol blue 
Formamide stop solution 95% v/v Formamide 
20 mM EDTA 
746 µM Bromophenol blue 
928 µM Xylene cyanol 
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Protein sample buffer 115 mm Tris-HC1(pH 6.8) 
69.4 mM SDS 
20% v/v Glycerol 
746 µM Bromophenol blue 
1.24 M ß-mercaptoethanol added just before use 
Protein gel buffers 
2x resolving gel buffer 0.75 M Tris-HC1 (pH 8.3) 
10 x stacking gel buffer 1.25 M Tris-HCl (pH 6.8) 
10 x Tris glycine buffer 248 mM Tris-HC1 
2M Glycine (Severn Biotech) 
SDS PAGE running buffer 34.7 mM SDS 
1x Tris glycine buffer 
Coomassie stain 50% v/v Methanol 
10% v/v Acetic acid 
2.42 mM Coomassie brilliant blue (Bio-Rad) 
Fast destain 40% v/v Methanol 
10% v/v Acetic acid 
Slow destain 10% v/v Methanol 
10% v/v Acetic acid 
Gel composition 
Agarose gels 
1% agarose 1% w/v Agarose (Helena) 
Ix TAE 
1.27 µM Ethidium bromide 
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Acrylamide gels 
DNA and electrophoretic mobility shift assay (EMSA) gels 
6% and 7.5% acrylamide 6/7.5% v/v Acrylamide (30% w/v acrylamide 37.5: 1 Bis 
Acrylamide) (Severn Biotech Ltd. ) 
Ix TBE 
4% acrylamide 4% v/v Acrylamide (30% w/v acrylamide 37.5: 1 Bis 
Acrylamide) 
0.5 x TBE 
lo mm MgC12 
Denaturing 6% acrylamide 7M Urea (Fisher) 
Ix TBE 
6% v/v Acrylamide (40% w/v acrylamide 19: 1 Bis 
Acrylamide) (Severn Biotech Ltd. ) 
SDS PA GE gel 
10% resolving protein 1x resolving gel buffer 
10% v/v Acrylamide (30% w/v acrylamide 37.5: 1 Bis 
Acrylamide) 
3.47 mM SDS 
6% stacking protein 1x Stacking gel buffer 
6% v/v Acrylamide (30% w/v acrylamide 37.5: 1 Bis 
Acrylamide) 
3.47 mM SDS 
Acrylamide gel supplements 
Polymerization of acrylamide gels was achieved by the addition of: 
4.38 mM APS (final concentration) 
861 µM TEMED (final concentration) 
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Plasmid DNA extraction buffers 
Solution I 50 mm Glucose 
10 mm EDTA 
25 mM Tris-HCl (pH 8.0) 
Solution II 0.2 M NaOH (Riedel-detlaen) 
34.7 mM SDS 
Solution III 3M KAc (pH 4.8) 
Buffers for western blots 
Transfer buffer 10% v/v Methanol 
1x Tris glycine 
1 xPBS 170 mM NaC1 
3 mM KCI 
1 mm Na2HPO4 
1.8 mm KH2PO4 (pH 7.4) 
PBS tween 0.05% v/v Tween 
lx PBS 
Blocking buffer 10% w/v Milk powder (Somerfield) 
Ix PBS 
Buffers for the purification of histidine-tagged proteins 
Wash buffer 50 mM NaH2PO4 
300 mM NaCl 
20 mM Imidazole 
pH to 8.0 using NaOH 
Elution buffer 50 mm NaH2PO4 
300 mM NaCl 
500 mm Imidazole 
pH to 8.0 using NaOH 
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Dialysis buffer 20 mM Tris-HC1 (pH 8.0) 
2 mM EDTA 
400 mM KCl 
4 mM DTT (Melford) added just before use 
Storage buffer 10 mm Tris-HC1 (pH 8.0) 
1 mm EDTA 
200 mM KC1 
50% v/v Glycerol 
2 mM DTT added just before use 
Reaction buffers 
1x repair buffer 40 mM Hepes (Apollo scientific) (pH 7.8) 
(Selby and Sancar, 1995b) 100 mM KCl 
8 mM MgC12 
4% v/v Glycerol 
100 µg/ml BSA (NEB) 
5 mM DTT 
1x transcription buffer 40 mM Tris-Ac (pH 7.9) 
(Savery et al., 1998) 100 mm KCI 
10 mm MgC12 
5 mM DTT 
Z buffer 10 mm KC1 
(Miller, 1972) 1 mm MgSO4 
60 mM Na2HPO4 
30 mM NaH2P04 
104 pM SDS 
38.6 mM ß-mercaptoethanol added just before use 
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Methods 
Centrifugation 
The six centrifuges used in this work are listed in Table 2.1. 
Gel electrophoresis 
Agarose gels 
Agarose gels were run at 100 V for one to two hours in 1x TAE buffer containing 0.5 
µg/ml ethidium bromide. DNA bands were visualised using a UV transilluminator (UVP). 
Non-denaturing acrylamide gels for analysis of DNA 
The 7.5% acrylamide gel solution and the acrylamide gel supplements were mixed and 
poured between gel plates 1.5 mm apart (part of the Bio-Rad mini protean 3 system). The 
gels were run at 100 V for approximately one hour in 1x TBE. Gels were stained in 1.27 
µM ethidium bromide for 30 minutes (unless SYBR Green had been added to the DNA 
samples). The DNA bands were visualised using a UV transillumintor and the amount of 
DNA quantified using Kodak imaging software. 
EMSA gels 
The 6% acrylamide gel solution or the 4% acrylamide gel solution (containing 10 mM 
MgC12) were mixed with the acrylamide gel supplements and poured between gel plates 
1.0 mm apart (part of the Bio-Rad protean II xi system). The gels were pre-run (in buffer 
containing the same concentration of TBE and MgC12 as the gel) at 40 mA (max 200 V) at 
4°C for 30 minutes before being loaded and run under the same conditions for three hours. 
The gels were dried and placed on phosphor screens overnight. 32P labelled DNA was 
detected using a Typhoon phosphoimager (Amersham) and visualised using ImageQuant 
software. 
Denaturing acrylamide gels 
10 ml urea sequencing gel solution and the acrylamide gel supplements were mixed and 
syringed between gel plates 0.4 mm apart (part of the BRL S2 system) to form a seal at the 
bottom. Once the seal had set the remaining space was filled by the addition of 50 ml urea 
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Centrifuge Rotor Max. Use 
speed 
Eppendorf Standard 16110 Bench top work at room temperature 
5415D 
Eppendorf Standard 16110 Bench top work at 4 °C 
5415DR 
Eppendorf A-4-44 4500 Used for centrifugation of samples between 3 
5804 and 100 ml (100 ml in two 50 ml aliquots) 
Sorvall RC6 SS34 50228 High s eed centrifugation 
Sorvall RC3B H-6000A 7200 Centrifugation of cultures greater than 100 ml 
Sorvall 65V13 602644 High speed CsCI maxiprep centrifugation step 
UltraPro 80 
Table 2.1 Centrifuges. 
The centrifuges and rotors used in this thesis are listed against their main use. 
51 
Chapter 2- Materials and Methods 
sequencing gel solution mixed with the acrylamide gel supplements. The gel was pre run 
until it reached 55°C (approximately one hour) (2000 V, 200 mA, 200 W max. ) in 1x TBE 
buffer. Gels were immediately loaded and run at 55°C under the same conditions. Gels 
were fixed in slow destain for two times two minutes and then dried and placed on 
phosphor screens overnight. 32P containing bands were detected using the Typhoon 
phosphoimager and visualised using ImageQuant software. 
SDS PAGE gels 
The 10% resolving gel solution and the acrylamide gel supplements were mixed and 
poured to a depth of 5 cm between gel plates 0.75 mm apart (part of the Bio-Rad mini 
protean 3 system). Isopropanol was gently placed over the top to create a smooth surface. 
Once the resolving gel was set the isopropanol was washed away with water and replaced 
by the 6% stacking gel solution containing the acrylamide gel supplements. Gels were run 
in SDS PAGE running buffer at 200 V for approximately one hour. Protein bands were 
visualised by staining the gel in coomassie stain for one hour and then destaining in fast 
destain for 30 minutes and slow destain overnight. Alternatively bands were visualised 
using the bio-safe coomassie stain (Bio-Rad) following the manufactures protocol. 
Microbiological techniques 
Bacterial strains 
E. coli strains used in this thesis are listed in Table 2.2. Either XL1-Blue, TOP10 or 
RLG221 were used for standard cloning procedures. KS1 and MG1655AuvrA were used to 
screen for mutants in the bacterial two-hybrid and UV sensitivity screens respectively. 
Conjugation -generation ofEscherichia coli strain MG1655duvrA 
Conjugation was used to transfer the F episome (encoding laclq) from XL1-Blue cells into 
FB21635, the AuvrA strain (essentially as described in (Miller, 1972)). Overnight cultures 
of XL1-Blue and FB21635 cells were diluted 100-fold in LB broth containing tetracycline 
or kanamycin respectively. The cultures were incubated at 37°C for three hours. I ml of 
each culture was combined (or kept separate as controls) and incubated at 37°C for one 
hour without shaking. A sample of cells were then plated onto LB agar plates containing 
IPTG, X-gal and either tetracycline, kanamycin or both. Colonies that appeared blue on 
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Strain Derivative Genotype Antibiotic Source 
of resistance1 




KS I MC 1000 placOR2-62 [F' lac14] Kan (Dove et al., 
1997) 
MC 1000 araD139([]), DE(araA- (Casadaban and 
leu)7697, DE(codB-lacI) 3, Cohen, 1980) 
ga1K16, gaiE15(Ga1S), LAM-, 
e14-, relAl, rpsL150(strR), 
oT1, mcrBI 
MG1655 F-, lambda-, ilvG-, rfb-50, rph-1 (Blattner et al., 
1997) 
MG1655 FB21635 F' proAB, lac19ZAM15, Tn10, Kan, Tet This Work 
AuvrA Tet 
RLG221 recA56, araD139, (ara- (Barnard et al., 
leu)7697, lacX74, galU, ga1K, 2003) 
hsdR, strA 
TOP 10 F- mcrA, A(mrr-hsdRMS- Invitrogen 
mcrBC), D801acZAM15, 
AlacX74, recA 1, araD139, 
A(ara-leu7697, galU, gaiK, ) 
, endA 1, nupG rpsL, St XL1-Blue endA1, gyrA96, hsdR17, lac, Tet Stratagene 
recA1, relAl, supE44, thi-1, [F' 
proAB, Iac]'ZAM15, Tn10, 
Tet 
Table 2.2 Escherichia coli strains. 
The E coil strains used in this thesis are listed with their genotype. The antibiotic that can be used for their 
selection and the source of the strain are also listed. ' The abbreviations used are: Kan, kanamycin; Tet, 
tetracycline. 
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LB agar plates containing IPTG, X-gal, tetracycline and kanamycin were streaked, 
incubated overnight and single colonies used to inoculate LB broth containing the above 
antibiotics. The cultures were incubated at 37°C for eight hours and then mixed with equal 
quantities of 50% glycerol, frozen in liquid nitrogen and stored at -80°C. The strain was 
named MG1655AuvrA. 
Competent cell preparation 
Chemically competent Escherichia coli 
Chemically competent cells were prepared essentially as described by Sambrook and 
Russell (Sambrook and Russell, 2001). LB broth (50 ml) containing the appropriate 
antibiotics were inoculated with 0.5 ml of an overnight culture. The cultures were 
incubated at 37°C to an A600 of 0.5 and then placed on ice for 10 minutes. The cells were 
centrifuged at 2770 g at 4°C for 10 minutes, the pellet suspended in 20 ml ice cold 0.1 M 
CaC12 (Fisher) and incubated on ice for a further 20 minutes. The cells were centrifuged at 
2770 g at 4°C for 10 minutes and the pellet suspended in 5 ml ice cold 0.1 M CaC12 and 
20% glycerol. The cells were incubated on ice for at least 30 minutes before use and were 
stored at -80°C if not used that day. 
Electrocompetent Escherichia coli 
Electrocompetent cells were prepared essentially as described by Sambrook and Russell 
(Sambrook and Russell, 2001). LB broth (50 ml) containing the appropriate antibiotics 
were inoculated with 0.5 ml of an overnight culture. The cultures were incubated at 37°C 
to an A600 of 0.5 and then placed on ice for 20 minutes. The cells were subjected to four 
cycles of centrifugation, suspension and incubation. Centrifugation was at 2770g at 4°C 
for 10 minutes. Suspension was in 50 ml (cycle 1), 25 ml (cycle 2), 2 ml (cycle 3) or 0.2 
ml (cycle 4) of ice cold 10% glycerol and the incubations were on ice for 10 minutes. The 
cells were incubated on ice for at least a further 30 minutes and used that day. 
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Transformations 
Transformation of chemically competent Escherichia coli 
Chemically competent E. coli were transformed essentially as described by Sambrook and 
Russell (Sambrook and Russell, 2001). Chilled chemically competent E. coli cells (100 µl) 
were transformed with 10 ng plasmid DNA or 10 µl ligation mix by premixing and 
incubating on ice for 30 minutes, incubating at 42°C for two minutes, incubating on ice for 
two minutes, adding 400 µl LB broth and incubating at 37°C for 30 minutes. 
Transformation mixtures were then centrifuged at 16110 g for one minute, 450 µl of 
supernatant discarded and the cells suspended in the remaining LB broth. The cells were 
spread onto agar plates containing the appropriate antibiotics and supplements and 
incubated overnight at 30°C or 37°C. 
Transformation of electrocompetent Escherichia coli 
Electrocompetent E. coli were transformed essentially as described by Sambrook and 
Russell (Sambrook and Russell, 2001). Chilled electrocompetent E. coli cells (40 µl) were 
transformed with 1 ng plasmid DNA or 2 RI ligation mix by mixing and placing in a 0.1 
cm MicroPulser cuvette (Bio-Rad), electroporating at 1.8 kV for four to six ms (using the 
bacterial setting on a micropulser electroporator (Bio-Rad)), adding 1 ml 2x YT and 
incubating at 37 °C for 30 minutes. Transformation mixtures were then centrifuged at 
16110 g for one minute and the pellet suspended in 50 µl M9 media. The cells were spread 
onto agar plates containing the appropriate antibiotics and supplements and incubated 
overnight at 30°C or 37°C. 
DNA manipulation 
DNA purification 
DNA purification from agarose gels and enzymatic reactions 
DNA was extracted from agarose gels using either the QIAquick gel extraction kit 
(Qiagen) or the GeneCleanlll kit (Q-Biogene). DNA was extracted from enzymatic 
reactions such as PCR and digests using the QlAquick PCR purification kit (Qiagen), the 
QlAquick nucleotide removal kit (Qiagen) or the GeneCleanlll kit. The manufacturers 
protocol was followed for these kits. 
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DNA purification by phenol chloroform extraction and ethanol precipitation 
The DNA solution to be extracted was made up to at least 200 µl by the addition of TE 
buffer. An equal volume of phenol: chloroform: isoamyl alcohol (25: 24: 1) was added and 
the solution vortexed for 15 seconds and centrifuged at 16110 g for five minutes. The 
upper layer was kept and 20 µg of glycogen (Fermentus Life Sciences), 0.1 volume of 3M 
NaAc (pH 5.2) and 2 volumes of ethanol added before placing at -20°C for at least 30 
minutes. The solution was centrifuged at 16110 g for 15 minutes, the pellet washed in 1 ml 
70% ethanol and air-dried before suspending in 5 to 50 µl TE buffer. 
Plasmid DNA extraction from culture 
Plasmid DNA was extracted from up to 5 ml of bacterial culture using the QlAprep spin 
miniprep kit (Qiagen) or by alkaline lysis (see below). Plasmid DNA was extracted from 
large cultures by the HiSpeed plasmid midi kit (Qiagen), the plasmid midi kit (Qiagen) or 
by CsCI maxiprep (see below). 
Alkaline lysis minipreps 
Plasmid DNA was extracted by the alkaline lysis technique essentially as described by 
Sambrook and Russell (Sambrook and Russell, 2001). 3 ml of overnight cultures were 
centrifuged at 16110 g for one minute. The pellet was suspended in 100 µl solution I and 
incubated at room temperature for five minutes. 200 µl of solution II was added and the 
tube gently inverted five times before incubating on ice for five minutes. 150 . tl solution 
III was added and the tube gently inverted five times before incubating on ice for five 
minutes. The solution was centrifuged at 16110 g for five minutes and the supernatant 
transferred to a fresh tube. 300 pl phenol: chloroform: isoamyl alcohol (25: 24: 1) was 
added, the solution vortexed for 15 seconds and centrifuged at 16110 g for two minutes. 
The upper 300 µl was kept, 600 pl ice cold ethanol (Fisher) added and the solution 
centrifuged at 16110 g for five minutes. The pellet was washed with 1 ml of 70% ethanol, 
air-dried and suspended in 50 gl TE buffer. 
CsCI Maxipreps 
Plasmid DNA was extracted by the CsCI technique essentially as described by Sambrook 
and Russell (Sambrook and Russell, 2001). 400 ml of LB broth containing the appropriate 
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antibiotics was inoculated with 4 ml of overnight culture and incubated at 37°C until an 
A600 of 1.2 was reached. Chloramphenicol was added to a final concentration of 170 pg/ml 
and the culture incubated at 37°C overnight. The culture was centrifuged at 4657 g at 4°C 
for 15 minutes, the pellet suspended in 5 ml solution I containing 5 mg lysozyme and 
incubated on ice for five minutes. 10 ml of solution II was added and the tube gently 
inverted five times before incubating on ice for five minutes. 7.5 ml of Solution III was 
added and the tube gently inverted five times before incubating on ice for 5 minutes. The 
solution was centrifuged at 26892 g at 4°C for 15 minutes, the supernatant added to 13 ml 
isopropanol and the tube inverted five times before incubating on ice for 15 minutes. The 
solution was centrifuged at 26892 g at 20°C for 15 minutes, the pellet washed with 5 ml 
70% ethanol, air-dried and suspended in 8 ml TE buffer. 8.2 g of CsCI (Melford) was 
added and the tube was incubated at 30°C until the CsC1 dissolved. 200 µl 10 mg/ml 
ethidium bromide was added and the solution centrifuged at 7649 g at 20°C for 10 
minutes. The supernatant was transferred to a 13.5 ml ultracentrifuge tube and the 
remainder of the tube filled up with paraffin. The solution was centrifuged at 192037 g at 
15°C for 16 hours. To prevent the introduction of DNA damage the DNA bands were 
visualised using a dark reader (Clare Chemicals). The lower band (containing the 
supercoiled DNA) was transferred to a fresh tube. The ethidium bromide was removed by 
six extractions with equal volumes of water saturated butanol. The DNA was dialysed 
twice in 12-14 kDa MWCO dialysis tubing (Visking) in 500 ml TE buffer at 4°C. The 
DNA was then extracted and purified by phenol chloroform extraction and ethanol 
precipitation following the standard protocol except that centrifugal speeds were 2988 g 
and 26892 g respectively and the DNA was dissolved in 1 ml TE buffer. (Sambrook and 
Russell, 2001). 
PCR 
Standard PCR using Pfu DNA polymerase 
PCR (50 µl) contained 10 ng DNA (or all the DNA generated by error-prone PCR (see 
below)), 200 µM dNTPs (Roche), 1 µM forward primer, 1 µM reverse primer and 1.25 U 
Pfu DNA polymerase (Promega) in the supplied buffer. The reactions were placed at 95°C 
for two minutes followed by 30 cycles of. 95°C for 30 seconds, 60°C for 30 seconds and 
72°C for two minutes (unless otherwise indicated in the plasmid section of this chapter). 
The reactions were completed by a 10 minute incubation at 72°C. 
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Standard PCR using Phu DNA polymerase 
PCR (50 µl) contained 10 ng DNA, 200 µM dNTPs, 0.5 µM forward primer, 0.5 µM 
reverse primer and 1U Phu DNA polymerase (Finnzymes) in the supplied Phusion HF 
buffer. The reactions were placed at 98°C for two minutes followed by 35 cycles of. 98°C 
for 10 seconds, 63.9°C for 30 seconds and 72°C for a specified time (indicated in the 
plasmid section of this chapter). The reaction was completed by a 10 minute incubation at 
72°C. This method was only used in generating pQE30UvrBRE183 and pQE30UvrB1 13- 
Error prone PCR 
The error-prone PCR protocol described by Greene was essentially followed (Greene, 
2002). Error-prone PCR (50 µl) contained 25 ng template DNA, 1 mM dCTP (Roche), 1 
mM dTTP (Roche), 0.2 mM dÄTP (Roche), 0.2 mM dGTP (Roche), 2 µM forward primer, 
2 µM reverse primer, 10 mM Tris-HCI (pH 8.3), 50 mM KCI, 7 MM M902,0.5 MM 
MnCI2 and 2.5 U Taq DNA polymerase (Promega). The reactions were placed at 94°C for 
five minutes followed by one to five cycles of 94°C for 30 seconds, 60°C for 30 seconds 
and 72°C for two minutes. The DNA was purified by phenol chloroform extraction and 
ethanol precipitation and amplified further following the standard PCR protocol. 
Site-directed mutagenesis 
Site-directed mutagenesis was carried out as shown in Figure 2.1 using the standard PCR 
protocol for each individual PCR (Sambrook and Russell, 2001). PCR-A and PCR-B each 
contain one mutagenic primer and one outer primer (that can contain a restriction site to 
aid cloning of the final product). PCR-C was subsequently set up using both outer primers 
and equal amounts (normally 5 µl) of the initial PCR products. 
Annealing oligonucleotides 
An annealing reaction was used to generate a short DNA insert that contained restriction 
sites for cloning (see pBRcI oXK). The annealing reaction (40 µl) contained 50 µM PLOT 
and 50 pM PL02. It was incubated at 100°C for two minutes and cooled to room 
temperature overnight. 
Annealing reactions were also used to generate short fragments for EMSA. These 
annealing reactions (90 µl) contained 50 µM RA0003-ann and 10 µM of either [y32P] 
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Figure 2.1 Site-directed mutagenesis. 
Site-directed mutagenesis that generates a single point mutation requires two initial PCRs to generate 
products PCR-A and PCR-B. These products and the outer primers (1 and 4) are used in a final PCR to 
generate the full-length mutant that can be cloned into the desired vector using the restriction sites (RS) 
generated by primers 1 and 4. 
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RA0004-F1dT or [, Y32P] RA0005-con. They were incubated at 37°C for five minutes and 
then cooled to 4°C at a rate of 0.1°C every second. 
DNA digestion, dephosphorylation and generation of blunt ends 
Analytical digests (10 µl) were incubated at 37°C for one hour and contained 100 to 200 
ng DNA and 10 U restriction enzyme (each) in the supplied buffer. Preparative digests (50 
µl) were incubated at 37°C for three hours and contained 1 to 2 µg DNA and 10 to 25 U 
restriction enzyme (each) in the supplied buffer. 
Following preparative digests (50 µl reaction volumes) the DNA could be blunt ended 
and/or dephosphorylated. To generate blunt ends from 5' overhangs 4 µ1 of 0.25 mM 
dNTPs and 0.5 µl 2 U/µl Klenow fragment (Roche) were added and the reaction incubated 
at 37°C for 30 minutes and then 70°C for 15 minutes. DNA was dephosphorylated at 37°C 
by the addition of 1 µl of 1 U/µl calf intestinal alkaline phosphatase (CIAP) (Promega) at 
the start of two consecutive 30 minute periods. 
Phosphorylation of DNA ([y32P] labelling) 
Phosphorylation reactions (20 to 50 µl) were incubated at 37°C for 30 minutes then 70°C 
for 20 minutes and contained 3 to 100 nM DNA (1 pM for a primer), 20 pCi [y 32P] ATP 
(Amersham) or 1 mM ATP (Roche) and 10 to 20 U polynucleotide kinase (Roche) in the 
supplied buffer. Reactions that contained [y32P] ATP were passed through a micro 
Bio-Spin 6 column (Bio-Rad) following the manufactures protocol to remove unbound 
nucleotides whilst standard reactions were purified by phenol chloroform extraction and 
ethanol precipitation. 
Ligations 
Ligations (20 µl) were incubated on thawing ice overnight and contained approximately 1 
µl vector, approximately 3 µl insert and 1U T4 DNA ligase (Fermentus Life Sciences) in 
the supplied buffer. 
Plasmids 
The plasmids used and generated in this thesis are listed in Table 2.3. Selected plasmid 
maps are shown in Figure 2.2. All plasmids constructed were sequenced either by MWG 
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Plasmid' (size (bp) and Description Source 
antibiotic resistance) 
pACYC184 Standard cloning vector containing the cat NEB 
(4245, chl and tet) gene. 
pBRcIo) Contains the ? cl gene upstream of rpoZ. (Dove and 
(4803, amp) Hochschild, 
1998) 
pBRcIooXK Derivative of pBRclo). Contains the A. cI This work 
(4554, amp) gene upstream of an Xbal and KpnI site. 
pBSII Standard cloning vector containing a Stratagene 
(pBluescript(RIIKS-) multiple cloning site (MCS). 
(2961, amp) 
pBSIIUvrA Derivative of pBSII. The uvrA gene Dr. N. Savery 
(5758, amp) amplified from MG1655 cells was cloned in 
on a BamHI/HindIII fragment. 
pBSIIUvrAAKpnI Derivative of pBSIIUvrA. The KpnI site This work 
(5758, amp) within the uvrA gene has been silently 
mutated. 
pBSIIUvrB Derivative of pBSII. The uvrB gene Dr. N. Savery 
(4957, amp) amplified from MG1655 cells was cloned in 
on a BamHI/HindIII fragment. 
pBSIIUvrC23-61o Derivative of pBSII. The DNA sequence Dr. N. Savery 
(4703, amp) coding for UvrC23öio amplified from 
MG1655 cells was cloned in on a 
BamHI/HindIII fragment. 
pBSIIUvrC Derivative of pBSIIUvrC23-6io" The 5' This work 
(4769, amp) region of the uvrC gene amplified from 
MG1655 cells was cloned in on a 
BamHI/SphI fragment to generate the 
full-length uvrC gene. 
pETMfd Contains the mfd gene downstream of its (Chambers et 
(9686, amp) promoter. al., 2003) 
pKD46 Plasmid used to generate the AuvrA genotype E. coli genome 
(amp) of FB21635 cells. project, 
University of 
Wisconsin 
pQE30 Standard expression vector containing a Qiagen 
(3461, amp) MCS downstream of a sequence that encodes 
a hexa-histidine tag enabling histidine-tagged 
proteins to be expressed. 
pQE30UvrA Derivative of pQE30. The uvrA gene has This work 
(and derivatives) been cloned into the MCS on a 
(6246, amp) BamHI/HindlI fragment enabling 
histidine-tagged UvrA to be expressed. 
pQE30UvrB Derivative of pQE30. The uvrB gene has This work 
(and derivatives) been cloned into the MCS on a 
(5445, amp) BamHI/HindIIl fragment enabling 
histidine-tagged UvrB to be expressed. 
61 
Chapter 2- Materials and Methods 
Plasmid (size (bp) and Description Source 
antibiotic resistance) 
pQE30UvrC Derivative of pQE30. The uvrC gene has This work 
(5257, amp) been cloned into the MCS on a 
BamHUHindIII fragment enabling 
histidine-tagged UvrC to be expressed. 
pRA02 Derivative of pSRIacUV5203" The lacUV52o3 This work 
(3601, amp) fragment was replaced with the promoter and 
5' region of rpoA. At the 3' end of the 
rpoA gene there are XbaI and KpnI sites that 
enable genes to be cloned in enabling al-gas 
fusion proteins to be expressed. 
pRA02UvrA1-252. mutations Derivative of pRA02UvrA1-252 containing the This work 
(4357, amp) coding sequence for the indicated UvrAi-252 
mutation. 
pRA02UvrAl. n Derivative of pRA02 containing the coding This work 
(Various2, amp) sequence for the indicated UvrA truncation 
in frame with the rpoA gene enabling 
al-248-UvrA1. n fusion protein to be expressed. 
pRA03 Derivative of pACYC184. The A. cI gene This work 
(4371, chl) upstream of Xbal and KpnI sites has been 
inserted as an EcoRI/SalI fragment. This 
allows XcI fusion proteins to be expressed 
from a chloramphenicol resistant plasmid. 
pRA03UvrB35-252 Derivative of pRA03 containing the coding This work 
(5022, chl) sequence for UvrB35.252 cloned in frame with 
A. c7 enabling AcI-UvrB35-252 fusion protein to 
be expressed. 
pRA03UvrB35-252. mutations Derivative of pRA03UvrB35-252 containing This work 
(5022, chl) the coding sequence of the indicated UvrB 
mutation. 
pRA03Mfd1-219 Derivative of pRA03 containing the coding This work 
(5025, chl) sequence of Mfd1-219 cloned in frame with A. 
cI enabling acI-Mfd1-219 fusion protein to be 
expressed. 
pREIIa Contains the rpoA gene downstream of a (Blatter et al., 
(amp) lacUVS promoter. 1994) 
pREIIaAXbaI Derivative of pREIIa in which the XbaI site This work 
(amp) between the promoter and the rpoA gene is 
destroyed. 
pSRIacUV52o3 Contains the lacUV52o3 promoter upstream pSR/lacUVS(-1 
(2646, amp) of a terminator sequence. 40/63) 
(Savery et al., 
2002 
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Plasmid' (size (bp) and Description Source 
antibiotic resistance) 
pSRT7A1 Derivative of pSRIacUV52o3. The Dr. N. Savery 
(2568, amp) EcoRUHindIII lacUV5203 promoter 
containing fragment was replaced with the 
T7A1 (-91 to +28) promoter fragment. The 
fragment contains (starting at position +26) a 
BseCI recognition sequence overlapping a 
Dam recognition sequence that will enable a 
single modification to be introduced. 
pUT18 Vector for use in the adenylate cyclase (Karimova et 
(3023, amp) bacterial two-hybrid screen. Contains a MCS al., 2001) 
upstream of the sequence coding for the T18 
domain of adenylate cyclase enabling fusion 
proteins to be expressed. 
pUT18Mfd1.219 Derivative of pUT18 containing the coding This work 
(3674, amp) sequence for Mfd1.219 on a XbaUKpnI 
fragment 
pUT18UvrAl. n Derivative of pUT18 containing the coding This work 
(Various2, amp) sequence for the indicated region of UvrA on 
a XbaUK nI fragment. 
pUT 18UvrB35-252 Derivative of pUT 18 containing the coding This work 
(3671, amp) sequence for UvrB35.252 on a XbaI/KpnI 
fragment. 
Table 2.3 Plasmids. 
The plasmids used and generated in this thesis are listed. 'Numbers in subscript in this column refer to amino 
acid residues (except for pSRIacUV52o3). 2'The size of these plasmids depends on the size of the uvrA 
truncation inserted. 
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Figure 2.2 Plasmid Maps. 
Plasmid maps are shown for pRA02, pRA03, pQE30 (Qiagen) and pSR1acUV5203. These plasmids and 
derivatives of these plasmids are described in the text and Table 2.3. The pSRT7A1 plasmid map can be 
derived from the pSR1acUV5203 plasmid map by exchanging the lacUV5203 promoter with the T7A1 
promoter. 
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or by the sequencing service at Dundee University to ensure undesired mutations were not 
present. 
Primers 
All primers used in this thesis were supplied by MWG and are listed in Table 2.4. 
pBSIIUvrAd KpnI 
The KpnI site at nucleotide position 694 of uvrA was altered (without effecting the amino 
acid sequence) by site-directed mutagenesis to generate uvrAAKpnI using the template and 
primers indicated in Table 2.5, an annealing temperature of 63°C and an elongation time of 
two minutes for PCR-A and PCR-B and two minutes 30 seconds for PCR-C (Figure 2.1). 
pBSIIUvrA and the uvrAAKpnI PCR product (purified by QlAquick gel extraction kit) 
were digested with BamHI, purified using the GeneCleanlll kit, and then digested with 
Styl. The 851 bp insert from uvrAAKpnI and the 4907 bp backbone from pBSIIUvrA were 
purified from a 1% agarose gel using the QlAquick gel extraction kit and then ligated to 
generate pBSIIUvrAAKpnI. 
pBSIIUvrC 
The uvrC sequence encoding the N-terminal 144 amino acids was amplified from MG1655 
E. coli genomic DNA using primers UvrCO5 and UvrC06, and an elongation time of five 
minutes 50 seconds. To generate the correct protein sequence the UvrC start codon (GTG) 
encoding formylmethionine was substituted with the methionine encoding codon (ATG). 
This would be important when introducing the uvrC gene into an expression vector 
downstream of and in-frame with a sequence encoding a histidine tag. pBSIIUvrC23.61o and 
the PCR product (purified using the QlAquick PCR purification kit) were digested with 
BamHI and SphI. The 371 bp insert from the PCR and 4398 bp backbone from 
pBSIIUvrC23-61o were purified from a 1% agarose gel using the GeneCleanIll kit and then 
ligated to form pBSIIUvrC. 
pQE3OUvrA, pQE3OUvrB andpQE3OUvrC 
pQE30, pBSIIUvrA, pBSIIUvrB, and pBSIIUvrC, were digested with BamHI and HindIII. 
At the same time pBSIIUvrA was also digested with Dral (that cleaved the pBSII 
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Primer Sequence Use 
Bluescri tl TGA CCA TGA TTA CGC CAA GC oSDM 
Bluescript2 GCG CGT AAT ACG ACT CAC TA EP, oSDM 
D5431 ACC TGA CGT CTA AGA AAC C PE 
MfdOOlF GCC GCT CTA GAC ATG CCT GAA CAA TAT sPCR 
CGT 
Mfd2l9R TTA TCG GTA CCT CGG TCG GAA ATT CGT sPCR 
GCG 
PLO1 GGC CGC TCT AGA GTC CCG GGT ACC GTA Annealing for 
AG plasmid 
construction 
PL02 TCG ACT TAC GGT ACC CGG GAC TCT AGA GC Annealing for 
plasmid 
construction 
Prom2 TAG GCG TAT CAC GAG GCC CTT TGG sPCR 
pSR1acUV5_ GAT CCC CGA CGA CGA CAT GG PE, SL 
BamHI 
RA0003-ann CTC ATA CGA CGC TGT CGA TCC AGT CAC Annealing for 
TGT CAT GCG CTA TCC GAT CCT AG EMSA 
RA0004-F1dT CTA GGA TCG GAT AGC GCA TGA CAG TGA Annealing for 
CTG GAT CGA CAG CGT CGT ATG AG EMSA 
RA0005-con CTA GGA TCG GAT AGC GCA TGA CAG TGA Annealing for 
CTG GAT CGA CAG CGT CGT ATG AG EMSA 
rpoA248R CTA GGG TAC CTA GTC TAG AGC CTC TGG sPCR 
TTT CTC TTC TTT CAC 
UvrAOO1F GCC GCT CTA GAT ATG GAT AAG ATC GAA sPCR 
GTT 
UvrAOI CGG GAT CCA TGG ATA AGA TCG AAG TTC oSDM, sPCR 
GGG GC 
UvrA06 TTA TCG GTA CCC AAC CAC CGG AAA GCT sPCR, 
CCA G 
UvrA07 TTA TCG GTA CCC AGG CGA AGT TGG CGG EP, oSDM, 
AGA A sPCR 
UvrA08 TTA TCG GTA CCC AGC AGG TCG GGC AGG EP, sPCR 
CCC C 
UvrA09 TTA TCG GTA CCC AAC CGT ACA ACA CCA oSDM, sPCR 
CTT T 
UvrAl O TTA TCG GTA CCC AAA ACT TGG CTA ATT sPCR, 
CTT C 
UvrAl 1 TTA TCG GTA CCC ACG CAC CAA TCT GGC sPCR, 
TCG C 
UvrA12 TTA TCG GTA CCC ACT CCA GCC CCT GAA sPCR, 
TAT C 
UvrAl3 TTA TCG GTA CCC ACA GCA TCG GCT TAA sPCR, 
GGA A 
UvrA14 GGA GCT TTC CGG TGG TAC GGC GGT AGT SDM-UvrAAKp 
GGC GG nI 
UvrA15 CCG CCA CTA CCG CCG TAC CAC CGG AAA SDM-UvrAAKp 
GCT CC nI 
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Primer Sequence Use 
UvrA17 GCC GCT CTA GAT ATG GAT AAG ATC GAA EP, oSDM 
GTT C 
UvrA18 GCT GTC GCA GCC GGT TGG CAA GCG TCT SDM-UvrAEV144 
GAT G 
UvrA19 CAT CAG ACG CTT GCC AAC CGG CTG CGA SDM-UvrAEV144 
CAG C 
UvrA20 GTC TGA TGC TAC ATG CGC CAA TCA TTA SDM-UvrALHi5i 
AAG 
UvrA21 CTT TAA TGA TTG GCG CAT GTA GCA TCA SDM-UvrAuj151 
GAC 
UvrA22 CCG CCA CTA CCG CGG TAC CAC CGG AAA sPCR 
GCT CC 
UvrA23 CCC GCG ACA AGC TAT TTG TCG TGA CCG SDM-UvrAIFo27 
GGC 
UvrA24 GCC CGG TCA CGA CAA ATA GCT TGT CGC SDM-UvrAFo27 
GGG 
UvrA25 CCT GGC AAG CCA GGA TTA CAT CCG TGC SDM-UvrAGD173 
TCG 
UvrA26 CGA GCA CGG ATG TAA TCC TGG CTT GCC SDM-UvrAGD173 
AGG 
UvrA27 GGC AAG CCA GGG CTG TAT CCG TGC TCG SDM-UvrAyci74 
TAT TG 
UvrA28 CAA TAC GAG CAC GGA TAC AGC CCT GGC SDM-UvrAyC174 
TTG CC 
UvrA29 GAA ACA TAC CAT TGT CGT GGT GGT TGA SDM-UvrAEV2o1 
TCG 
UvrA30 CGA TCA ACC ACC ACG ACA ATG GTA TGT SDM-UvrAEV2o1 
TTC 
UvrB035F GCC GCT CTA GAA CAG ACG TTA CTT GGC oSDM, sPCR 
GTG 
UvrB08 GAC ATT GCA CTT GCC GTG GAA CTG TTT SDM-UvrBRa213 
GAC 
UvrB09 GTC AAA CAG TTC CAC GGC AAG TGC AAT SDM-UvrBRa213 
GTC 
UvrB10 GAGCTGCAATACGCTGAGAATGATCAAGCATT SDM-UvrBRE183 
C 
UvrB 11 GAATGCTTGATCATTCTCAGCGTATTGCAGCT SDM-UvrBRE183 
C 
UvrB252R TTA TCG GTA CCC GCG GTG TGA CGT AGT GC oSDM, sPCR 
UvrCO5 AGT AGC GCC AGT GTT TCA CG sPCR 
UvrC06 CGG GAT CCA TGA GTG ATC AGT TTG AC sPCR 
Table 2.4 Primers. 
The primers used in this thesis are listed. ' Key for column is: EP, primer for error-prone PCR; oSDM, outer 
primer for site-directed mutagenesis; PE, primer for primer extension; SDM-, mutagenic primer for 
site-directed mutagenesis (with mutant indicated); SL, primer for sequencing ladders; sPCR, primer for 
standard PCR s . The bold T indicates that a fluorescein molecule is attached. 
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Mutation Template Primer 1 Primer 2 Primer 3 Primer 4 
uvrAAK nI BSIIUvrA UvrA01 UvrA15 UvrA14 UvrA09 
UVrAIFO27 BSIIUvrAAK nI UvrA17 UvrA24 UvrA23 UvrA07 
UvrAEVlaa BSIIUvrAAK nl UvrA17 UvrAl9 UvrA18 UvrA07 
UvrALH151 BSIIUvrAAK nl UvrA17 UvrA21 UvrA20 UvrA07 
UvrAGD173 BSIIUvrAAK nI UvrA17 UvrA26 UvrA25 UvrA07 
UvrAyC174 BSIIUvrAAK nI UvrA17 UvrA28 UvrA27 UvrA07 
UvrAEV2o1 BSIIUvrAAK nI UvrA17 UvrA30 UvrA29 UvrA07 
UvrBRE183 BSIIUvrB Bluescript2 UvrBll UvrB10 Bluescri tl 
UvrBRE183 BSIIUvrB UvrB035F UvrBll UvrB10 UvrB252R 
UVrBRA213 pBSIIUvrB Bluescri t2 UvrB09 UvrB08 Bluescri tl 
UVrBRA2I3 UT18UvrB35-252 UvrB035F UvrB09 UvrB08 UvrB252R 
Table 2.5 Templates and primers used for site-directed mutagenesis. 
Site-directed mutagenesis requires four primers to generate the mutant of interest as shown in Figure 2.1. 
Primers 2 and 3 are the mutagenic primers and 1 and 4 are the outer primers. PCR-A is carried out using 
primers 1 and 2 and PCR-B using primers 3 and 4. PCR-C uses primers 1 and 4 and the products of PCR-A 
and PCR-B to generate a full-length mutagenic PCR product. 1,2,3,4 and 5 indicate that these mutants were 
generated to be cloned into pBSIIUvrA, pRA02UvrA1.252, pQE30UvrB, pRA03UvrB35-2s2 and 
pUT18UvrB35-252 respectively. 
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backbone that was a similar size to the uvrA fragment). The 2827 bp insert from 
pBSIIUvrA, the 2026 bp insert from pBSIIUvrB, the 1838 bp insert from pBSIIUvrC and 
the 3419 bp backbone from pQE30 were purified from a 1% agarose gel using the 
GeneCleanlll kit and then ligated to form pQE30UvrA, pQE30UvrB and pQE30UvrC. 
p UT18 UvrA 1_,,, p UT18 UvrB35-252 and p UT18Mfdr_219 
PCR was used to introduce restriction sites at the ends of various truncations of uvrA, uvrB 
and mfd using the conditions indicated in Table 2.6. pUT18 and the purified PCR products 
(purified using the GeneCleanIIl kit) were digested with XbaI, purified using the 
GeneCleanIIl kit and then digested with Kpnl. pUT18 was then dephosphorylated. The 
3008 bp backbone from pUT18 and the various inserts (sizes indicated in Table 2.6) were 
purified from a 1% agarose gel using the GeneCleanIIl kit and then ligated to form 
pUT18UvrA1_,,, pUT18UvrB35.252 and pUT18Mfd1-219" 
pREIIad XbaI 
pREIIa was digested with XbaI, the 5' overhangs blunt ended and then ligated to form 
pREIIaAXbaI. 
pRA02 
The promoter and 5' region of rpoA was amplified from pREIIahXbal using primers 
Prom2 and rpoA248R and an elongation time of seven minutes. The PCR product was 
purified using the GeneCleanlll kit and then phosphorylated. pSRlacUV5203 was digested 
with EcoRI and Hindlll, the 5' overhangs blunt ended and then dephosphorylated. The 
2547 bp backbone from pSR1acUV5203 and the 1146 bp insert from the PCR were purified 
from a 1% agarose gel using the GeneCleanlll kit and then ligated to generate pRA02. 
pBRcIcvXK 
Primers PLO1 and PL02 were annealed forming double stranded DNA containing internal 
XbaI and KpnI sites with ends complementary to Notl and Sall digested DNA. pBRclw 
was digested with NotI and Sall and the 4524 bp backbone purified from a 1% agarose gel 
using the QIAquick gel extraction kit. The backbone and the annealed primers were ligated 
to form pBRcIuoXK. 
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Table 2.6 Information for construction of pUT1S derivatives. 
The PCR conditions to generate uvrA, uvrB and mfd truncations are indicated. 1 The insert size is the size of 
the PCR product once digested with XbaI and Kpnl. 2 The plasmid size is given for pUT18 with the coding 
sequence for the region of UvrA, UvrB or Mfd (indicated at the left) inserted. 
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pRA03 
pBRcIoXK and pACYC184 were digested with EcoRI and Xbal respectively. The 5' 
overhangs were blunt ended, the DNA purified using the GeneCleanlll kit and then 
digested with Sall. The 3527 bp backbone from pACYC184 and the 844 bp insert from 
pBRcIoXK were purified from a 1% agarose gel using the QlAquick gel extraction kit and 
then ligated to form pRA03. Sequence analysis indicated that the generation of 
pACYC 184 blunt ends did not go to completion with the final G of the TCTAG sequence 
not being present, thus instead of TCTAGAATTC the sequence TCTAAATTC is present 
at the XbaI/EcoRI join. 
pRA02UvrA1_ 
pRA02 and pUT18UvrAi.,, were digested with Xbal, the DNA was purified using the 
GeneCleanIIl kit and then digested with KpnI. The 3592 bp backbone from pRA02 and 
inserts from pUT18UvrAi.,, (see Table 2.6 for sizes) were purified from a 1% agarose gel 
using the QlAquick gel extraction kit and then ligated to form pRA02UvrAi.,,. 
pRA03UvrB3s-2s2 and pRA03Mfd1.219 
pRA03, pUT18UvrB35-252 and pUTl8Mfd1-219 were digested with Xbal, the DNA was 
purified using the GeneCleanlll kit and then digested with KpnI. The 4359 bp backbone 
from pRA03 and inserts from pUT18UvrB35-252 and pUT18Mfd1-219 (see Table 2.6 for 
sizes) were purified from a 1% agarose gel using the QlAquick gel extraction kit and then 
ligated to form pRA03UvrB35-252 and pRA03Mfd1-219. 
pRA 02 UvrA 1 _2s2. mutauts 
Error-prone PCR was carried out to amplify and randomly mutate the first 756 nucleotides 
of uvrA (corresponding to the N-terminal 252 amino acids), using pBSIIUvrAAKpnl as 
template and UvrAl7 and UvrA07 as primers. Alternatively specific mutants were 
generated by site-directed mutagenesis using the template and primers indicated in Table 
2.5. pRA02UvrA1.252 and the PCR products (purified using the GeneCleanlll kit) were 
digested with XbaI, the DNA purified using the GeneCleanlll kit and then digested with 
KpnI. pRA02UvrA1.252 was then dephosphorylated. The 3592 bp backbone from 
pRA02UvrAI. 252 and the 765 bp insert from the PCR products were purified from a 1% 
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agarose gel using the QlAquick gel extraction kit and then ligated to create 
pRA02UvrA1-252. mutations. Single UvrA mutants VE202 and DG205, and double UvrA 
mutants indicated in chapter 3 were generated by error-prone PCR. Single UvrA mutants 
IF027, EV144, LH 151, GD173, YC174 and DG205 were generated by site-directed 
mutagenesis. 
p UT18 UvrB3s-2sz. RA2t3 
The sequence coding for UvrB3s-252.1LA213 was generated by site-directed mutagenesis using 
the template and primers indicated in Table 2.5. pUT18UvrB3s-252 and the PCR product 
(purified using the GeneCleanlll kit) were digested with XbaI, the DNA purified using the 
GeneCleanlll kit and digested with KpnI. pUT18UvrB35-252 was then dephosphorylated. 
The 3008 bp backbone from pUT18UvrB35-252 and the 663 bp insert from the PCR were 
purified from a 1% agarose gel using the QlAquick gel extraction kit and then ligated to 
create pUT18UvrB35-252. RA213" 
pRA03UvrB3s-252. RE183 and pRA03UvrB3s-252. RA213 
The sequence coding for UvrB35-252. RE183 was generated by site-directed mutagenesis using 
the template and primers indicated in Table 2.5. pRA03UvrB35-252, the PCR product 
(purified using the GeneCleanlll kit) and pUT18UvrB35-2s2. RA213 were digested with XbaI, 
the DNA purified using the GeneCleanlll kit and digested with KpnI. pRA03UvrB35-252 
was then dephosphorylated. The 4359 bp backbone from pRA03UvrB35-252 and the 663 bp 
insert from both the PCR and pUT I 8UvrB35-252. RA213 were purified from a 1% agarose gel 
using the QlAquick gel extraction kit and then ligated to form pRA03UvrB35-2s2. RE183 and 
pRA03UvrB35-252. RA213 
pQE30UvrAmutants 
Error-prone PCR was carried out to amplify and randomly mutate the first 690 nucleotides 
of uvrA (corresponding to the N-terminal 230 amino acids), using pBSIIUvrA as template, 
Bluescript2 and UvrA08 as primers and an annealing temperature of 55°C. Alternatively 
standard PCR was carried out using pRA02UvrA1.252 that contained the desired mutation, 
UvrAO1 and UvrA22 as primers and an annealing temperature of 55°C. pQE30UvrA and 
the PCR products (purified using the QlAquick PCR purification kit) were digested with 
BamHI, the DNA purified using the QlAquick PCR purification kit and digested with 
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KpnI. pQE30UvrA was then dephosphorylated. The 5553 bp backbone from pQE30UvrA 
and the 693 bp inserts from the PCR products were purified from a 1% agarose gel using 
the QlAquick gel extraction kit and ligated to form pQE30UvrAmutants" Single UvrA 
mutants RL023, GS034, SA038, SP038, FI064, FS064. LQ065, VD073, SY080, QL087, 
GR099, CR120, LP151 and KE159 were generated by error-prone PCR and LH151, 
GD173, YC174, EV201, VE202 and DG205 were generated by standard PCR. 
pQE30UvrBRE183 and pQE3OUvrBRA213 
UvrB single mutants were generated by site-directed mutagenesis using the template and 
primers indicated in Table 2.5 and the Phu DNA polymerase PCR protocol with an 
elongation time of 25 seconds for PCR-A and PCR-B and 35 seconds for PCR-C (Figure 
2.1). pQE30UvrB and the PCR product (purified using the QlAquick PCR purification kit) 
were digested with BamHI and Hindlll. pQE30UvrB was then dephosphorylated. The 
3419 bp backbone from pQE30UvrB and the 2026 bp insert from the PCR products were 
purified from a 1% agarose gel using the QlAquick gel extraction kit and then ligated to 
form pQE30UvrBmutations" Single UvrB mutants RE 183 and RA213 were generated in this 
way. 
Preparation of DNA fragments for incision assays 
pSR1acUV5203 EcoRI/BamHI fragment to be 32P labelled at the 5' BamHI end 
The 347 bp pSR1acUV5203 EcoRI/BamHI fragment to be 32P labelled at the 5' BamHI end 
was generated from a CsCl maxiprep preparation of pSR1acUV5203" A preparative 100 111 
digest contained 25 µg of pSR1acUV5203 and 25 U BamHI in the supplied buffer. The 
digested DNA was dephosphorylated, purified by phenol chloroform extraction and 
ethanol precipitation and digested with 25 U EcoRI in a 50 µ1 preparative digestion 
reaction. 6x DNA loading dye and 100 x SYBR green were added to a final concentration 
of 1x and 10 x respectively. The DNA was run on a 7.5% acrylamide gel, visualised on a 
dark reader and the 347 bp fragment excised. The gel slice was placed in 12-14 kDa 
MWCO dialysis tubing and the DNA extracted by electroelution at 40 mA for 45 minutes 
in 0.1 x TBE buffer. The DNA was purified by phenol chloroform extraction and ethanol 
precipitation. Samples of fragment and DNA ladders of known concentrations were run on 
a 7.5% acrylamide gel and the DNA concentration quantified using Kodak imaging 
software. The fragment was subsequently ready for 32P labelling at the 5' BamHI end. 
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pSRT7A1 EcoRIBamHI fragment to be 32P labelled at the S' BamHI end 
The 268 bp pSRT7A1 EcoRI/BamHI fragment to be 32P labelled at the 5' BamHI end was 
generated from a Qiagen maxiprep preparation of pSRT7A1 purified by Dr. N. Savery 
from the dam+ E. coli strain XLI-Blue. A preparative BamHI digest was carried out and 
the DNA purified by phenol chloroform ethanol precipitation before some was internally 
biotinylated by a member of the Prof. E. Weinhold laboratory (Pljevaljcic et al., 2004). 
The biotinylated and unmodified DNA were dephosphorylated, purified by phenol 
chloroform extraction and ethanol precipitation, digested with EcoRI and purified by 
phenol chloroform extraction and ethanol precipitation. The DNA was subsequently ready 
for 32P labelling at the 5' BamHI end of both the 268 bp and the 2300 bp fragments. 
32P DNA ladders 
32P DNA ladders for urea sequencing gels were generated using a T7 sequencing kit 
(USB). Template DNA was denatured as follows: 2 µg of DNA was suspended in 30 µ1 TE 
buffer, 3 gI 2M NaOH was added, the reaction incubated at room temperature for 15 
minutes, 3 µl 5M NH4Ac (pH 4.8) and 75 µl ethanol were added and the reaction 
incubated at -20°C for 15 minutes. The DNA was centrifuged at 16110 g, 4°C for 15 
minutes and the pellet washed in 1 ml 70% ethanol. The pellet was air-dried and 
suspended in 10 µl H2O. The annealing, labelling and termination reactions were carried 
out according to the manufacturer's protocol using the components of the T7 sequencing 
kit and [a32P] dATP (Amersham). Ladders of pSRT7A1 and pSRIacUV5203 were 
generated in this way using primer pSR1acUV5 BamHI. 
Screening protocols 
Bacterial two-hybrid screening procedures to identify UvrA mutants 
One-step screen 
pRA02UvrA1-252. mutants were generated as described above using five cycles of error-prone 
PCR. Electrocompetent KS I cells that contained either pRA03UvrB35.252 or 
pRA03Mfd1.219 were transformed with the ligation mixtures. The transformation mixtures 
were spread onto LB indicator plates (LB agar supplemented with 100 jig/ml ampicillin, 
50 µg/ml kanamycin, 25 µg/ml chloramphenicol, 1 mM IPTG and 80 pg/ml X-gal) and 
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incubated at 30°C for 20 hours and then at room temperature for 24 hours. Colonies that 
appeared white were streaked to single colonies on LB X-gal indicator plates. From this 
plate a single white colony was used to inoculate 5 ml LB broth containing the above 
antibiotics. The cells were incubated at 37°C overnight and then the plasmid DNA 
extracted. The section of plasmid that had originally been amplified by error-prone PCR 
was sequenced. 
Modification to one-step screen 
The one-step screen protocol was used but this time one, two, three, four, or five cycles of 
error-prone PCR was used. KS 1 cells that contained pRA03Mfd1_219 were then transformed 
with the subsequent ligations. 
Two-step screen 
The two-step screening protocol started in the same way as the modified one-step screen 
except that only one or two cycles of error-prone PCR were used. In this protocol the 5 ml 
overnight cultures (of white colonies) were pooled in groups of 10. DNA was extracted 
from 3 ml of the pooled culture and then digested with Nhel to cleave the pRA03Mfd1-219 
plasmid. KS 1 cells that contained pRA03UvrB35-252 were then transformed with the DNA 
mix. Colonies that appeared blue were streaked to single colonies on LB X-gal indicator 
plates. From this place a single blue colony was then used to inoculate 5 ml LB broth 
containing the above antibiotics. The cells were incubated at 37°C overnight and then the 
plasmid DNA extracted. The DNA was digested with NheI to destroy pRA03UvrB35-252" 
KS 1 cells containing pRA03UvrB35-252 or pRA03Mfd1-219 were then transformed with the 
DNA mix to confirm phenotype. If the phenotype was correct (i. e. KS 1 colonies 
expressing XcIMfd1.219 and the a fusion protein were white and KS1 colonies expressing 
), cIUvrB3s. 252 and the a fusion protein were blue) the section of plasmid that had originally 
been amplified by error-prone PCR was sequenced. 
Isolation of pRA02UvrA derivatives from the bacterial two-hybrid screen 
From the screening procedures DNA preparations contained two plasmids. One was 
pRA02UvrA1-252. mutant and the other was either pRA03UvrB35.252 or pRA03Mfd1.219. The 
DNA was treated with Nhel to cleave derivatives of pRA03. XL1-Blue cells were 
transformed with the DNA and spread onto LB agar plates supplemented with ampicillin 
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and tetracycline. Single colonies were used to inoculate 5 ml of LB broth containing the 
above antibiotics which were incubated at 37°C overnight. The DNA was extracted 
generating a pure pRA02UvrA1-252. mutaut preparation. 
UV sensitivity screen 
Libraries of pQE30UvrAmutants were generated using error-prone PCR as described above. 
Electrocompetent MG1655AuvrA cells were transformed with the ligation mix and spread 
onto LB agar plates supplemented with ampicillin, kanamycin and tetracycline. The plates 
were incubated at 30°C for approximately 16 hours. Type 1 filter paper (two sheets 70 mm 
and two sheets 110 mm diameter) (Whatman) covering a replica plater was used to transfer 
colonies from the overnight plates onto two fresh LB plates containing the same 
antibiotics. The first replica plate was irradiated for 10 seconds at 2 J/m2/s using a 
UVLS-28 254 nm lamp (UVP) to give a final dose of 20 J/m2 254 nm UV light. The 
second replica was left unirradiated. Both replica plates were incubated at 30°C for 16 
hours. Colonies from the unirradiated control plate that had not grown on the irradiated 
plate were streaked onto LB agar plates containing the above antibiotics and incubated at 
30°C for approximately 16 hours. Single colonies were used to inoculate 10 ml LB broth 
containing the above antibiotics which were then incubated overnight at 37°C. A sample 
was centrifuged (equivalent to 100 / A600 µl) and the pellet suspended in 20 µl SDS PAGE 
loading dye and heated to 95°C for five minutes. Samples (5 µl) were resolved on 10% 
SDS PAGE gels alongside cells containing pQE30UvrA and pQE30 that would and would 
not express full-length UvrA. 3 ml of each overnight culture that expressed full-length 
UvrA protein was harvested and the plasmid DNA extracted. 
To confirm the UV sensitivity phenotype a UV sensitivity assay was used. LB broth (5 ml) 
containing 100 µg/ml ampicillin and 50 gg/ml kanamycin was inoculated with 
MG1655AuvrA cells transformed with the purified pQE30UvrA derivative (or pQE30 and 
pQE30UvrA as controls). The cells were incubated at 37°C for 16 to 18 hours and then 
diluted to an A600 of 0.0625 in LB broth (10 ml) containing the above antibiotics. The cells 
were incubated at 37°C until an A600 of at least 0.4 was reached and then placed on ice. 
Cells (2.5 / A600 ml) were centrifuged at 2770 g at 4°C for 10 minutes and the pellet 
suspended in 5 ml M9 buffer to give approximately 5x 108 E. coli cells/ml. A1 ml sample 
of each culture was placed in one well of a six well plate and irradiated for 30 seconds at 2 
J/m2/s to give a final dose of 60 J/m2 254 nM UV light. The cells (irradiated and 
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unirradiated) were subjected to five 10-fold serial dilutions in M9 broth. 2 µl samples of 
each diluted irradiated and unirradiated culture were spotted onto LB agar plates 
containing the above antibiotics and incubated at 30°C overnight. If the UV sensitivity 
phenotype was confirmed the plasmid DNA was sequenced. 
Protein purification and protein detection 
UvrA, UvrB and UvrC protein purification 
Wild-type and mutant UvrA proteins (A) were purified from MG1655AuvrA cells 
transformed with the appropriate pQE30UvrA derivative. Wild-type and mutant UvrB 
proteins (B) were purified from XL1-Blue cells transformed with the appropriate 
pQE30UvrB derivative. UvrC (C) was purified from XL1-Blue cells transformed with 
pQE30UvrC. 100 ml of LB broth was supplemented with 100 gg/ml ampicillin (A, B, C) 
and 50 gg/ml kanamycin (A) or 25 gg/ml tetracycline (B, C) and was inoculated with a 
single colony and incubated at 37°C for 16 hours. The cells were harvested by 
centrifugation at 2770 g (A, B) or 4657 g (C) at 4°C for 10 minutes, the pellet suspended 
in 20 ml of wash buffer containing 10 mg of lysozyme and then incubated on ice for 30 
minutes. The cells were lysed on ice by three 15 second bursts of sonication. 15 ml of 
wash buffer was added and the cells centrifuged at 38724 g at 4°C for 30 minutes. The 
supernatant was passed through a 0.45 gm filter (Millipore) and wash buffer was added to 
a total volume of 50 ml. The protein of interest was purified from the lysate using a1 ml, 
NiSO4 charged, HiTrap chelating column (Amersham) on anÄKTA FPLC (Amersham). 
The protein was eluted from the column using a 20 to 500 mM imidazole gradient 
generated from the wash and elution buffers. Fractions containing only the protein of 
interest were dialysed at 4°C overnight in 1L of dialysis buffer and then for four hours in 
1L of storage buffer. 
Mfd protein purification 
Mfd was a gift from Dr. A. Smith who purified it as described by Chambers et al. 
(Chambers et al., 2003). 
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Protein concentration 
The concentration of UvrA, UvrB, UvrC and Mfd was determined using the Bio-Rad 
protein assay following the manufactures microassay protocol. BSA (0,1,2,4,6 and 8 µg) 
(Pierce) was used as a standard. Proteins were analysed on a 10% SDS PAGE gel to 
confirm relative concentration and purity. 
Western blotting 
Proteins from cell lysates of the bacterial two-hybrid samples of interest were resolved on 
a 10% SDS PAGE gel. The stacking gel was removed and the resolving gel was soaked in 
transfer buffer for 15 minutes. Immobilon-P PVDF membrane (Millipore) was soaked in 
methanol for 30 seconds, water for two minutes and transfer buffer for five minutes. The 
blotting apparatus (mini trans-blot cell) were assembled according to the manufactures 
instructions (Bio-Rad). The transfer took place at 100 V (250 mA) for one hour. The 
membrane was placed in methanol then dried on filter paper for 15 minutes. The 
membrane was placed in blocking buffer overnight and then washed in 1x PBS for two 15 
minutes periods. The membrane was rewetted in methanol and was probed with a rabbit 
polyclonal anti-RNAPa subunit primary antibody (a gift from Prof. A. Ishihama) in 10 ml 
of blocking buffer for two hours and then five washes of five minutes in PBS tween took 
place. The membrane was probed with 5 µl HRP conjugated anti-rabbit IgG secondary 
antibody (Santa Cruz) in 10 ml of blocking buffer for one hour. The membrane was 
washed for five times five minutes in PBS tween followed by a final five minute wash in I 
x PBS. The membrane was then developed using the POD chemilluminescence system 
(Roche) following the manufactures protocol and the film exposed in the Curix60 (AGFA) 
machine. 
In vivo assays 
ß-galactosidase assays 
ß-galactosidase assays were carried out essentially as described by Miller (Miller, 1972). 
LB broth (10 ml) containing 50 gg/ml kanamycin, 100 pg/ml ampicillin and 25 µg/ml 
chloramphenicol was inoculated with KSI cells transformed with a pRA02 derivative and a 
pRA03 derivative. The cultures were incubated at 30°C for 16 to 18 hours and then diluted 
to an A600 of 0.007 in fresh LB broth (10 ml) containing the above antibiotics and 1 mM 
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IPTG. The cultures were incubated at 30°C until they reached an A600 of approximately 
0.35 and then placed on ice. 100 µl of each culture were transferred into two tubes 
containing 900 µl Z buffer and 30 pl chloroform (Fisher) (as a control 100 µl Z buffer was 
added instead of culture). The tubes were vortexed for 10 seconds and incubated for 15 
minutes at 30°C before 200 pl of 4 mg/ml ONPG in Z buffer was added to each tube. The 
reactions were incubated for two hours at 30°C and stopped by the addition of 500 Al 1M 
Na2CO3 (Fisher) and vortexed for five seconds. The A420 and A550 were measured and 
specific ß-galactosidase activity determined using the formula: 
Activity (Miller Units) = 1000 x ((A420 - (1.75 x A550)) / (12 x A600)). Assays were carried 
out in triplicate and averages and standard deviations calculated. 
UV survival assay 
LB broth (5 ml) containing 100 gg/ml ampicillin and 50 gg/ml kanamycin was inoculated 
with MG1655AuvrA cells transformed with a pQE30UvrA derivative (or pQE30 as a 
control). The cells were incubated at 30°C for 16 to 18 hours and then 200 gl transferred 
into 10 ml LB broth containing the above antibiotics. The cells were incubated at 37°C 
until an A600 of at least 0.5 was reached and then placed on ice. Cells (0.5/A600 ml) were 
centrifuged at 16110 g for one minute and the pellet suspended in I ml M9 broth. The cells 
were 10-fold serial diluted five times in M9 broth. 2 gl of each diluted culture were spotted 
onto 21 LB agar plates containing the above antibiotics. The 21 plates were split into seven 
groups of three. The seven groups were irradiated for 0,10,20,30,40,50 and 60 seconds 
at 0.4 J/m2/s to give a final dose of 0,4,8,12,16,20 and 24 J/m2 254 nm UV light 
respectively. The plates were incubated at 30°C for 16 hours. UV survival was calculated 
by counting the number of colonies within the most diluted viable spot and multiplying 
this number by its dilution factor. The three values within each group were then averaged. 
The assays were carried out in triplicate with an average of averages taken and standard 
deviation calculated. 
In vitro assays 
Nucleotide hydrolysis assays 
Nucleotide hydrolysis assays were carried out in a final volume of 200 µ1. A 170 µl 
cocktail of phosphoenolpyruvate (PEP), nicotinamide adenine dinucleotide (NADH), 
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pyruvate kinase / lactate dehydrogenase (PK/LDH) and repair buffer was prepared. A 20 µl 
cocktail of UvrA, UvrB, and Mfd in 1x storage buffer was added. Reactions were 
incubated at 37°C for five minutes before 10 µl ATP or GTP was added. The final 
component concentrations were 500 µM PEP, 400 µM NADH, 4.2 U PK, 4.8 U LDH, 1x 
repair buffer, 0.1 x storage buffer and the indicated concentrations of UvrA, UvrB, Mfd, 
ATP and GTP (see chapter 5). Reactions were incubated at 37°C in a 96 well plate 
spectrometer (Versamax) and A340 readings taken every 15 seconds for one hour. Reaction 
rates were determined by taking the steepest gradient, generally over 120 data points (30 
minutes) after the first five minutes of the reaction using SOFTmax PRO software. The 
reactions were carried out in triplicate. A plot of the average rates against NTP 
concentration allowed Vma,, and K. values to be determined using GraFit software. 
EMSAs 
DNA binding by UvrA 
EMSAs to determine DNA binding by UvrA(mutants) were carried out in a final volume of 
10 µ1. An 8 µl cocktail of y32P labelled DNA, ATPyS and repair buffer was prepared and 
incubated at 37°C for five minutes before 2 µl UvrA(mutant) in 1x storage buffer was added. 
The final component concentrations were 1 nM y32P labelled DNA, 1 mM ATPyS, 0.8 x 
repair buffer, 0.2 x storage buffer and the indicated concentration of UvrA (see chapter 5). 
Reactions were incubated at 37°C for 30 minutes and then 8 µl loaded onto a 6% 
acrylamide gel. Each assay was performed at least twice. 
DNA binding by UvrA and UvrB 
EMSAs to determine DNA binding by a mixture of UvrA(mutants) and UvrB were carried 
out in a final volume of 10 µl. A7 µl cocktail contained ATPyS and repair buffer. 1 µl of 
UvrA(mutant) and 1 µl of UvrB were added and the reaction incubated at 37°C for 15 
minutes. 1 µl of y32P labelled DNA was then added. The final component concentrations 
were 1 mM ATPyS, 0.8 x repair buffer, 0.2 x storage buffer, 1 nM y32P labelled DNA and 
the indicated concentration of UvrA and UvrB (see chapter 5). Reactions were incubated at 
37°C for 15 minutes and then 8 µl loaded onto a 6% acrylamide gel. Each assay was 
performed at least twice. 
81 
Chapter 2- Materials and Methods 
Biotin modified DNA binding by streptavidin 
EMSAs to confirm the biotinylation of DNA were carried out in a final volume of 10 µ1. A 
9 µl cocktail contained biotinylated DNA, BSA and transcription buffer. The reactions 
were preincubated at 37°C for two minutes before the addition of 1 gl of streptavidin in 
transcription buffer (a gift from Dr. M. Dillingham). The final component concentrations 
were 0.25 nM biotinylated DNA, 0.1 mg/ml BSA, 1x transcription buffer and the 
indicated concentration of streptavidin tetramer (see chapter 4). The reactions were 
incubated at 37°C for 10 minutes before 2 µl of 6x loading dye was added. The reactions 
were loaded onto a 6% acrylamide gel. 
DNA irradiation 
For DNA irradiation 100 nM pSR1acUV5203 was placed in 10 µl spots and irradiated for 75 
seconds at 0.4 J/m2/s to give a final dose of 30 J/m2 254 nm UV light. Alternatively 8 nM 
of the pSRIacUV5203 BamHI/EcoRI fragment was placed in 10 µ1 spots and irradiated for 
75 seconds at 4 J/m2/s to give a final dose of 300 J1m2 254 nm UV light. 
Incision assays 
Incision of UV damaged plasmid DNA 
Incision assays were carried out in a final volume of 10 µl. A6 µl cocktail contained 
pSR1acUV5203 (that had or had not been irradiated) and repair buffer. A3 µl cocktail of 
UvrA, UvrB and UvrC in storage buffer was added and the reactions incubated at 37°C for 
five minutes before the addition of 1 µl ATP. The final component concentrations were 
5.73 nM pSR1acUV5203,1 x repair buffer, 0.3 x storage buffer, 100 nM UvrA, 100 nM 
UvrB, 200 nM UvrC and 1 mM ATP. The reactions were incubated at 37°C for 30 minutes 
before the addition of 5 µl of STEB stop buffer and a further incubation at 67°C for 20 
minutes. The samples were resolved on a 1% agarose gel. As a control a 10 µl reaction 
containing 2U of T4EV (Epicentre), 5.73 nM pSR1acUV5203 and 1x repair buffer was 
incubated at 37°C for 30 minutes before the addition of STEB stop buffer. 
Assay to determine UvrABC 5' incision activity 
To determine the specific UvrABC 5' incision site in relation to a biotin adduct a different 
incision assay was used. These incision assays were carried out in a final volume of 10 µl. 
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The reaction contained 0.25 nM T32P labelled DNA, 0.8 x repair buffer, 0.3 x storage 
buffer, 100 nM UvrA(mutant), 100 nM UVrB(mutant), 200 nM UvrC and 1 mM ATP where 
present. As a control the DNA was digested with HindIIl or mock treated without enzymes 
and/or ATP. The reactions were incubated at 37°C for 30 minutes. The DNA was purified 
by phenol chloroform extraction and ethanol precipitation and suspended in 5 µ1 of water 
and 5 µl formamide stop solution, incubated at 95°C for five minutes, centrifuged briefly 
and loaded onto a denaturing 6% acrylamide gel. 
Assay to determine UvrABC 3' incision activity 
To determine the specific UvrABC 3' incision site in relation to a biotin adduct the DNA 
was first incubated with UvrABC and then used as the template for primer extension 
reactions. Nicking reactions were carried out in a final volume of 10 µ1 and contained 
1.025 nM DNA, 0.8 x repair buffer, 0.2 x storage buffer, 100 nM UvrA, 100 nM UvrB, 
200 nM UvrC and 1 mM ATP. The reaction was incubated at 37°C for 15 minutes before 
an additional 1 pl of 10 mM ATP was added (making the reaction 11 µl) for a further 15 
minute incubation. As a control the DNA was digested with Hindill or mock treated 
without enzymes. The DNA was purified by phenol chloroform extraction and ethanol 
precipitation and suspended in 8.2 pl of water to make a final DNA concentration of 1.25 
nM. 
Primer extension reactions were carried out in a final volume of 20 µl and contained 0.25 
nM DNA (4 µl of the above DNA), 0.5 mM dNTPs, 1.5 mM MgCl2,5 gM 32P labelled 
primer and 2.5 U Taq DNA polymerase in the supplied buffer. The reactions were 
incubated at 95°C for five minutes, 55°C for 30 seconds and 72°C for 10 minutes. The 
DNA was then purified by phenol chloroform extraction and ethanol precipitation and 
suspended in 5 µl H2O and 5 gl formamide stop solution, incubated at 95°C for five 
minutes, centrifuged briefly and loaded onto a denaturing 6% acrylamide gel. 
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Introduction 
In NER UvrA acts as a molecular matchmaker, scanning the DNA for damage and then 
loading UvrB directly onto the damaged DNA (Sancar and Hearst, 1993). In TCR UvrA is 
proposed to be recruited to the damage site through interactions it makes with Mfd (Selby 
and Sancar, 1995a). UvrA then loads UvrB onto the DNA as part of the NER process. At 
the start of this work there was very little information available about how UvrA interacts 
with UvrB and Mfd. No amino acid residues had been identified that were specifically 
involved in either the UvrA-UvrB or the UvrA-Mfd interaction. It was therefore of interest 
to identify residues of UvrA that are important for the UvrA-UvrB and the UvrA-Mfd 
interaction. 
Two approaches were taken to identify amino acid residues of UvrA that are involved in 
interacting with UvrB and/or Mfd. The first approach was based on a bacterial two-hybrid 
system. This system was used to specifically identify mutants of UvrA that were unable to 
interact with UvrB or Mfd within the bacterial two-hybrid context. The second approach 
was based on the UV sensitivity phenotype of AuvrA cells. This system would identify a 
variety of physiologically relevant UvrA mutants. However the mutants could be deficient 
in any property of UvrA that was essential for the UV resistant phenotype of uvrA+ cells. 
Lambda cl RNAP bacterial two-hybrid screen 
The main aim of this work was to identify UvrA residues that are important for the 
interaction of UvrA with UvrB and Mfd. A bacterial two-hybrid system in which truncated 
versions of the wild-type proteins interacted to show a detectable phenotype was used to 
screen libraries of UvrA mutants to identify these residues. The system required 
protein-protein contact between the proteins of interest in order to give enhanced 
transcriptional activation of a reporter gene (Figure 3.1) (Dove et al., 1997). The system 
was designed to enhance transcription of an artificially introduced chromosomal copy of 
lacZ on protein-protein contact (Dove et al., 1997). Upstream of lacZ in KS 1 cells there is 
a placOR2-62 promoter that is a derivative of the lac promoter with a Xcl operator site 
(OR2) centred at position -62 from the transcriptional start site (Figure 3.1 A) (Dove et al., 
1997). As with the yeast two-hybrid system (Fields and Song, 1989) there were two 
partners: Xcl and the NTD (residues 1-248) of the RNAP a subunit (that will be referred to 
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Figure 3.1 Bacterial two-hybrid ß-galactosidase reporter screen. 
(A) KS 1 cells contain a chromosomal copy of IacZ with a placOR2-62 promoter upstream. KS I cells were 
transformed with two plasmids; one coded for a XcI fusion protein and the other a al-248 fusion protein. (B) 
Interacting partners that were fused to )-cl and a brought RNAP to the promoter. RNAP then transcribed IacZ 
leading to the expression of ß-galactosidase. The presence of ß-galactosidase in a cell was detected as a blue 
colony phenotype on indicator plates (LB agar supplemented with the appropriate antibiotics, 1 mM IPTG 
and 80 gg/ml X-gal). (C) When one (or both) interacting partner was missing or (D) one of the interacting 
partners had a mutation in disrupting the interaction, RNAP was not recruited to the promoter and a white 
colony phenotype was observed on indicator plates. 
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as a). Both these proteins were fused at their C-terminus to truncations of either UvrA, 
UvrB or Mfd. XcI would bind to the OR2 site and if the fusion partners interacted RNAP 
would be recruited to the promoter and transcription of lacZ would be initiated (Figure 
3.1B). This would result in expression of ß-galactosidase leading to the development of a 
blue phenotype on indicator plates (LB agar supplemented with 100 µg/ml ampicillin, 50 
µg/ml kanamycin, 25 µg/ml chloramphenicol, 1 mM IPTG and 80 µg/ml X-gal). If the 
fusion partners failed to interact, one of the interacting partners was missing or if the 
interaction was disrupted due to a mutation then RNAP would not be recruited to the 
promoter and only a basal level of ß-galactosidase would be produced (Figure 3.1C). The 
strength of the protein-protein interaction could be determined by measuring the level of 
ß-galactosidase activity. 
Identification of interacting domains of UvrA, UvrB and Mfd 
Within the bacterial two-hybrid system a UvrA-UvrB and a UvrA-Mfd interaction was 
required that would result in a phenotype that was sufficiently different from the 
phenotype detected in the absence of an interaction. UvrA (104 kDa), UvrB (76 kDa) and 
Mfd (130 kDa) are all large proteins. Truncations of each protein were made to find 
conditions under which an interaction resulted in the highest level of ß-galactosidase 
activity. At the time of truncation construction crystal structures were not available for 
UvrA and Mfd, and the crystal structures that were available for UvrB lacked domain 2 
which is believed to contain the UvrA binding region (Theis et al., 1999) (Machius et al., 
1999). Therefore the truncations were based on secondary structure predictions (PSIPRED 
and NNPREDICT) and available truncation data (Figure 3.2) (Claassen and Grossman, 
1991) (Selby and Sancar, 1993). UvrB114-251 and Mfd82.219 are homologous (Selby and 
Sancar, 1993) and UvrB115-250 was shown to interact with UvrA (Hsu et al., 1995). This 
homology region was therefore present in the region of UvrB (amino acids 35 to 252) and 
Mfd (amino acids 1 to 219) used. 
UvrB can stimulate the ATPase activity of UvrA1.230 and full-length UvrA to the same 
extent (Claassen and Grossman, 1991). Claassen and Grossman concluded that the 
N-terminal 230 amino acids of UvrA are important for the UvrA-UvrB interaction 
(Claassen and Grossman, 1991). There was little additional information available on the 
UvrB binding domain of UvrA and no information available on the Mfd binding domain of 
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Figure 3.2 Truncations of UvrA, UvrB and Mfd used in the bacterial two-hybrid system. 
Truncations of UvrA, UvrB and Mfd were used in the bacterial two hybrid system. A series of C-terminal 
truncations of UvrA were constructed: UvrA1_2_3a, UvrA1_252, UvrA1_280, UvrA1_350, UvrAl_400, UvrA1.503, 
UvrA1_680 and UvrA1_940 (full-length). UvrB and Mfd each had one truncation made: UvrB35_252 and Mfd1.219. 
The coloured boxes indicate the following domains. UvrA - green, the predicted UvrB interaction domain 
(UvrA1.23o); purple, the predicted UvrA dimerization domain (UvrA1 _6sO); and red, the 
damage recognition 
and stabilisation domain (UvrA _940). 
UvrB - dark blue, domain la; purple, domain lb; aqua, domain 2; 
orange, domain 3; yellow, domain 4; and red the ß-hairpin (Theis et al., 1999). Mfd - dark blue, domain la; 
purple, domain lb; aqua, domain 2; orange, domain 3; pink, domain 4; yellow, domain 5; green, domain 6; 
and red, domain 7 (Deaconescu et al., 2006). See Figure 1.9 for descriptions of the motifs (thick black lines). 
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UvrA. It was assumed that the same area of UvrA was involved in interacting with UvrB 
and Mfd because of the UvrB-Mfd homology (Selby and Sancar, 1993). A series of 
C-terminal UvrA truncations were made. UvrA1.230 and UvrA1.680 were made as they 
correspond to the predicted UvrB binding domain and the predicted UvrA dimerization 
domain respectively (Claassen and Grossman, 1991), (Myles and Sancar, 1991). UvrA1-252 
and UvrA1.28o were truncated before and after the N-terminal zinc finger sequence. 
UvrA1-35o, UvrAj. aoo and UvrAl_503 were truncated after predicted alpha helical structures 
and UvrAl. 94o was the full-length protein. 
A series of plasmids were constructed to enable expression of a and XcI fusion proteins. 
Truncations of uvrA were cloned into pRA02 downstream of, and in-frame with, the 5' 
gene sequence of rpoA to create plasmids pRA02UvrA1.,, (where n is the most C-terminal 
amino acid) that code for aUvrA1.,, fusion proteins. The uvrB and the mfd truncations were 
cloned into pRA03 downstream of, and in-frame with, the a, cl gene to create plasmids 
pRA03UvrB35.252 and pRA03Mfd1.219 that code for XclUvrB35-252 and a, clMfdl-219 
respectively. 
To identify which truncation of UvrA gave the strongest interaction with UvrB3s-252 and 
which gave the strongest interaction with Mfd1.219, KS1 cells containing placOR2-62 
upstream of lacZ were first transformed with pRA03, pRA03UvrB35-252 or pRA03Mfd1-219 
They were then each transformed with pRA02 or pRA02UvrAl. n. ß-galactosidase activity 
was determined from subsequent cultures. KS 1 cells that contained pRA02UvrA1-940 failed 
to grow after subculture as did KS1 cells that contained pRA02UvrA1.680 in combination 
with pRA03Mfd1-219" ß-galactosidase activity was determined for those combinations that 
did grow (Figure 3.3). When one or both interacting partners were absent a basal level of 
ß-galactosidase activity was detected. When aUvrA1-230 and either %clUvrB35-252 or 
? cIMfd1.219 were present the ß-galactosidase activity remained near this basal level. When 
any of the other aUvrA1.,, fusion proteins were present in combination with %cIUvrB35-252 
or XcIMfd1.219 an elevated level of (3-galactosidase activity was detected. The level of 
ß-galactosidase activity altered with the different aUvrA1.,, fusion proteins but the same 
trend was seen when either XclUvrB35-252 or a. CIMfd1-219 were present. The greatest 
ß-galactosidase activity detected with XcIUvrB35-252 or XcIMfd1.219 was when aUvrA1-252 
was present. 
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Figure 3.3 Effect of UvrA truncations in ß-galactosidase reporter screen. 
KS 1 cells were transformed with pRA02 and pRA03 derivatives encoding a and 41 fusion proteins 
respectively. Cultures were grown to an A600 of 0.35 to 0.4 and specific ß-galactosidase activity was 
determined. Yellow, green and orange bars indicate cells expressing xcl, 4IUvrB35-252 and %, clMfdt-219 
respectively. Assays were carried out in triplicate (with the exception of ? clUvrB-aUvrA1-350which was 
assayed only once due to poor growth) and results averaged. Error bars shown are standard deviations. 
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The level of j3-galactosidase activity detected when aUvrA1-252 and either XcIUvrB3s. 252 or 
XcIMfd1-219 were present is assumed to be because of a direct protein-protein contact 
between the proteins of interest. The control reactions in which one of these interacting 
partners was not present indicated that there were no protein-protein contacts of sufficient 
affinity between UvrA1.252 and Acl, or between a and UvrB35-252 or Mfd1.219, to cause an 
increase in ß-galactosidase activity over the basal level detected when only a and ? cI were 
present. Therefore the elevated ß-galactosidase levels detected when both partners were 
present is almost certainly due to a direct UvrA1.252-UvrB35-252 or UvrA1.252-Mfd1-219 
interaction. In conclusion we have identified a variety of truncated forms of UvrA that 
interact with UvrB35-252 and Mfd1.219. Of the truncated forms tested within this system, 
cells expressing aUvrA1.252 and either ), clUvrB3s. 252 or ?, cIMfd1.219 resulted in the greatest 
level of ß-galactosidase activity. 
Identification of UvrA mutants - one-step screen 
The phenotype resulting from the interaction between UvrA1.252 and UvrB35.252 or Mfd1.219 
was used to identify residues within UvrA that affected these interactions. Colonies of KS 1 
cells that expressed aUvrA1-252 and either XcIUvrB35-252 or XcIMfd1.219 showed a blue 
phenotype (light blue with a dark blue centre) on X-gal indicator plates. Colonies that 
lacked one or other of the interacting partners appeared white. The two phenotypes were 
distinguishable and therefore cells that expressed mutant proteins which disrupted the 
interaction were expected to be detectable as white colonies on indicator plates. 
Random mutants of UvrAl-252 were generated using error-prone PCR (Figure 3.4). Initially 
five error-prone PCR cycles were followed by 30 standard PCR cycles. The PCR products 
were cloned into pRA02UvrA1.252 on a XbaI/KpnI fragment to generate a library of uvrA 
mutant plasmids. KS I cells that already contained either pRA03UvrB35-252 or 
pRA03Mfd1-219 were then transformed with the uvrA mutant library. The transformation 
mixtures were spread onto LB indicator plates and incubated. There were a significant 
proportion of white colonies on the indicator plates. Single white colonies were grown in 
LB broth containing the appropriate antibiotics and the plasmid DNA extracted and 
sequenced. Of eight clones sequenced seven contained a frameshift or a stop codon. The 
remaining candidate, which had been selected from KS1 cells expressing X, clUvrB35-252, 
encoded aUvrA 1-252, EV 144+L>-1151 
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i Digestion with Xbal and KpnI followed by ligation into 
li pRA02UvrA1_252. pRA02UvrA1_252. 
Transformation into KS I cells pre-transformed with 
pRA03UvrB35-252 or pRA03Mfd1.219. Cells were incubated on 
X-gal indicator plates at 30°C for 20 hours and then room 
temperature for 24 hours. White colonies selected and streaked to 
single colonies. 
I DNA digested with Nhel to cleave the pRA03 plasmid derivative. i 
Cultures grown and plasmid DNA extracted. 
DNA sequenced. 
DNA transformation into KSI cells that had previously been 
transformed with pRA03, pRA03UvrB35-252 or pRA03Mfd1-219. 
Incubation on X-gal indicator plates at 30°C for 20 hours and 
room temperature for 24 hours. 
Figure 3.4 Bacterial two-hybrid one-step screening strategy. 
The 5' region of the uvrA gene was amplified by error-prone PCR, digested and ligated into pRA02UvrA, -252. 
KSI cells containing pRA03UvrB35-252 or pRA03Mfdl-n9 were transformed with the plasmid library. White 
colonies were selected and plasmid DNA extracted and sequenced. The DNA was digested with Nhel to 
linearise the pRA03 derivative. KSI cells containing pRA03, pRA03UvrB35-252 or pRA03Mfd, -219 were 
transformed with the DNA for use in ß-galactosidase assays. 
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At this stage the purified DNA contained two plasmids: pRAO2UvrA1-252. EV144+LH151 and 
pRA03UvrB35.252. The DNA was digested with NheI to cleave pRA03UvrB35.252 but not 
pRAO2UvrA1-252. EV144+LH151" KS1 cells that contained pRA03, pRA03UvrB35.252 or 
pRA03Mfdl-219 were transformed with this DNA, pRA02 and pRA02UvrA1-252" The 
transformation mixtures were spread onto X-gal indicator plates. Single colonies of each 
combination were streaked onto a X-gal indicator plate to compare phenotype (Figure 3.5). 
Only cells expressing aUvrA1-252 and either %cIUvrB35-252 or AcIMfd1-219 exhibited a blue 
phenotype. Cells expressing the double mutant aUvrA1-252. EV144+LH151 and either 
%cIUvrB35-252 or ?. cIMfd1.219 appeared white. The white phenotype of cells containing 
aUvrA1-252. EV144+LH151 indicated that UvrA1.252. EV144+LH151 was unable to interact with 
UvrB35-252 or Mfd1.219. This implied that residue E144 or L151 is important for the 
UvrA1.252-UvrB35-252 and the UvrA1.252-Mfd1-219 interactions. 
To identify whether the UvrA EV 144 or LH 151 substitution caused the loss of interaction 
individual point mutations were constructed. The two mutants were generated by 
site-directed mutagenesis using the appropriate primers (Table 2.5). The PCR products 
were cloned into pRA02UvrA1-252 on a XbaI/KpnI fragment. XL1-Blue cells were 
transformed with the resulting plasmids. Single colonies were grown in LB broth 
containing ampicillin and tetracycline and the plasmid DNA extracted and sequenced. KS 1 
cells containing pRA03, pRA03UvrB35.252 or pRA03Mfd1.219 were transformed with the 
plasmid DNA. The ß-galactosidase activity was then measured (Figure 3.6). The single 
mutant aUvrAl-2s2. EV144 showed a wild-type level of ß-galactosidase activity when 
expressed in conjunction with ? clUvrB35-252 or XcIMfd1.219. The single mutant 
aUvrAl-252. Lx151 and the double mutant aUvrA1.252. EV144+Lx151 showed a similar low level 
of ß-galactosidase activity as a when expressed in conjunction with ), cIUvrB3s-252 or 
XcIMfd1.219. The low level of ß-galactosidase activity detected in cells expressing the 
aUvrAl-252. Lx151 mutant indicates that residue L151 is important for protein-protein 
contact. The wild-type ß-galactosidase activity seen in cells expressing aUvrAI-252. EV144 
indicates that residue E144 has no direct role in the protein-protein interaction detected in 
this screen. 
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Figure 3.5 Phenotypes from the ß-galactosidasc reporter screen. 
The phenotypes of KS I cells expressing either ),. cl (A. D and G), kclUvrB35_2 2 (B, E, H) or kclMfd, _3,,, 
(C. F. 
I) and either a (A, B, C), aUvrA1_2c2 (D, E. F) or aUvrAi 2s:,.; v,,,.,,,,, {,;, (G, H, 1) on an indicator plate (LB 
agar supplemented with the appropriate antibiotics, 1 mM IPTG and 80 µg/ml X-gal). Blue colonies indicate 
a positive interaction whilst white colonies indicate that no interaction was detected. 
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Figure 3.6 Effect of UvrA mutants EV144 and LH151 on ß-galactosidase activity. 
ß-galactosidase activity was determined on KS1 cells transformed with a pRA02 and a pRA03 derivative 
which enable expression of a and acI fusion proteins respectively. Yellow, green and orange bars indicate 
cells expressing xcl, Ä. cIUvrB35-252 and ). clMfd, _219 respectively. 
Assays were carried out in triplicate and 
results averaged. Error bars shown are standard deviations. 
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Identification of UvrA mutants - modifications to the one-step screen 
In an effort to identify single rather than multiple amino acid substitutions per clone the 
above screen was modified to try and reduce the mutation frequency. In the first screen 
five error-prone PCR cycles were used to generate the mutant library. From the resulting 
sequence data a mutation frequency of one in every 230 bp was determined. Only one 
mutation was required every 756 bp (the size of the PCR product) and therefore the 
number of error-prone PCR cycles was reduced (one to five cycles used) to try and 
decrease the mutation frequency. The screening protocol used to identify the 
aUvrAl-252. Lx151 mutation was followed except that only KS1 cells that contained 
pRA03Mfd1-219 were initially transformed with the library of uvrA mutants. This time nine 
potential mutants of uvrA were sequenced, four of which contained a frameshift and three 
of which contained stop codons. Of the other two candidates one encoded 
aUvrA1-252.1F027+GD173 and the other encoded aUvrA1.252. vE202" Site-directed mutagenesis 
was used to generate the DNA sequence from which the single mutants aUvrA1.252.1F027 
and aUvrAl-252. GD173 could be expressed (Table 2.5). KS1 cells containing pRA03, 
pRA03UvrB35-252 or pRA03Mfd1-219 were transformed with pRA02UvrA1-252.1F027, 
pRA02UvrA1-252.0D173 or pRA02UvrA1-252. vE202 and the subsequent ß-galactosidase activity 
measured. Cells expressing the mutant protein aUvrA1-252.1F027 had similar levels of 
ß-galactosidase activity to wild-type (data not shown). Cells expressing aUvrAl-252.0D173 or 
aUvrAl-252. VE2o2 only had a low level of ß-galactosidase activity when expressed in 
conjunction with XcIUvrB35-252 or XcIMfd1.219 (Figure 3.7). The low level of 
ß-galactosidase seen with aUvrA1-252. GD173 and aUvrA1.252. vE202 indicates that G173 and 
V202 are important for the protein-protein contacts detected in this system. 
Identification of UvrA mutants - two-step screen 
It is possible that some residues of UvrA are involved solely in either the UvrA-UvrB or 
the UvrA-Mfd interaction. Modifications to the one-step screen were made to identify 
residues of UvrA that are important for interacting with Mfd but are not required to 
interact with UvrB (Figure 3.8). The uvrA mutant plasmid libraries were produced from 
one and two cycles of error-prone PCR (followed by 30 standard PCR cycles). KS1 cells 
containing pRA03Mfdt-219 were transformed with the uvrA mutant plasmid library. 
Colonies expressing a white phenotype (indicating the absence of a UvrA-Mfd interaction) 
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Figure 3.7 Effect of UvrA mutants in the ß-galactosidase reporter screen. 
ß-galactosidase activity was determined on KS I cells transformed with a pRA02 and a pRA03 derivative 
which enable expression of a and A. cI fusion proteins respectively. Yellow, green and orange bars indicate 
cells expressing xcl, a. cIUvrB35-252 and acIMfd, _219 respectively. 
Assays were carried out in triplicate and 
results averaged. Error bars shown are standard deviations. The data for No UvrA, Wt UvrA and UVrALH151 
is the same as in Figure 3.6. 
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Error-prone PCR of uvrA fragment encoding UvrA1 252. 
Digestion with Xbal and Kpnl followed by ligation into 
pRA02UvrA1-252. pRA02UvrA1-zsz- 
Transformation into KS 1 cells containing pRA03Mfd1_219. 
Incubated on X-gal indicator plates at 30°C for 20 hours and room 
temperature for 24 hours. 
10 overnight cultures combined. 
Plasmid DNA extracted. 
DNA digested with Nhel to cleave pRA03Mfd1-219 plasmid. 
DNA transformation into KS I cells containing pRA03UvrB35 252. 
Incubation on X-gal indicator plates at 30°C for 20 hours and 
room temperature for 24 hours. Blue colonies streaked. 
Overnight cultures grown and plasmid DNA extracted. 
DNA sequenced. 
DNA digested with Nhel to cleave UvrB plasmid. 
0 0, DNA transformation into KS I cells that contained 
UvrB 
pRA03UvrB35-252 or pRA03Mfd1-219. Incubation on X-gal 
indicator plates at 30°C for 20 hours and room temperature for 24 
hours. 
98 
Chapter 3- Identification of UvrA Mutant Proteins 
Figure 3.8 Bacterial two-hybrid two-step screening strategy. 
The 5' region of the uvrA gene was amplified by error-prone PCR, digested and ligated into pRA02UvrAi-252. 
KS1 cells containing pRAO3Mfd1.219 were transformed with the plasmid library. White colonies were 
selected and cultured. 10 cultures were pooled and the plasmid DNA extracted. The DNA was digested with 
NheI to linearise the pRA03Mfd1.219 plasmid. KS1 cells containing pRA03UvrB35-252 were then transformed 
with DNA. Blue colonies were selected and cultured and the DNA extracted and digested with NheI to 
linearise the pRA03UvrB35-252 plasmid. Phenotype was confirmed by transforming KS1 cells that contained 
pRA03Mfd1.219 or pRA03UvrB35.252 with the DNA. The DNA was sequenced once the phenotype had been 
confirmed. 
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were used to inoculate 5 ml LB broth containing ampicillin, kanamycin and 
chloramphenicol that were then incubated at 37°C overnight. 10 cultures were pooled and 
their plasmid DNA extracted. At this stage the DNA samples contained pRA03Mfdi. 219 
and 10 potentially different pRA02UvrA1-252 mutant plasmids. The DNA mix was digested 
with Nhel to cleave the chloramphenicol resistant plasmid pRA03Mfdi-219" KS1 cells 
containing the chloramphenicol resistant plasmid, pRA03UvrB35-252, were transformed 
with the digested DNA mix. Colonies expressing a blue phenotype (indicating the presence 
of a UvrA-UvrB interaction) were streaked to single colonies. The single colonies were 
incubated overnight in LB broth containing ampicillin, kanamycin and chloramphenicol 
and then their plasmid DNA extracted. The DNA was digested with NheI to cleave 
pRA03UvrB35-252" KS 1 cells containing either pRA03UvrB35-252 or pRA03Mfd1-219 were 
again transformed with the DNA to confirm phenotype. Seven clones were identified that 
failed to interact with Mfd (white phenotype) but still interacted with UvrB (blue 
phenotype). These clones were sequenced. One contained a frameshift, four contained 
double mutations (coding for aUvrA1-252.1F021+YC174) aUvrA1.252. ND138+EV201, 
aUvrA1-252. AT009+DG2o5 and aUvrA1.252. QH130+DG2os) and two contained single mutations 
(both coding for aUvrA1-252. DG2o5)" The two double mutants in which the UvrADG205 
substitution was present were not taken further forward. 
The results from the modified one-step screen indicated that UvrA residues G173 and 
V202 are important for the UvrA1-252-UvrB35-252 and the UvrA1.252-Mfd1.219 interaction. 
UvrA mutants YC174 and EV201 from the double mutants were adjacent to G173 and 
V202 respectively. It was therefore predicted that YC174 and EV201 were responsible for 
the change in phenotype and therefore these single mutants (not IF021 or ND138) were 
generated by site-directed mutagenesis (Table 2.5). KSI cells that contained pRA03, 
pRA03UvrB35-252, or pRA03Mfd1-219 were transformed with pRA02UvrA1-252. YC174, 
pRA02UvrA1-252. EV2o1 and pRA02UvrA1-252. DG2o5" ß-galactosidase activity was then 
measured (Figure 3.7). When aUvrA1-252. YC174, aUvrA1.252. EV201 or aUvrA1.252. DG2o5 was 
expressed in KS I cells expressing XcIMfd1.219 only a low level of ß-galactosidase activity 
was detected. When they were expressed in KS 1 cells expressing XcIUvrB35-252 the level of 
ß-galactosidase activity measured was lower than when aUvrA1.252 was expressed but was 
still greater than the basal level seen when a was present. Therefore residues Y174, E201 
and D205 are important for the UvrA1.252-Mfd1.219 interaction but are not as important for 
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the UvrA1-252-UvrB35-252 interaction. The different effect of these mutants on the 
UvrA1-252-UvrB3s-252 and the UvrA1-2s2-Mfd1.219 interaction is interesting. At least some of 
the UvrA residues involved in the UvrA1.252-Mfd1.219 and the UvrA1.252-UvrB3s-252 
interaction are the same whilst other residues have a greater role in the UvrA1.252-Mfd1.219 
interaction than in the UvrA1.252-UvrB35-252 interaction. 
Expression levels of UvrA mutants under bacterial two-hybrid conditions 
Six UvrA mutants have been identified that appear to affect the UvrAl-252-UvrB35-252 and 
the UvrA1.252-Mfd1.219 interaction that is detected in this bacterial two-hybrid screen. One 
possible reason for a reduction in ß-galactosidase activity is that the mutant proteins are 
not expressed or are unstable and degrade faster than the wild-type fusion protein. To 
confirm protein levels KS 1 cells containing pRA03 and a pRA02 derivative were analysed 
by western blot. The membrane was probed with an anti-a antibody. Cultures containing 
all six of the mutant plasmids expressed the correct size fusion protein with the same 
intensity as the wild-type fusion protein (Figure 3.9). The level of endogenous RNAPa 
was detected at the same intensity in all lanes. Therefore the six UvrA amino acid 
substitutions: LH151, GD173, YC174, EV201, VE202 and DG205, did not significantly 
affect the fusion protein concentration within the cell. 
Mutations in UvrB 
Interactions detected in bacterial two-hybrid screens are not always physiologically 
relevant. A mutant known to disrupt the UvrA-UvrB or the UvrA-Mfd interaction would 
be a good control to check that the correct interaction was being detected in this screen. At 
the time of establishing the screen no mutants of UvrA, UvrB or Mfd had been identified 
that were specifically defective in these protein-protein interactions. Sequence alignments 
revealed only one fully conserved residue within the homology region of all UvrB and 
Mfd proteins sequenced to date. This residue within the E. coli UvrB protein was R213 
and seemed a reasonable candidate to be involved in the interaction with UvrA. In 2004, 
after the identification of the six UvrA mutants from this bacterial two-hybrid screen, a 
mutant that affected the B. caldotenax (Bca) UvrA-UvrB interaction was identified 
(Truglio et al., 2004). EMSA and pull-down assays indicated that the 
BC°UvrA-BC°UvrBRE183 interaction was much weaker than the BC°UvrA BC°UvrB interaction 
(Truglio et al., 2004). Truglio et al. also published the BC°UVrBYA096 crystal structure with 
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Figure 3.9 Expression levels of uUvrA1_252 mutants in the ß-galactosidasc activity assay. 
A sample of KSI cells containing plasmid pRA03 and either no additional plasmid, pRA02 or 
pRA02UvrA, _2s2 
(encoding the indicated mutant) were harvested at an A(o between 0.35 and 0.45. The 
samples were run on a 10%) SDS PAGE gel and transferred onto a membrane. The membrane was probed 
with a polyclonal anti-a primary antibody and then an HRP anti-rabbit lgG secondary antibody. i, indicates 
the NTD of the RNAPa subunit expressed from plasmid pRA02; ii, indicates the endogenous RNAPa 
subunit in the cell; iii, indicates the NTD of the RNAPa subunit fused at its C-terminus to the NTD of UvrA 
(either Wt or mutant). The ladder (kDa) is Preincision Plus protein standard (BioRad). 
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an intact domain 2 (the UvrA interaction domain) (Truglio et al., 2004). Both R183 and 
R213 are on the surface of domain 2 of B`°UvrBYAO96 (Figure 3.10). 
The effect of these mutants within the bacterial two-hybrid screen could be measured to 
determine the physiological relevance of the UvrAl_252-UvrB35-252 interaction identified 
within this system. Site-directed mutagenesis was used to generate the gene sequence 
coding for E. coli UvrB35-252.1 183 and UvrB35-252. RA213 (Table 2.5). The PCR products were 
cloned into pRA03UvrB35.252 to generate pRA03UvrB35-252. RE183 and 
pRA03UvrB35-252. RA213" KS1 cells containing pRA02 or pRA02UvrA1-252 were transformed 
with these plasmids and ß-galactosidase activity measured (Figure 3.11). The level of 
ß-galactosidase activity in KS1 cells expressing aUvrA1.252 and %cIUvrB35-252, 
XcIUvrB35-252. RE183 or XcIUvrB35-2s2. xA213 was very similar. The interaction detected in the 
bacterial two-hybrid screen is therefore not affected by mutating UvrB35-252 at residue 
RI83 or R213. 
UV sensitivity screen 
In a complementary approach a second screen was established to identify UvrA mutants. 
This in vivo screen was based on the observation that AuvrA cells are UV sensitive 
(Howard-Flanders et al., 1966). On exposure to UV light the DNA within cells would be 
damaged (Figure 3.12). In AuvrA cells where there is no functional UvrA the damaged 
DNA would remain as the cells would have no functional NER pathway (Figure 3.12A). 
DNA damage that was not repaired would result in a decrease in cell viability. Therefore 
AuvrA cells would exhibit a UV sensitive phenotype. If a plasmid based copy of uvrA was 
introduced into AuvrA cells the cells would be able to express UvrA. When UvrA was 
present the damaged DNA could be repaired by the NER pathway (Figure 3.12B). 
Therefore uvrA+ cells would be UV resistant. If a mutated copy of uvrA was introduced 
into the cells instead of wild-type uvrA a UvrA mutant would be expressed. The damaged 
DNA would not be repaired if the residue that was mutated was essential for one of the 
NER properties of UvrA (Figure 3.12C). These cells would therefore be UV sensitive. 
The bacterial two-hybrid system was designed to specifically identify protein-protein 
contact mutants. The UV sensitivity screen would identify physiologically relevant UvrA 
mutants that were defective in any essential UvrA property important for the NER 
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Figure 3.10 Crystal structure of UvrB. 
The crystal structure of UvrBYAO96 from B caldotenax (PDB code 1D9X) (Truglio et al., 2004). Domain 2, 
the proposed UvrA interaction domain is shown as a molecular surface. Two residues, R183 and R213, 
whose corresponding E. coli resides are also R183 and R213 and have been mutated in this work, are 
indicated in black. The domains are coloured as follows: dark blue, domain la; purple, domain lb; aqua, 
domain 2; orange, domain 3; and red, ß-hairpin. 
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Figure 3.11 Effect of UvrB mutants on ß-galactosidase activity. 
ß-galactosidase activity was determined in KS I cells transformed with a pRA02 and a pRA03 derivative 
which express a and AcI fusion proteins respectively. Yellow and purple bars indicate cells expressing a and 
aUvrA, _252 respectively. 
Assays were carried out in triplicate and results averaged. Error bars shown are 
standard deviations. 
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Figure 3.12 Principle behind the UV sensitivity screen. 
(A) DNA damage introduced by UV irradiation can not be repaired by AuvrA cells. Therefore the cells die 
(UV sensitive phenotype). (B) DNA damage introduced by UV irradiation can be repaired by uvrA+ cells. 
Therefore the cells survive (UV resistant phenotype). (C) DNA damage introduced by UV irradiation is not 
repaired in cells expressing UvrA mutants deficient in any essential UvrA property. Therefore the cells die 
(UV sensitive phenotype). 
106 
Chapter 3- Identification of UvrA Mutant Proteins 
pathway. UvrA mutants identified using this screen could therefore be defective in a 
variety of properties including ATP binding, ATP hydrolysis, UvrA dimerization, DNA 
binding and protein-protein contact. Subsequent assays would allow mutants defective in 
protein-protein contacts to be identified. 
In order for the UV sensitivity screen to work a AuvrA strain was required. FB21635, 
which is a AuvrA derivative of MG1655, was obtained from the Genetic Stock Centre at 
Wisconsin. At this stage the strain contained the plasmid pKD46 that had been used to 
introduce a transposon coding for kanamycin resistance into the uvrA gene. pKD46 was 
ampicillin resistant and would compete with the ampicillin resistant derivatives of pQE30 
that would need to be introduced as part of the screen. FB21635 cells were cured of 
pKD46 by streaking on LB agar containing kanamycin but not ampicillin. Colonies were 
selected and checked for a lack of ampicillin resistance by streaking onto LB agar 
containing kanamycin and onto LB agar containing ampicillin and kanamycin. Colonies 
that only grew on the kanamycin plates were selected and used for the next stage. 
In these experiments the uvrA gene was to be introduced into cells under the control of the 
lac promoter. To try and prevent high levels of UvrA expression under uninduced 
conditions a high concentration of the lac repressor was required. The lac repressor should 
bind to the lac promoter preventing RNAP from binding and thus prevent transcription of 
uvrA. To achieve this the F episome from XL1-Blue that contains lace that encodes for 
large quantities of Lac repressor was introduced into FB21635 cells (that had been cured 
of pKD46) by conjugation. These cells were named MG1655AuvrA. MG1655 cells have a 
functional uvrA gene and are not resistant to any antibiotics. MG1655AuvrA cells have a 
kanamycin resistant cassette within the uvrA gene (making it AuvrA) and also contain the 
Fepisome from XL1-Blue cells. 
The UV phenotype of cells that contained uvrA (MG1655) and cells that did not 
(MG1655AuvrA and FB21635) was determined using a survival assay protocol that 
involves cell irradiation then dilution. 1 ml of each cell type was irradiated with 60 J/m2 
254 nm UV light whilst the remaining cells were not irradiated. The irradiated and 
unirradiated cells were subject to 10-fold serial dilutions, spotted onto LB agar plates and 
incubated at 30°C for 16 hours. Approximately 10% of MG1655 cells (uvrA+) survived 
irradiation (Figure 3.13) whilst all FB21635 (LuvrA) cells died. MG1655AuvrA cells that 
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Figure 3.13 UV irradiation phenotype of Escherichia coli cells. 
MG 1655, FB21635, MG 1655AuvrA pQE30 and MG1655AuvrA pQE30UvrA were grown at 37°C from 
culture until an A(, (u) of 0.4 was obtained. The cells were harvested and suspended in M9 media. I ml of each 
culture was irradiated at 60 J/m` 254 mm UV light and 10-fold serial dilutions of both the irradiated and the 
unirradiated cells were made. The serial dilutions were spotted (2 Id) on two LB agar plates and incubated 
overnight at 37°C. 
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had been transformed with pQE30 all died when irradiated. Approximately 10% of 
MG1655AuvrA cells transformed with pQE30UvrA survived irradiation. The 
MG1655AuvrA cells transformed with pQE30UvrA survived despite the absence of an 
inducer that should have been required to remove the Lac repressor. There was no 
significant difference detected between MG1655 and MG1655AuvrA pQE30UvrA cells 
indicating that histidine-tagged UvrA was able to substitute for wild-type UvrA. The UV 
resistant phenotype of MG1655AuvrA pQE30UvrA cells is due to the introduction of the 
plasmid copy of uvrA. The UV resistance was not because of the F episome or the 
backbone of pQE30. The difference in UV phenotype between MG1655AuvrA 
transformed with pQE30 or pQE30UvrA is sufficient to enable screening of UvrA mutants 
that are unable to complement the UV sensitive phenotype of AuvrA cells. 
Identification of UvrA mutants 
MG1655t uvrA cells were used as a basis to screen for mutants of UvrA that were unable 
to complement the cells UV sensitive phenotype. Two cycles of error-prone PCR were 
carried out on the 5' region of uvrA that coded for the N-terminal 230 amino acids. These 
were cloned into pQE30UvrA on a BamHI/KpnI fragment to generate a library of mutant 
plasmids. Electrocompetent MG1655AuvrA cells were subsequently transformed with the 
mutant plasmids. The transformation mix was spread onto LB agar plates containing 
ampicillin and kanamycin and incubated overnight at 30°C. Two replica plates were made 
of which the first was irradiated with 20 J/m2 254 nm UV light. Both the irradiated and the 
unirradiated plates were incubated overnight at 30°C, A total of approximately 2500 
colonies grew on unirradiated plates of which 199 failed to grow on the irradiated plate 
(Figure 3.14). The 199 colonies that failed to grow on the irradiated plates contained 
pQE30UvrA plasmid derivatives that were unable to complement the MG1655EuvrA 
phenotype. Therefore it was assumed that the pQE30UvrA plasmids within these 199 
colonies did not code for fully functional UvrA proteins. These 199 colonies were 
analysed further. 
The next step was to identify which of the 199 colonies expressed full-length UvrA 
protein. A reason for the colonies being UV sensitive was if expression of full-length 
UvrA did not take place. During the error-prone PCR protocol mutations could have been 
introduced that would code for a stop codon or a frameshift within the 5' region of UvrA. 
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Replica Plate I 
20 J/m2 254 nm light 
Replica Plate II 
0 J/m2 254 nm light 
Figure 3.14 Screening for UV sensitive colonies. 
MG1655AuvrA cells were transformed with a uvrA mutant library cloned into pQE30UvrA and incubated 
overnight at 37°C (original). Two replica plates of the overnight plate were produced. The first of these 
replicas was exposed to 20 J/m2 254 nm UV light. Both plates were incubated at 30°C for 16 hours. Yellow 
circles indicate replica colonies that are present on replica plate II but are absent on the irradiated replica 
plate I indicating that they are UV sensitive. 
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This would result in a UvrA truncation being expressed instead of the full-length protein. 
The truncation would be unable to complement the UV sensitive phenotype of 
MG1655AuvrA cells. In order to identify which colonies expressed full-length UvrA 
overnight cultures of the 199 UV sensitive colonies were resolved on SDS PAGE gels. At 
the same time proteins from MG1655AuvrA cells that had been transformed with pQE30 
or pQE30UvrA were also analysed. MG1655AuvrA cells that contained pQE30UvrA 
expressed full-length UvrA (Figure 3.15). When the cells contained pQE30 instead of 
pQE30UvrA the band corresponding to UvrA was not present. Of the 199 colonies that 
were UV sensitive 58 expressed a protein band corresponding to the size of full-length 
UvrA. The 141 colonies that did not were discarded. 
The next step in the screening procedure was to confirm the UV sensitive phenotype of the 
58 mutants. This was done by following the UV sensitivity assay irradiation then dilution 
protocol exposing the cells to 0 and 60 J/m2 254 nm UV light. Of the 58 colonies that 
expressed full-length protein 27 were found to be UV resistant on reanalysis and 31 were 
confirmed as UV sensitive (Figure 3.16). The 31 colonies that were UV sensitive and 
expressed full-length UvrA must express mutated forms of UvrA that are deficient in an 
essential UvrA property. From an initial 2500 colonies 31 (1.2%) expressed a full-length 
copy of UvrA and were UV sensitive (Table 3.1). The plasmid DNA from the 31 clones 
was sequenced. Of the 31 clones 14 contained single point mutations, eight contained 
double point mutations seven contained multiple (>2) point mutations and two failed to 
sequence. The 14 single UvrA mutants encoded amino acid substitutions: RL023, GS034, 
SA038, SP038, FI064, FS064, LQ065, VD073, SY080, QL087, GR099, CR120, LP151 
and KE159. 
In vivo properties of UvrA mutants 
As a result of the two screening procedures 20 single mutants of UvrA had been identified 
and required further characterisation. An UV survival assay was used to quantify the affect 
of each mutation on the UV resistant phenotype of MG1655AuvrA cells transformed with 
pQE30UvrA. In this assay the irradiation was applied after the cells had been diluted and 
spotted onto LB agar plates. A variety of irradiation doses were used in this assay instead 
of 60 J1m2 that had been used in the screening procedures. Initially MG1655AuvrA cells 
were transformed with pQE30 or pQE30UvrA. The number of cells surviving different UV 
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Figure 3.15 Protein expression of UV sensitive colonies. 
MG1655AuvrA pQE3OUvrAm,,, H,,,, that were identified as being UV sensitive were analysed for protein 
expression. Samples of overnight cultures were harvested, SDS PAGE loading dye added and heated to 95°C 
for five minutes. The samples were loaded onto a 10% SDS PAGE gel. MG165SAuvrA cells containing 
pQE30 or pQE30UvrA that do and do not express full-length UvrA were also loaded onto the gel. i, indicates 
the band corresponding to full-length UvrA. The ladder (kDa) is SigmaMarker. 
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Figure 3.16 Confirmation of UvrA mutants UV irradiation phenotype. 
MG 1655Auvr. l cells containing pQE30UvrAu, tants expressing full-length UvrA were grown at 37°C from 
culture until an A&x) of 0.5 was obtained. At the same time MG1655Auvr. 4 cells containing pQE30 or 
pQE30UvrA were also grown. The cells were harvested and suspended in M9 media. I ml of each culture 
was irradiated at 60 J/m` 254 nun UV light and 10-fold serial dilutions of both the irradiated and the 
unirradiated cells were made. The serial dilutions were spotted (2 µl) on two LB agar plates containing the 
appropriate antibiotics and incubated overnight at 30°C. Example plates are shown. 
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Stage of screen Total number % of total screened 
Total number screened -2500 100 
Step 1 UV sensitive 199 8.0 
Step 2 Full-length UvrA expressed 58 2.3 
Step 3 UV sensitivity assay 31 1.2 
Table 3.1 UV sensitivity screen statistics. 
Mutants were identified via the UV sensitivity screen by initially screening for cells that appeared UV 
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dosages was recorded, averaged and plotted on a log graph (Figure 3.17). MG1655AuvrA 
cells transformed with pQE30 struggled to survive UV irradiation greater than 4 J/m2. 
MG1655AuvrA cells transformed with pQE3OUvrA were able to survive UV irradiation. A 
dose of 24 J/m2 saw a 100-fold reduction in survival. 
Before the UV phenotype of cells expressing the UvrA mutants could be analysed the 
UvrA mutations identified from the bacterial two-hybrid screen needed to be transferred to 
the full-length gene. The region of uvrA encoding the identified mutation was amplified by 
PCR, cloned into pQE30UvrA on a BamHI/Kpnl fragment and sequenced. 
The UV irradiation phenotype of all mutants from both the bacterial two-hybrid and UV 
sensitivity screen were analysed quantitatively. MG1655AuvrA cells were transformed 
with the pQE30UvrA mutant plasmids or the control plasmids pQE30 and pQE30UvrA 
and UV survival assays carried out as above. The cells were exposed to seven different 
dosages of UV ranging from 0 to 24 J1m2 and incubated overnight at 30°C. The cells were 
counted and plotted on log graphs (Figure 3.18) (the results from cells that did and did not 
express wild-type UvrA are as shown in Figure 3.17). The mutants fall into three 
categories. The six mutants identified from the bacterial two-hybrid assay (UvrALHI5I, 
UvrAGD173, UvrAYC174i UvrAEV2ol, UvrAvE2o2 and UvrADG205) conferred UV resistance to 
the cells (uvrA+). UvrAsP038 and UvrAGR099 (isolated on the basis of their UV sensitivity) 
were unable to confer any UV resistance to the cells (AuvrA). Cells that expressed either 
UvrARL023, UvrAGS034, UVrASA038, UvrAFI064, UvrAFS064, UVrALQ065, UvrAVD073, 
UvrAsyo8o, UvrAQL087, UvrACRI2o, UvrALPI5I or UvrAKEI59 (all isolated on the basis of UV 
sensitivity) were 10 to 1000-fold more sensitive than cells expressing wild-type UvrA but 
did confer some UV resistance to the cells. 
Discussion 
A total of 17 UvrA residues have been identified that are important for UvrA function. Of 
these five were uniquely identified from the bacterial two-hybrid screen, 11 were uniquely 
identified from the UV sensitivity screen and one residue (L151) was identified from both 
screens. 
The bacterial two-hybrid screen was designed to identify a UvrA-UvrB interaction and a 
UvrA-Mfd interaction. Several truncations of UvrA were tested within the system. 
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Figure 3.17 UV sensitivity. 
UV irradiation phenotype of MG1655AuvrA cells transformed with pQE30 (blue) or pQE30UvrA (purple). 
Spot assays were used in which cells were 10-fold serial diluted, spotted onto 21 LB agar plates containing 
kanamycin and ampicillin and then exposed to UV irradiation for differing times (three plates for each time 
period). The number of colonies in the most diluted viable spots were counted. Each individual assay result 
was an average of three spots (one spot from each plate) and each assay was carried out five times. A 
survival of 0.0001% would correspond to one individual colony present in the undiluted spot. No colonies 
were present for MG 1655AuvrA cells transformed with pQE30 and irradiated at 16 J1m2. 
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Figure 3.18 UV survival curves. 
MG1655AuvrA cells were transformed with pQE30UvrAmt, v (red lines). Cultures were grown overnight 
and subsequently subcultures were taken and incubated until an A® of 0.5 was reached. The cells were 
harvested and suspended in M9 media and 10-fold serial dilutions were made. The cultures were spotted (2 
pl) onto three sets of seven plates which were irradiated with 0,4,8,12,16,20 or 24 J/m2 254 nm UV light. 
The graphs summarise the results of three independent experiments and error bars indicate standard 
deviations. The wild-type (purple lines) and no UvrA (blue lines) graphs are the same as in Figure 3.17. 
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UvrA1.252 was able to interact with the truncation of UvrB and the truncation of Mfd to 
give a detectable phenotype. Thus this region of UvrA was taken as the basis for the 
bacterial two-hybrid screen. Interestingly the region of UvrA that had previously been 
proposed to interact with UvrB (UvrAl-230) was unable to interact with either truncation of 
UvrB or Mfd to give a detectable phenotype (Claassen and Grossman, 1991). The evidence 
to suggest that UvrA1.230 is involved in the UvrA-UvrB interaction was based on the 
results of an ATPase assay. In this assay an ATPase deficient mutant of UvrB (UvrBKAO45) 
stimulated the activity of wild-type full-length UvrA. This UvrB mutant was also able to 
stimulate the ATPase activity of UvrA1_230. However this region of UvrA lacks a Walker B 
motif and thus would not be expected to hydrolyse ATP with or without the presence of 
UvrBKAO45" In this assay UvrA1.230 had been purified from uvrA+ cells (Claassen et al., 
1991). It is therefore possible that the low level of ATPase activity detected in the absence 
of UvrBKAO45 was due to contamination by full-length UvrA. If this is true then the 
increased ATPase activity detected when UvrBKA045 was added to the UvrA1.230 
preparation is actually more likely to be due to the stimulation of full-length UvrA. 
The UvrA mutants identified from the bacterial two-hybrid screen fall into two categories: 
those that almost completely disrupted the UvrAl-252-UvrB35-252 and the UvrA1.252-Mfd1.219 
interaction which include UvrAl-252. LH151, UvrAl-252. GD173 and UvrA1.252. YE202; and those 
that disrupted the UvrAi-252-Mfd1-219 interaction but were still capable to some degree of 
forming the UvrAl-252-UvrB3s-252 interaction which include UvrA1.252. YC174, UvrA1.252. EV201 
and UvrA1.252. DG2o5" The bacterial two-hybrid mutants are clustered in three patches 
centred at residues 151,173 and 203 (purple residues in Figure 3.19). All three patches 
contain a residue (L151, G173 and V202) whose mutation resulted in both the 
UvrAl-252-UvrB3s-252 and the UvrA1-2s2-Mfd1-219 interactions being almost completely 
disrupted. The UvrA residues Y174, E201 and D205, which when mutated resulted in the 
loss of the UvrA1-2s2-Mfd1-219 interaction but were still able to partially maintain the 
UvrAl-252-UvrB35-252 interaction, could play a supportive but unessential role in the 
UvrAl-252-UvrB35-252 interaction. The three different patches could indicate that the UvrA 
tertiary structure brings these regions close together to form one patch through which it 
interacts with UvrB and Mfd. Alternatively UvrA could interact with UvrB and Mfd via a 
variety of structurally separated sites. 
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251 FA 
Figure 3.19 UvrA mutants identified from the bacterial two-hybrid and UV sensitivity screens. 
The amino acid sequence of the NTD of UvrA, which was subjected to random mutagenesis, is indicated. 
Purple boxes above the sequence indicate the UvrA mutations identified from the bacterial two-hybrid 
screen. Orange boxes above the protein sequence indicate the UvrA mutations identified from the UV 
sensitivity screen. The yellow box corresponds to the Walker A motif. 
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The physiological relevance of the interaction detected in the bacterial two-hybrid screen 
could not be confirmed. One amino acid mutation of BcaUvrB (UvrBREI83) was known to 
cause a partial (but not complete) disruption of the B`°UvrA-B`°UvrB interaction (Truglio et 
al., 2004) but the equivalent residue in E. coli UvrB failed to disrupt the identified 
UvrAl-252-UvrB35-252 interaction within the bacterial two-hybrid system. As previously 
mentioned more than one region of UvrA may interact with UvrB. Thus UvrBR183 may 
interact with residues of UvrA outside the N-terminal region used in the bacterial 
two-hybrid screen. If this were true then the interaction between %cIUvrB35-252. RE183 and 
aUvrAl-252 would result in the wild-type levels of ß-galactosidase activity observed. The 
evidence to indicate that this residue is important in the full-length UvrA-UvrB interaction 
comes from a series of experiments (Truglio et al., 2004). Experiments in which the 
UVrBRE183 mutant has been used include incision assays, pull-downs, EMSAs, helicase 
assays and nucleotide hydrolysis assays (Truglio et al., 2004). In all these assays some 
activity was detected. This suggests that the UvrA-UvrB interaction is probably not solely 
dependent on this residue of UvrB indicating that other residues are involved. Therefore an 
interaction between aUvrA1.252 and %cIUvrB35-252. RE183 within the bacterial two-hybrid 
screen could be expected. 
The inability of UvrBiw13 to interrupt the bacterial two-hybrid interaction was expected as 
a double mutant within B. caldotenax UvrB (in which the equivalent residue was mutated) 
(UvrB113+EA21s) had little effect on the UvrA-UvrB interaction detected by EMSAs 
(Truglio et at, 2004). 
When the six substitutions identified from the bacterial two-hybrid screen were transferred 
into full-length UvrA they are all are able to confer UV resistance to AuvrA cells. An 
explanation for this is that the UvrA mutants are overexpressed compared to the expression 
of chromosomal wild-type UvrA (in uvrA+ cells). The high expression levels could 
compensate for an interaction affinity defect associated with these mutants. Alternatively, 
the UV resistant phenotype could indicate that other regions of each protein interact in vivo 
and that these interactions are sufficient to enable wild-type levels of NER to take place. A 
further region of UvrB (domain 4) has been implicated in binding full-length UvrA (Hsu et 
al., 1995). It is possible that further regions of UvrA are also involved in the UvrA-UvrB 
interaction. Additional interactions between the proteins may help to stabilise the 
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interaction detected in the bacterial two-hybrid screen, eliminating the effect of the 
mutations within the full-length protein. 
The region encoding the N-terminal 230 amino acids of UvrA was randomly mutagenized 
as part of the UV sensitivity screen. However all 12 single amino acid mutants that were 
identified in this screen were between residue 23 and 159 with nine of the 12 in the 
N-terminal 100 amino acids (orange residues in Figure 3.19). Two UvrA residues, S38 and 
F64, were each identified by two different single point mutants. As expected some (three) 
mutations were present within the Walker A region. Mutations within the Walker A region 
would be expected to have low or no ATPase activity and therefore would be unable to 
support NER, essential for a UV resistant phenotype. The identification of the Walker A 
mutants confirmed that the screen was working as expected and was identifying mutants 
that altered essential properties of UvrA. Interestingly there was very little overlap 
between the residues identified in the UV sensitivity screen and the residues identified 
from the bacterial two-hybrid screen. However residue L151 was identified from both 
screens indicating that the bacterial two-hybrid screen may be physiologically relevant. 
The mutants identified from the UV sensitivity screen could be deficient in any number of 
different functions. The properties of these mutants are discussed further in chapter 5. 
123 
Chapter 4- Protein Purification and Assay Development 
CHAPTER 4 
PROTEIN PURIFICATION AND ASSAY DEVELOPMENT 
124 
Chapter 4- Protein Purification and Assay Development 
Introduction 
In vitro assays are useful tools in understanding the biochemical nature of protein-protein 
interactions. Therefore the UvrA mutant proteins identified in the previous chapter were 
characterised in vitro. Bulky DNA damage can be incised in vitro by the combined action 
of UvrA, UvrB and UvrC in the presence of Mg2+ and ATP (Seeberg et al., 1976) (Sancar 
and Rupp, 1983) (Yeung et al., 1983). UvrA, UvrB and UvrC have each been purified to 
homogeneity by other groups (Seeberg and Steinum, 1982) (Thomas et al., 1985) (Yeung 
et al., 1986b). It was important to develop a simple and reproducible purification protocol 
for UvrA, UvrB and UvrC that could also be used to purify the mutant proteins. One of the 
simplest ways to achieve this would be to introduce a tag. The addition of extra amino 
acids could potentially alter the structure and function of the protein of interest. Therefore 
it would be important that tagged proteins were assayed for their expected functions. Many 
tagged proteins function normally (Yin and Proteau, 2003) and thus tagging the NER 
proteins is a potential way of establishing quick and simple purification procedures. In the 
previous chapter, results of in vivo experiments indicated that histidine-tagged UvrA could 
complement AuvrA cells. 
The combined action of UvrA, UvrB and UvrC should result in incision of DNA both 3' 
and 5' of bulky damage (Sancar and Rupp, 1983). In vitro the UvrABC protein complex 
has previously been shown to incise DNA containing a variety of bulky lesions including 
CPDs (Sancar and Rupp, 1983), cholesterol (Moolenaar et al., 1998a) and fluorescein 
(Skorvaga et al., 2004). To study NER and TCR it would be ideal to have one modification 
in all DNA molecules at a specified site. Irradiating DNA with UV light is one way of 
introducing damage. However the type, position and number of damage sites will vary 
between the DNA molecules within the same experiment. This can make the interpretation 
of results difficult. A second way to introduce damage is to use direct chemical methods to 
synthesise oligonucleotides to contain specific lesions such as cholesterol and fluorescein. 
This method results in the molecules being identical but the DNA fragment size is 
restricted. The modified oligonucleotides can be used to generate longer fragments using 
PCR. This will enable extension 3' of the lesion but the length of the DNA 5' to the lesion 
is still restricted. These methods were therefore not ideal to introduce a single site of 
damage within a transcriptional unit to study the process of TCR. To study NER and TCR 
identical modified large DNA fragments were required. The modification had to be 
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recognised as a site of damage by the NER proteins and also had to act as a substrate for 
TCR assays by causing RNAP to stall. In a novel method sequence-specific 
methyltransferase induced labelling (SMILing), that can be used to introduce 
modifications at specific DNA sequences, was used to introduce a modification to a single 
specified base within a plasmid. 
Purification of UvrA, UvrB and UvrC 
For in vitro NER based assays UvrA, UvrB and UvrC were required. Therefore the genes 
were cloned in-frame downstream of a sequence encoding a hexa-histidine tag. The 
expressed UvrA, UvrB and UvrC proteins would consequently have a N-terminal 
hexa-histidine label. This hexa-histidine tag would enable simple purification over one 
FPLC column using the strong binding affinity histidine residues have for metal ions such 
as Nit+. 
Cloning of uvrA, uvrB, and uvrC 
To enable expression and purification of UvrA, UvrB and UvrC, uvrA, uvrB and uvrC 
were cloned into plasmids. The plasmids pBSIIUvrA, pBSIIUvrB and pBSIIUvrC23.610 
contained the gene sequences for uvrA, uvrB and all but the 5' 56 nucleotides of uvrC that 
had each been amplified by PCR from the genomic DNA of E. coli strain MG1655. The 5' 
region of the uvrC gene from the genomic DNA of E. coli strain MG1655 was amplified 
and cloned into pBSI1UvrC23-610 to generate pBSIIUvrC as described in chapter 2. The 
PCR amplified complete uvrA, uvrB and uvrC genes were sequenced within the pBSII 
plasmids. The genes were then cloned into the commercially available expression vector 
pQE30 on a BamHI/HindIII fragment. The genes were cloned so that they were in-frame 
and downstream of the hexa-histidine coding sequence present within the plasmid. 
Upstream of the hexa-histidine coding sequence there was a T5 promoter that could be 
recognised and bound by E. coli RNAP. Overlapping the T5 promoter was a lac operator 
site enabling transcription of the gene of interest to be controlled. Therefore plasmids had 
been generated that would allow the controlled expression of N-terminal hexa-histidine 
labelled UvrA, UvrB and UvrC. 
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Expression of histidine-tagged UvrA, UvrB and UvrC 
It was necessary to determine the conditions required for protein expression of UvrA, 
UvrB and UvrC. XL1-Blue cells, which carry the laclq gene on aF episome, were 
transformed with plasmids pQE30UvrA or pQE30UvrB. Cultures were incubated 
overnight and then duplicate subcultures were set up, one of which contained 1 mM IPTG. 
The cultures were incubated at 37°C overnight and then expression levels of UvrA and 
UvrB were analysed on SDS PAGE gels (data not shown). Expression of UvrA and UvrB 
was detected but interestingly these proteins were only seen when the cultures had not 
been induced. 
The expression of UvrA and UvrB seen in the uninduced XL1-Blue cultures was 
unexpected. The system was designed so that transcription of the gene would be repressed 
without the addition of the inducer, IPTG. In principle the Lac repressor protein should 
have been abundant due to laclq. The Lac repressor should have bound to the operator site 
preventing RNAP from binding and transcribing the genes of interest. For expression to be 
detected in the uninduced system RNAP must have been able to transcribe the gene. 
Therefore the Lac repressor can not have been tightly bound to the operator site if it was 
bound at all. This could indicate that an inducer such as lactose was present. 
It was also unexpected to see lower or no expression of UvrA and UvrB in the induced 
cultures than the uninduced cultures. Addition of IPTG should have resulted in the release 
of Lac repressor from the operator site allowing RNAP to transcribe the genes of interest. 
An explanation for the reduced protein expression seen in the induced cultures could be 
due to the Uvr proteins being toxic to the cells in amounts greater than their uninduced 
levels. 
Further analysis of the XL1-Blue cultures containing pQE30UvrA or pQE30UvrB 
revealed that the highest level of protein expression was seen in cultures that had been 
incubated from a single colony for 16 hours at 37°C without induction. Figure 4.1 
indicates typical levels of UvrA, UvrB and UvrC expression from cultures of XL1-Blue 
cells containing pQE30UvrA, pQE30UvrB and pQE30UvrC respectively after a 16 hour 
incubation at 37°C. Bands corresponding to the correct MW for each protein (UvrA 104 
kDa, UvrB 76 kDa, UvrC 70 kDa) were easily detected. UvrA and UvrB were expressed at 
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Figure 4.1 UvrA, UvrB and UvrC expression levels. 
A single colony of XL! -Blue E. co/i cells that had been transformed with plasmid pQE30UvrA, pQE30UvrB 
or pQE30UvrC was incubated at 37°C for 16 hours in 100 ml LB broth supplemented with ampicillin and 
tetracycline. A small sample (1000/A6w gl) was harvested. The pellet was suspended in 100 gl protein 
sample buffer and incubated at 95°C for five minutes. The samples (5 gl) were resolved on a 10% SDS 
PAGE gel. i, ii, and iii correspond to the expected size for UvrA, UvrB and UvrC respectively. The ladder 
(kDa) used was SigmaMarker. 
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a higher level than UvrC. UvrC has been reported to degrade faster than UvrA and UvrB 
and thus it is unsurprising that the level of protein detected is lower (Thomas et al., 1985). 
MG1655AuvrA cells were transformed with pQE30UvrA. This was to prevent 
contamination by wild-type UvrA (expressed from the chromosome), which would be 
important when purifying the UvrA mutant proteins. UvrA expression was achieved in the 
same way as UvrA expression in XL1-Blue cells with cultures incubated at 37°C for 16 
hours. Similar levels of expression were seen for the wild-type UvrA protein in both 
XL1-Blue and MG1655AuvrA cells (data not shown). The expression level of all three 
proteins was sufficient to attempt protein purification. 
Purification of UvrA, UvrB and UvrC 
UvrA was purified from 100 ml MG1655LuvrA cells transformed with pQE30UvrA. UvrB 
and UvrC were purified from 100 ml XL1-Blue cells transformed with pQE30UvrB and 
pQE30UvrC respectively. The expressed UvrA, UvrB and UvrC each had a hexa-histidine 
tag at their N-terminus. Histidine binds strongly to metal ions such as nickel and 
consequently this property was used in the purification process. Single colonies were used 
to inoculate 100 ml LB broth and incubated according to the protocol described in chapter 
2. The hexa-histidine tagged proteins were purified by passing the cells over a HiTrap 
chelating column that had been charged with Ni2+ which would bind the hexa-histidine 
tagged proteins. The bound protein was washed and then eluted using imidazole to 
compete with the hexa-histidine tag for the metal ions. UvrA, UvrB and UvrC were eluted 
from the column when the imidazole concentration had reached approximately 120 mM, 
100 mM and 140 mM respectively (Figure 4.2). A single peak was observed for both UvrA 
and UvrB and samples of these fractions contained a single protein corresponding to the 
expected size. The trace for UvrC contained a shouldered peak of which the main peak 
contained the band of the correct size. Fractions of each sample that contained pure protein 
were dialysed into dialysis buffer and then into storage buffer. Protein concentration was 
determined. From 100 ml of culture approximately 8 mg of UvrA, 15 mg of UvrB and 0.25 
mg of UvrC were purified in a final volume of approximately 500 µl. 1 µg of each purified 
wild-type protein was resolved on a SDS PAGE gel to confirm relative concentration and 
purity (Figure 4.3). Each protein was purified more than once during this work. UvrA and 
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Figure 4.2 UvrA, UvrB and UvrC protein purification profiles. 
UvrA was purified from 100 ml MG1655AuvrA cells that contained pQE30UvrA. UvrB and UvrC were 
purified from 100 ml XL1-Blue cells that contained pQE30UvrB and pQE30UvrC respectively. The cells 
were sonicated, centrifuged and the soluble fraction purified over a1 ml chelating column that had been 
charged with Ni2+ using a FPLC. The A280 elution profiles are shown: the purple line corresponds to UvrA, 
the green line to UvrB, the light blue line to UvrC and the grey line to the percentage of elution buffer (0 to 
100%). Panel A represents a typical purification profile and panel B is a close up of the elution profile of 
panel A. 
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Figure 4.3 Samples of purified UvrA, UvrB and UvrC proteins. 
1 gg of purified UvrA, UvrALH1SI. UvrB and UvrC were run on a 10% SDS PAGE gel. i, ii, and iii 
correspond to the expected size for UvrA, UvrB and UvrC respectively. The ladder (kDa) used was 
SigmaMarker. 
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UvrB were stable at -20°C. UvrC was unstable at -20°C after approximately four to eight 
weeks and consequently was purified frequently during the course of the work. 
Incision activity of wild-type UvrABC 
Incision assays were carried out to establish whether the purified proteins were working as 
expected. Initially plasmid pSRlacUV5203 was treated with 30 J1m2 254 nM UV light to 
introduce approximately one site of damage per plasmid (based on (Sancar and Rupp, 
1983)). This would introduce UV photoproducts that would act as a substrate for the repair 
proteins. Combinations of UvrA, UvrB, UvrC and ATP were added (Figure 4.4). As a 
control the DNA was treated with the enzyme T4EV that specifically recognises and 
cleaves CPDs, a type of UV photoproduct. Supercoiled DNA runs faster than linear DNA 
which runs faster than nicked DNA. Untreated damaged DNA ran at the supercoiled 
position. When the damaged DNA was treated with T4EV the DNA was nicked at sites of 
pyrimidine dimers and ran at the nicked position on the gel. Damaged DNA that had been 
treated with UvrA, UvrB, UvrC and ATP also ran at this position. If one or more of the 
repair components were eliminated then the DNA ran at the higher mobility band 
corresponding to supercoiled DNA. The DNA that had not specifically been treated with 
UV but was treated with either T4EV or the Uvr proteins ran at both the supercoiled and 
the nicked position. 
The results indicated that all the repair proteins were required in the presence of ATP for 
nicking to occur. Eliminating one of the repair enzymes completely prevented nicking 
indicating that there was no contamination of the purified proteins with the other repair 
proteins. The reaction was dependent on ATP being present which is consistent with the 
published data indicating that the repair proteins require ATP for function (Yeung et al., 
1983). The DNA appeared to be damaged to some extent before the irradiation took place 
as some nicked DNA was detected when the unirradiated DNA was treated with either 
T4EV or the NER proteins (Figure 4.4 lane 15 and 16 respectively). In conclusion the 
repair proteins and ATP are sufficient to nick UV damaged DNA. 
To check that the 5' incision reaction was occurring eight phosphodiester bonds 5' of the 
damaged site further incision assays were carried out. This time the 5' 32P labelled 
pSR1acUV5203 EcoRIBamHI fragment was irradiated with 300 J/m2 UV light to introduce 
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Figure 4.4 Incision assay on pSRIacUV52()3. 
pSRIacUV52(,, was exposed to 30 J/m2 254 nm UV light where indicated. The DNA was then treated where 
indicated with 20 U T4EV, 40 nM UvrA, 100 nM UvrB, 70 nM UvrC and 2 mM ATP. The reactions were 
incubated at 37°C for 30 minutes and then nun on a 1% agarose gel. The ladder is GeneRuler (Fermentus Life 
Sciences). i, indicates the position of nicked pSRIacUV5,, )3, ii, indicates the position of supercoiled 
pSRIacUV52;. 
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approximately one site of damage per fragment. The fragment was then treated with either 
T4EV, or the repair proteins UvrA, UvrB and UvrC in the presence of ATP. Reactions 
were incubated and run on sequencing gels to identify the exact position of cleavage 
(Figure 4.5). The DNA fragment was nicked in a variety of places with T4EV. Each 
incision occurred between two pyrimidine bases. The UvrABC cleavage in the presence of 
ATP was identical to the T4EV lane except that the detected bands had been shifted eight 
nucleotides in the 5' direction. This data corresponds to published data which states that 
the NER proteins nick the DNA eight phosphodiester bonds 5' to the site of damage 
(Sancar and Rupp, 1983). Therefore the histidine-tagged Uvr proteins are functioning as 
expected. 
Development of a novel in vitro incision assay 
The use of UV irradiation to introduce damage into DNA has advantages and 
disadvantages when studying NER and more specifically TCR. One disadvantage is that 
pyrimidine dimers and 6-4 photoproducts could be introduced at any 
pyrimidine-pyrimidine position on the DNA. This would lead to a variety of different 
DNA templates in one reaction. A second disadvantage is that whilst it is ideal to have one 
damage site per molecule the use of UV would result in some DNA molecules containing 
multiple damage sites whilst others would have none. For NER and TCR experiments it 
would be beneficial to have a substrate with a single modified site at a specific position 
particularly in the context of a transcription unit. Primers containing a single modification 
such as cholesterol, fluorescein or a thymine dimer at a specific site are now commercially 
available. These modified primers are synthesised within a short sequence of DNA and as 
such are unsuitable for TCR assays in which 90 bp of DNA is required 5' of the lesion 
(Selby and Sancar, 1995b). Therefore to easily introduce a modification at a specific site in 
the middle of a long DNA fragment we utilised the relatively new method of SMILing 
DNA (Pljevaljcic et al., 2004). 
SMILing DNA utilises DNA methyltransferases (MTases) to modify the DNA. In vivo 
methyltransferases normally modify the DNA by transferring a methyl group from a 
cofactor such as S-adenosylmethionine (AdoMet) onto the DNA at a specific site (Cheng 
and Roberts, 2001). Each DNA methyltransferase (MTase) recognises a specific DNA 
sequence and transfers the methyl group from the cofactor onto a specific nucleotide 
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Figure 4.5 Incision assay on 5'-12P labelled pSRIacUV520, EcoRI/BamHl fragment. 
The pSRIacUV52o I? coRl/l3amlll 5' 'P labelled fragment was exposed to 300 J/m2 254 nm UV light. The 
DNA was then mock treated (lane 1), treated with 100 nM UvrA, 100 nM UvrB and 200 nM UvrC with I 
mM ATP in repair huller (lane 2) or treated with 2U T4EV (lane 3). The reactions were incubated at 37°C 
for 30 minutes, purified using the Qiagen nucleotide removal kit and run on a 6% acrylamide 7M urea 
sequencing gel. The `A' sequencing ladder was generated using pSRIacUV5 RamHl as the primer and 
pSRIacUV5,,, i as the template (lane 4). The gel is a typical representative of three independent experiments. 
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within that sequence at a specific position (Urig et al., 2002). Two methyltransferases are 
important for the following discussion: Dam and M. BseCI. Dam is one of the most 
common DNA MTases in prokaryotes acting to protect the host DNA (Urig et al., 2002). It 
specifically recognises the sequence GATC and transfers a methyl group onto each 
adenine base (one on each strand) at the N6 position. M. BseCI also acts to transfer a 
methyl group onto the N6 position of adenine but would only do so if the adenine residue 
was in the sequence ATCGAT 3' and then only the adenine at position 5 would be 
modified (Rina and Bouriotis, 1993). The ability of DNA MTases to recognise and modify 
different recognition sequences was utilised in the concept of SMILing DNA. 
Methyl groups on DNA molecules are not recognised by NER as sites of damage 
presumably because they are small and do not cause helical distortions. Methylation also 
plays a role in protecting host DNA and as such it would be unbeneficial to the cell if the 
methyl groups acted as substrate for NER. As mentioned above MTases require cofactors 
from which the methyl group is transferred. AdoMet, a common methyl donor, has been 
chemically modified so that the entire cofactor becomes covalently linked to the DNA in 
the presence of certain MTases (Pljevaljcic et al., 2004). This modified cofactor, 
N-adenosyl-aziridine, can be further modified to contain a label such as a fluorophore 
(Pljevaljcic et al., 2003) or a biotin group (Pljevaljcic et al., 2004). Thus when a MTase is 
added to a DNA solution in the presence of the biotin or fluorophore modified cofactor the 
DNA is modified in such a way as to have an internal modification. This labelling will 
occur at the usual methylation position within DNA sequences that were recognised by 
that specific MTase. 
SMILing DNA therefore allows a single unique recognition sequence to be modified 
within a plasmid. However the modification will occur on both strands (depending on the 
methyltransferase used). The DNA base sequence can not be altered as this would result in 
the loss of recognition by the MTase. However the bases within the sequence can be 
modified by methylation. Figure 4.6 indicates an example of overlapping methylation sites 
for the MTases Dam and M. BseCI. If methylation of the Dam recognition sequence occurs 
then one of the adenine residues that would normally be methylated by M. BseCI would 
have already been methylated as it was also part of the Dam recognition sequence. If the 
Dam methylated DNA was then placed in a reaction with M. BseCI and a modified 
cofactor only one strand of the M. BseCI recognition sequence would be available for 
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CCATCGATCAAGCTT 
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Figure 4.6 Methylation patterns. 
(A) Plasmid map of pSRT7A I. (B) pSRT7A1 was used as the substrate for the SMILing DNA reaction. The 
relevant DNA sequence is shown. Bold type indicates the M. BseCI recognition sequence and underlined type 
indicates the Dam recognition sequence. M represents a methyl group that would be introduced in the 
presence of Dam and B represents a 6Baz group that would be introduced in the presence of M. BseCI and a 
modified cofactor. 
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modification, assuming that the methylated adenine residue did not interfere with the 
M. BseCI binding. Thus only one strand at one specific location would be modified within 
the plasmid. 
Criteria for a plasmid that can be modified at a single specific position 
A DNA sequence was required that would enable a variety of repair assays to be carried 
out. Several factors were considered in the design of the DNA. A plasmid was constructed 
containing a unique M. BseCI site that overlapped a Dam recognition sequence (Figure 
4.6). This ensured that when SMILing of the plasmid took place only one site was 
modified. Several factors were considered when deciding the final position of the 
recognition sequence within the plasmid. First, the recognition sequence needed to be able 
to be isolated on a fragment of sufficient length (300 bp) for use in EMSA and nicking 
assays. This was achieved by placing it between unique EcoRI and BamHI sequences that 
were separated by 268 bp. A plasmid designed to the above specifications would be of use 
for NER but further considerations were needed to ensure it would also be useful for TCR 
assays. TCR takes place on the template strand of transcribed DNA. Furthermore TCR 
would only take place once RNAP formed an elongation complex, which occurs once it 
transcribed past base +15 of a transcriptional unit (reviewed in (Hsu, 2002)). Therefore the 
base that is to be modified must be present in a region of DNA that is under the control of 
a promoter but at least 15 bases downstream from the start of transcription. The DNA was 
therefore placed downstream of a T7A1 promoter within a section of DNA that would be 
transcribed. TCR should therefore be detected on this DNA. However a further point was 
considered. For simplicity and ease of understanding we wanted to ensure that only one 
RNAP complex could be present on the DNA from the start of the promoter to the 
damaged site. RNAP covered a region of 77 bp (-57 to +20) in its initiation complex 
(Krummel and Chamberlin, 1989) and 31 bp (-16 to +15) in its elongation complex 
(Korzheva et al., 2000) and thus the damage site could not be greater than 36 bp from the 
start of the gene in order to prevent multiple loading of RNAP. Thus the final position of 
the base to be modified was at +27. With these criteria in mind plasmid pSRT7A1 was 
constructed by Dr. N. Savery. 
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Single site-specific modification of DNA 
The plasmid, pSRT7A1, was designed and constructed to enable the addition of a single 
specific modification. The next step was to modify the plasmid to introduce the single 
specific modification. The plasmid needed to be modified first using Dam and then using 
M. BseCI. Methylation of the DNA by Dam was achieved by transforming the E. coli strain 
XL1-Blue, which is dam+, with the plasmid. The plasmid was then purified from this strain 
and thus contained methyl groups at all adenine residues within GATC sequences. This 
would include the GATC sequence that overlapped with the M. BseCI sequence ATCGAT. 
It was not known if the topology of the DNA would affect the success of the modification 
(biotinylation) reaction and therefore a linear template was used. The Dam methylated 
pSRT7A1 plasmid was linearised by digestion with BamHI. The DNA was then 
biotinylated using the SMILing technique (E. Weinhold laboratory). They treated the DNA 
with M. BseCI to deliver the biotin containing cofactor 6Baz onto the DNA (Figure 4.7). 
They confirmed that the biotinylation had been successful by carrying out streptavidin 
binding assays at certain time points through the procedure. To do this they digested 
aliquots of DNA with EcoRI to produce a shorter fragment whose binding to streptavidin 
could be detected on an agarose gel. Only samples from mixes that contained M. BseCI and 
6Baz were successfully shifted to a higher position. The DNA was successfully modified 
to completion as by the end of the incubation procedure the DNA fragment was all in the 
shifted lower mobility position (data not shown). 
Fragment preparation 
A fragment of the 6Baz modified DNA was generated for use in incision assays. The 
BamHI digested modified DNA, as well as the equivalent unmodified DNA (for use as a 
control), was dephosphorylated and then digested with EcoRI to generate two fragments: a 
2300 bp unmodified fragment and a 268 bp modified fragment (Figure 4.8). The fragments 
were then Sr 32P end labelled. To confirm the presence of the 6Baz molecule a streptavidin 
EMSA was carried out (Figure 4.9). A high and a low mobility band were detected in the 
original mix corresponding to the short and the long fragment respectively. When 
Streptavidin was added an extra band at a lower mobility than the short fragment was 
detected. This extra band is presumably a streptavidin-biotinylated DNA complex as it was 
not detected in the lanes where the DNA was not biotinylated. The 
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Figure 4.7 6Baz modified DNA. 
The chemical structure of adenine covalently bound by the cofactor 6Baz (containing a biotin group). 
M. BseCI was used to catalyse the reaction. 
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Digest with BamHI 
Modify using M. BseCI to introduce a biotin molecule 
Dephosphorylate and then digest with EcoRI 








Long unmodified fragment Short biotinylated fragment 
Figure 4.8 Preparation of SMILing DNA fragment. 
Plasmid DNA purified from a dam+ strain was: digested with Baniffl, biotinylated by M. BseCI with the 
modified cofactor 6Baz, dephosphorylated and digested with EcoRl. A short biotinylated fragment and a 
long unmodified fragment are the end products that are 5' labelled at their Bami end. Methyl groups that 
would be present at all Dam recognition sites are not indicated for clarity. 
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Figure 4.9 Streptavidin EMSA to confirm SMILing DNA. 
The indicated concentration of Streptavidin tetramer was incubated at 37°C for 10 minutes with 0.25 nM 5' 
labelled pSRT7AI Bamill/EcoRl biotinylated (lanes 4 to 8) or unmodified (lanes Ito 3) fragments. i, refers 
to the short fragment (268 bp); ii, to the streptavidin bound short fragment; iii, to the long fragment (2300 
bp). 
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streptavidin-biotinylated DNA complex appeared as the short fragment disappeared 
indicating that the modification was present on the short fragment as expected. At least 
96% of the DNA molecules had been successfully biotinylated. 
Incision of biotinylated DNA by UvrABC 
For all the reported types of damage recognised by UvrABC there is a clear pattern for 
cleavage. In all cases only the damaged strand was cleaved and the cleavage occurred eight 
phosphodiester bonds 5' of the damage and either three, four or five phosphodiester bonds 
3' of the damage. At this stage it was unknown if the 6Baz modified DNA would be a 
substrate for NER. Therefore assays were carried out to determine if cleavage occurred and 
where the 5' and 3' cleavage sites were in relation to the modified base. Assays were also 
carried out to determine if the undamaged strand was cleaved. A sample of the DNA was 
also digested with Hindlll. Hindlll cleaves close to the modified lesion and would 
therefore act as a marker to enable the precise locations of UvrABC incision to be 
measured. 
Incision 5' to the biotinylated site 
To determine if UvrABC recognised 6Baz as a site of damage an incision assay was used 
that was designed to detect the 5' cleavage site furthest from the damaged site (Figure 4.10 
lanes 1 to 8). In a separate reaction the DNA was digested with Hindlll that should cleave 
the l 1t" phosphodiester bond 5' of the biotinylated nucleotide. This would act as a marker 
to which the UvrABC cleavage could be compared. The DNA fragment on its own 
resolved as a single band corresponding to the initial size of the 268 bp fragment (lane 8). 
The expected 2300 bp fragment ran as a smear near the top of the gel. The DNA had been 
completely digested by Hindill (lane 7). A band that was three bases longer than the 
Hindill digested band was seen in the lane containing UvrABC and ATP (lane 2). This 
appears to confirm that the 6Baz molecule will act as a substrate for NER. The band 
corresponds to a cleavage position eight phosphodiester bonds 5' of the damage, 
corresponding with previously published data of the 5' cleavage by UvrABC proteins. 
Without ATP only a band corresponding to the full-length fragment was detected, 
indicating that ATP was required for the incision reaction to occur. A secondary band in 
the UvrABC incision reaction was detected 15 phosphodiester bonds 5' of the modification 
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Figure 4.10 Incision assay on 5' 32P labelled pSRT7A1 EcoRIBamHI SMILing DNA. 
The pSRT7A1 EcoRIBamHI fragment that had (lanes 1-8) or had not (lanes 9-16) been biotinylated by the 
SMILing reaction was 5' 32P labelled. The DNA (0.25 nM) was then mock treated (lanes 8 and 16), treated 
with 100 nM UvrA, 100 nM UvrB and 200 nM UvrC with (lanes 2 and 10) or without (lanes I and 9) 1 mM 
ATP in repair buffer or treated with 5U Hindill (lanes 7 and 15). The reactions were incubated at 37°C for 
30 minutes, purified and run on a 6% acrylamide 7M urea sequencing gel. i, indicates the full-length short 
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fragment (268 bp); ii, indicates the primary product of UvrABC. ATP cleavage (142 bp); iii, indicates the 
product of Hindlll cleavage (139 bp); iv, indicates the secondary product of UvrABC. ATP cleavage (135 
bp). The sequencing ladder was generated using pSR1acUV5 BamlE as the primer and pSRT7A1 as the 
template (lanes 3-6 and 11-14). The red boxes indicate the relative position of the modified base. 
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(band iv). A band corresponding to this has previously been detected in UvrABC incision 
assays on other types of damage (Moolenaar et al., 2000). The secondary band detected in 
the Hindill digest (lane 7) is at this stage unexplained. Thus in conclusion in can be stated 
that UvrABC appears to incise the DNA eight phosphodiester bonds 5' of a 6Baz 
molecule. 
To confirm that the cleavage was due to specific recognition of the SMILing modification 
by UvrABC the same reactions were carried out on control DNA that had not been 
biotinylated but had been digested with BamHI, dephosphorylated and digested with 
EcoRI (Figure 4.10 lanes 9 to 16). The UvrABC proteins did not cleave this DNA in the 
presence of ATP confirming that it was the 6Baz modification that was recognised by the 
UvrABC proteins. The Hindill digest again produced a primary band at the same site as on 
the biotinylated fragment and also produces the same secondary band 11 phosphodiester 
bonds 5' to the main cleavage site indicating that this extra cleavage was not due to 
alterations caused by the 6Baz molecule. 
Incision 3' to the biotinylated site 
Having established the 5' cleavage site we wanted to know at what position the 3' cleavage 
occurred. Unlabelled pSRT7A1 DNA that had been digested with BamHI and biotinylated 
was treated with the UvrABC proteins in the presence of ATP. As a control the DNA was 
also treated with HindIIl. This time the reactions were purified and then used as the 
template for primer extension using the primer D5431 which anneals to the modified 
strand 3' to the biotinylated site (Figure 4.11). If the DNA template was not nicked the 
DNA polymerase should continue to the end of the fragment generating a fragment of 358 
nucleotides. If the DNA template was nicked then the DNA polymerase would only 
continue up to the nicked site. In the uncut DNA lane there was a single band 
corresponding to the DNA length from the 5' end of the primer to the end of the DNA 
template (Lane 1). With the Hindill digested DNA acting as template a shorter band was 
observed corresponding to the position of Hindlll cleavage with regard to the primer (Lane 
7). Two bands were observed and it is thought that the longer one is due to Taq DNA 
polymerase adding an extra adenine once it reached the end (Friedberg et al., 2006). 
Interestingly seven bands are observed in the lane containing the primer extension of the 
UvrABC and ATP digest. One of the bands corresponded in size to the DNA only lane and 
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Figure 4.11 Primer extension to show 3' cleavage of biotinylated DNA. 
Nicking reactions were incubated at 37°C for a total of 30 minutes and contained 1.025 nM pSRT7A I 
BamHl/BamlIl biotinylated DNA and where indicated 100 nM UvrA, 100 nM UvrB, 200 nM UvrC, 1 mM 
ATP and 10 UI lindlll. Additional ATP was added after the first 15 minutes to the reaction containing ATP. 
The DNA was purified from the reactions and primer extension was carried out using primer D543 1. The 
ladder (lanes 3 to 6) was derived from pSRT7Al using pSRIacUV5_Bamlll as the primer. i, indicates the 
full-length primer extension product (358 hp); ii, indicates the length of primer extension on Hindill digested 
DNA; iii, indicates the length of primer extension on UvrABC. ATP cleaved DNA (212 bp). The red box 
indicates the relative position of the modified base. 
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thus indicated that the nicking reaction did not go to completion. There was then a group 
of bands around the area of expected 3' cleavage. Of these the band of lowest mobility 
corresponded to a cleavage site four phosphodiester bonds 3' of the biotinylated site which 
would fit the expected nicking properties of UvrABC. The bands of higher mobility could 
be a result of single or multiple incision reactions. The intensity of each band is not 
significant as the bands of higher mobility may or may not have been derived from the 
band corresponding to incision four phosphodiester bonds 3' of the modification. The 
reason for the extra bands is unclear as it has not previously been reported that extra 3' 
incisions take place on any of the damage substrates tested (Moolenaar et al., 2000). It is 
likely to be due to the incision reaction and not a fault in the primer extension as the DNA 
only lane does not contain extra bands. The first of these extra bands was four bases away 
from the expected site thus if the nicked DNA acted as a substrate for NER then it would 
be feasible for a second 3' cleavage reaction to occur. Nicked DNA does act as a substrate 
for NER but to date only 5' cleavage has been assayed (Moolenaar et al., 1998a) 
(DellaVecchia et al., 2004). Another alternative is that there is a contamination by Cho, 
another enzyme that can recognise and bind UvrB complexes (Moolenaar et al., 2002). 
Cho incises DNA nine phosphodiester bonds 3' of the damage (Moolenaar et al., 2002). 
However Cho, a much smaller protein than UvrC, was not detected on the SDS PAGE gels 
of my UvrC protein. Due to time constraints it was not possible to further investigation the 
3' cleavage reaction. 
Strand specificity of the SMILing reaction 
The above experiments confirmed that 6Baz modified DNA was a substrate for NER. 
However it was not yet known if only the template strand had been modified as predicted 
or if the SMILing reaction had biotinylated the non-template strand as well. The plasmid 
was extracted from a Dam+ strain and subsequently the non-template strand should have 
been methylated and as such unavailable for biotinylation. A primer extension reaction 
was carried out on the digests used for the above reaction however this time the primer 
pSR1acUV5 BamHl which bound to the non-template strand was used. Multiple bands 
were seen in the vicinity of the modification but these bands were not specific to UvrABC 
cleavage as they were also visible in the DNA-only lane (Figure 4.12). This time the DNA 
could extend to the end of the 2568 bp plasmid although the extension reaction stopped 
short in the majority of instances (Figure 4.12 band ii). The HindIII digest, which should 
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Figure 4.12 Primer extension of the undamaged strand. 
Nicking reactions were incubated at 37°C fir a total of 30 minutes and contained 1.025 nM pSRT7A I 
BamlII/BamIII hiotinylated DNA and where indicated 100 nM UvrA, 100 nM UvrB, 200 nM UvrC, I mM 
ATP and 10 U Ilindill. Additional ATP was added after 15 minutes to the reaction containing ATP. The 
DNA was purified from the reactions and primer extension was carried out using primer 
pSRlacUV5_Baml IL The ladder (lanes 3 to 6) was derived from pSRT7AI using pSRIacUV5_Bamlll as the 
primer. i, indicates the length of primer extension on 11indlll digested DNA (139 hp); ii, indicates a region of 
premature termination of the primer extension reaction. The red box indicates the relative position of the 
modified base. 
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nick both strands, produced a band corresponding to the expected size indicating that the 
primer extension reaction was working as it should. The SMILing reaction had therefore 
only modified the template strand and had not affected the non-template strand. 
Summary of incision activity by UvrABC on a 6Baz modified substrate 
Figure 4.13 indicates the sites of cleavage as determined by the various nicking assays. 
The incision reactions of NER take place as expected with cleavage reactions occurring 
eight phosphodiester bonds 5' (and a secondary 5' cleavage 15 phosphodiester bonds away) 
of the site of damage and four phosphodiester bonds 3' to the site of damage. The extra 3' 
cleavage sites have yet to be fully investigated but could indicate that nicked DNA is a 
substrate for NER. No incision occurs on the undamaged strand. Thus the 6Baz modified 
DNA acts as a substrate for NER. 
Discussion 
Wild-type UvrA, UvrB and UvrC have been purified. Each protein was expressed with a 
N-terminal hexa-histidine tag to aid its purification. The purification procedure was rapid, 
taking less than two days to get from a single colony to pure protein stored at -80°C. The 
purified histidine-tagged UvrA, UvrB and UvrC proteins in combination with ATP could 
incise UV damaged DNA as previously reported for untagged UvrA, UvrB and UvrC 
(Yeung et al., 1986b). 
The proteins were expressed in XL1-Blue or MG1655AuvrA cells without the need for 
induction despite being under the control of a T5 promoter that contained a lac operator 
site downstream. Both strains contained the laclq sequence that should have enabled the 
strains to overproduce the Lac repressor to ensure that each operator site was occupied. 
The large quantity of Uvr proteins that were generated suggested that a proportion of the 
operator sites were not occupied by Lac repressor as expected. However the addition of 
IPTG to the cells reduced rather than increased expression of the plasmid uvr gene within 
the cell. Expression of the protein in large quantities could harm the cell as it would be 
more likely that NER of undamaged sections of DNA would occur resulting in a high 
mutation frequency. As a result cells that were unable to produce the Uvr protein for any 
number of reasons including sequence or promoter mutations would be selected. The 
reason behind the reduction in expression was not investigated as the main aim was to 
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Figure 4.13 Position of cleavage. 
Position of cleavage of modified SMILing DNA. The red arrows indicate 3' cleavage by UvrABC as shown 
by primer extension (dashed arrows indicate a weak band which in some instances could be due to an 
adenine base added by Taq DNA polymerase during the primer extension reaction). Orange arrows indicate 
5' cleavage by UvrABC. Purple arrows indicate cleavage by HindIII under the conditions used for 5' 
cleavage, pink arrows indicate cleavage by HindIII under the conditions used for primer extension reactions, 
and turquoise arrows indicate cleavage seen by Hindili on the undamaged strand under primer extension 
conditions. The red type indicates the 6Baz (B) modified residue, bold type indicates the M. BseCI 
recognition sequence, underlined type indicates the Dam methylation sequence, and blue type indicates the 
HindIIl recognition sequence. 
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express proteins in sufficient quantities to enable the protein to be purified. This could be 
achieved by a 16 hour 37°C incubation without induction. 
The properties of the purified N-terminal hexa-histidine tagged wild-type proteins were 
checked and shown to have ATP dependent incision activity when all were present. The 
purification procedure was quick, simple and reproducible, and the purified proteins 
worked within an NER incision assay. 
SMILing DNA 
Natural and manmade substrates for repair by NER are constantly being identified. 
However there was no simple way of introducing a single modification at a specific 
location within a long DNA molecule. A method for generating a single site of damage on 
a DNA molecule has been successfully established. The method relies on the activity of 
methyltransferases to introduce modifications within the DNA at their recognition 
sequences. This enabled the position of the damage to be controlled by simple cloning 
techniques. A single modified substrate was generated by: overlapping a Dam and a 
unique M. BseCI methyltransferase recognition sequence; Dam methylating the DNA; and 
then modifying the M. BseCI site using a modified cofactor. It is theoretically possible that 
any methyltransferases could be used providing that: the two recognition sequences 
overlapped and modified the same base in the same position; and the modified cofactor 
could be recognised by the MTase. In this way DNA can be modified at a wide variety of 
different sites within a molecule. 
Currently the only type of modification that has been attached for use in this system is a 
biotin molecule. However there is no reason why any molecule cannot be attached in this 
manner providing it can be chemically attached to a modified cofactor and then 
accommodated by a MTase. Our collaborators in Germany have currently been able to 
introduce a number of different types of molecules onto different positions within DNA 
using cofactors that have been modified in a variety of ways and using different 
methyltransferases to carry out the modification procedure (Pljevaljcic et al., 2004). 
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Characterisation of 6Baz as a substrate for NER 
6Baz (or biotin) modified DNA had not previously been analysed as a substrate for NER. 
The results indicated that it was a suitable substrate for NER as cleavage of the DNA was 
detected both 5' and 3' of the modified base. For NER of 6Baz modified DNA the 5' nick 
was in the classical position eight phosphodiester bonds away from the damage however 
there seems an abundance of 3' nick sites. The reason behind the multiple 3' nick sites has 
not yet been investigated but could be due to a variety of reasons. Firstly 6Baz has not 
been analysed within this system before and may interfere with the 3' nicking activity. This 
however is unlikely as every NER substrate reported so far has consistently only had one 
site of cleavage at the 3' side of damage and in these instances the cleavage is three to five 
phosphodiester bonds away from the damaged site. However, extra 5' cleavage bands have 
been seen for various substrates (Moolenaar et al., 2000). The 3' site of cleavage is 
believed to be more controlled due to the nature of the protein DNA interaction with the 
positioning of the undamaged strand and damaged strand being separated by the ß-hairpin 
of UvrB, locking it in position for UvrC to incise 3' of the damage. A second possibility 
for the extra cleavage is that there is a contaminating nuclease within one of the purified 
protein preparations. Cho, the homologue of the NTD of UvrC, would causes incision of 
the DNA nine phosphodiester bonds 3' of the damaged site (Moolenaar et al., 2002). This 
could be responsible for the incision activity detected especially if it can recognise both 
nicked DNA and 6Baz modified DNA as damage substrates in collaboration with UvrB. 
Alternatively a different nuclease could be present. Thirdly the results could indicate that 
nicked DNA acts as a substrate for NER under the conditions used in this assay. At this 
stage the reason for the multiple incision sites is unclear but further analysis should be able 
to determine the reasons behind this. 
Characterisation of 6Baz as a site of dantage for TCR 
Having established that a 6Baz adduct would be recognised and repaired by NER it would 
be useful to determine if it could be used as a tool for TCR. For TCR to occur the damage 
must stall the RNAP elongation complex enabling the recruitment of the NER apparatus. 
Initial experiments carried out by Dr. N. Savery (data not shown) indicated that RNAP was 
not stalled by the 6Baz modification and carried on transcribing until it reached a stop 
signal. The 6Baz molecule must therefore be small enough to pass through the DNA tract 
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of the RNAP molecule. Thus it would appear that although the 6Baz damaged molecule 
was a suitable substrate for NER experiments it was not of use for TCR. 
Further work to develop a substrate for TCR experiments is ongoing. Two approaches are 
being taken. The first is to bind Streptavidin to the biotinylated DNA molecule to create a 
suitable blockade that will cause RNAP to stall. The second is to modify the DNA with 
larger molecules such as TexasRed in order to try and block RNAP. 
At this stage we are confident that the SMILing method will be useful for developing a 
group of DNA molecules with the same modification at the same position for use in the 
TCR assay. Further work is required to identify a modification that will stall RNAP. 
Despite 6Baz not being a suitable roadblock for transcription it is still effective within 
NER and therefore useful for analysing in vitro NER activity. 
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Introduction 
Within the process of NER UvrA forms homodimers, binds and hydrolyses ATP, binds to 
UvrB and DNA, and assists the loading of UvrB onto sites of DNA damage. Failure at any 
of these steps could reduce or even prevent successful NER, leading to a decrease in UV 
resistance of the cell. 
The role of UvrA in the process of NER is complex with its nucleotide hydrolysis, DNA 
binding and UvrB binding activities all interlinked (Figure 5.1). UvrA initially forms 
homodimers in a reaction that can be stimulated by high UvrA concentration and/or ATP 
binding (Orren and Sancar, 1989) (Oh et al., 1989). The UvrA dimer is then believed to 
bind UvrB (which is found in excess of UvrA in vivo (Crowley and Hanawalt, 1998)) to 
form a UvrA-UvrB complex which then goes on to bind DNA. However in vitro UvrA can 
first bind DNA and then recruit UvrB (Yeung et al., 1986a). The formation of the 
UvrA-UvrB-DNA complex is dependent on ATP binding. Upon ATP hydrolysis within 
this complex UvrA loads UvrB onto the DNA (Orren and Sancar, 1989). The UvrA dimer 
is released and subsequently restarts the UvrA cycle to bind and load a different molecule 
of UvrB onto a different lesion within the DNA. The NER steps involving UvrA have been 
well characterised. However the specific regions and amino acid residues of UvrA 
involved in these individual steps have yet to be fully determined. 
Within the process of TCR UvrA is proposed to be recruited to DNA damage through 
interactions with Mfd (Selby and Sancar, 1993). The Mfd-UvrA interaction has been 
suggested to involve the region of UvrA that interacts with UvrB, and the region of Mfd 
that shares sequence and structural similarity to UvrB (Selby and Sancar, 1993) 
(Assenmacher et al., 2006) (Deaconescu et al., 2006). Lesions are repaired 10-fold faster 
by TCR than by global NER (Bohr et al., 1985). This is presumably due to a decrease in 
the time taken to form the UvrA-UvrB-DNA complex after the DNA has been damaged. 
This in turn is presumably due to the recruitment of UvrA to the lesion by Mfd. There is no 
evidence to suggest that Mfd can recruit UvrB to the lesion either directly by the formation 
of a UvrB-Mfd complex or indirectly by recruitment of a UvrA-UvrB complex through 
interactions made with UvrA. 
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Figure 5.1 The role of UvrA in NER. 
UvrA forms homodimers in a reaction that is stimulated by ATP binding and reversed by ATP hydrolysis. In 
a two-step reaction the UvrA dimer can first bind UvrB and then DNA or it can first bind DNA and then 
UvrB to form a UvrA-UvrB-DNA complex. The formation of the UvrA-UvrB-DNA complex requires ATP 
binding. Upon ATP hydrolysis UvrA loads UvrB onto the DNA and is then released. Solid red arrows 
indicate reactions requiring ATP to be bound whilst the solid blue arrow indicates a requirement for ATP 
hydrolysis. The dashed arrows indicate that these reactions are enhanced by but do not require ATP binding 






Chapter 5- In vitro Analysis of UvrA Mutant Proteins 
Of the 20 UvrA mutants identified from the bacterial two-hybrid or UV sensitivity screens 
(chapter three) 15 have been expressed and purified. The 15 mutants have been 
characterised in vitro by experiments designed to measure nucleotide hydrolysis activity, 
DNA binding activity and their ability to interact with UvrB. The results offer insights into 
the key UvrA residues within these steps. Within this chapter the effect of Mfd on UvrA 
and the UvrA-UvrB complex has been further characterised, by assessing the effect of Mfd 
on their nucleotide hydrolysis activity. 
Expression and purification of UvrA and UvrB mutants 
In order to further characterise the UvrA mutants identified in chapter three they were 
expressed and purified for use in in vitro assays. The UvrA mutant proteins were expressed 
and purified following the protocol developed for the purification of wild-type UvrA 
except that the cells were transformed with the relevant pQE30UvrA derivative. 15 of the 
20 UvrA mutants containing a single amino acid substitution were purified in this manner. 
The elution profiles of each mutant were similar to wild-type UvrA and no contaminants 
of the final products could be detected on SDS PAGE gels. UvrAcso34, UvrASP038, 
UvrAF1064, UvrAGRO99 and UvrAcR12o were not purified. 
UvrBRE183 and UVrBRA213 were also analysed in vitro. UvrBRE183 would act as a negative 
control in UvrA-UvrB interaction assays as it had previously been shown to have a weak 
interaction with UvrA (Truglio et al., 2004). UvrBlu13 was the only fully conserved 
residue within the proposed UvrA interaction domain of UvrB (Truglio et al., 2004). 
UvrBRE183 and UvrBfw13 were expressed and purified following the protocol developed 
for the purification of wild-type UvrB except that the cells were transformed with the 
relevant pQE30UvrB derivative. The elution profiles were similar to wild-type UvrB and 
no contaminants of the final products could be detected on SDS PAGE gels. Therefore 15 
UvrA mutants and two UvrB mutants had been successfully purified ready for in vitro 
analysis. 
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Effect of amino acid substitutions in UvrA and UvrB on incision activity 
Effect of amino acid substitutions in UvrB on incision activity 
Loss of the UvrA-UvrB interaction was expected to influence downstream NER processes 
including incision. UvrBRE183 had previously been shown to have a reduced UvrA binding 
affinity (Truglio et al., 2004). To determine if the incision activity detected on SMILing 
DNA (chapter four) would be affected by this known UvrA-UvrB interaction mutant, 
UvrBRE183 was tested within the 5' incision assay (Figure 5.2). At the same time the effect 
of UvrBRA213 was also tested. The assay was carried out as described in chapter four except 
that the biotinylated DNA had not been digested with EcoRI (Figure 4.8). 
When wild-type UvrB was present incision was detected eight and 15 phosphodiester 
bonds 5' of the lesion as expected. UvrBRA213 enabled incision of the DNA comparable to 
the incision level seen under wild-type conditions. When UvrBRE183 was present only a 
small amount of cleavage was detected eight phosphodiester bonds 5' from the biotin and 
no cleavage was detected 15 phosphodiester bonds away. 
In this assay UvrBRA213 was able to facilitate incision to wild-type levels which is 
consistent with published data in which this substitution had no detectable in vitro effect 
(Truglio et al., 2004). The result of the known UvrA-UvrB interaction mutant, UvrBRE183, 
indicated that a change in the UvrA-UvrB affinity has a detectable effect on cleavage 
under our assay conditions. 
Effect of amino acid substitutions in UvrA on incision activity 
The incision assay was repeated with the UvrA mutants to determine if any of the 
substitutions affected incision (Figure 5.3). 
Most of the 15 UvrA mutants were able to facilitate incision activity although some were 
unable to support the secondary cleavage 15 phosphodiester bonds 5' from the biotin site. 
UvrARLO23, UvrAVDO73, UvrALP151 and UvrAVE2o2 were unable to support incision activity. 
The majority of the UvrA mutants were still able to fulfil their overall role in NER. 
However some were unable to do so and some behaved slightly differently than wild-type. 
At this stage it was not known if the UvrA mutants that failed to support incision of the 
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Figure 5.2 Effect of amino acid substitutions in UvrB on incision activity. 
The pSRT7AI Bamlll/l3amlll fragment that had been biotinylated by the SMILing reaction was 5' `2p 
labelled. The DNA (0.25 nM) was then treated with 100 nM UvrA, 100 nM UvrB mutant (as indicated), 200 
nM UvrC and 1 mM ATP in repair butler (lanes 5-7) or mock treated (lanes 8 and 9). The reactions were 
incubated at 37°C fix 30 minutes, purified and run on a 6% acrylamide 7M urea sequencing gel. The arrows 
indicate: i, the full-length fragment (2568 bp); ii, the cleavage product eight phosphodiester bonds 5' from 
the biotin site (142 hp); iii, the cleavage product 15 phosphodiester bonds 5' from the biotin site (135 bp). 
The sequencing ladder was generated using pSRlacUV5_Baml11 as the primer and pSRT7AI as the template 
(lanes 1-4). The unexpected incision product detected in lane 8 may be due to an experimental error. 
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Figure 5.3 Effect of amino acid substitutions in UvrA on incision activity. 
The pSRT7Al Bamlll/Bamlll fragment that had been biotinylated by the SMILing reaction was 5' `'P 
labelled. The DNA (0.25 nM) was then treated with 100 nM of the indicated UvrA mutant, 100 nM UvrB, 
200 nM UvrC and I mM ATP in repair butler (lanes 3-18) or mock treated (lanes 19 and 20). The reactions 
were incubated at 37°(' tier 30 minutes, purified and run on a 6% acrylamide 7M urea sequencing gel. The 
arrows indicate: i, the full-length fragment (2568 hp); ii, the cleavage product eight phosphodiester bonds 5' 
from the biotin site (142 hp); iii, the cleavage product 15 phosphodiester bonds 5' from the biotin site (135 
bp). The sequencing ladder was generated using pSRIacUV5_BamHI as the primer and pSRT7Al as the 
template (lanes 1-2). 
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DNA were functional in any aspect of NER. The band corresponding to incision 15 bases 
5' of the damage has previously been reported to be caused by a UvrA independent 
UvrB-UvrC incision reaction (Moolenaar et al., 1998a). It would therefore be expected in 
all UvrA mutant lanes in which the original cleavage eight phosphodiester bonds 5' form 
the biotin site had occurred. However, this was not observed and could indicate that this 
secondary incision reaction required UvrA. 
Whilst this incision assay demonstrated that several of the mutant proteins facilitated NER 
the assay was not expected to detect mutants that only subtly affected individual steps of 
the NER process. When a defect was detected the nature of the defect could not be 
determined as many different UvrA functions were required to enable the incision reaction 
to occur. Therefore further in vitro assays were used to analyse the effect of the UvrA 
amino acid substitutions within the individual steps of NER. 
Nucleotide hydrolysis activity 
A high throughput (96 well) pyruvate kinase lactate dehydrogenase (PK/LDH) assay was 
utilised to monitor ATP hydrolysis rates by the UvrA protein (Figure 5.4) (Kiianitsa et al., 
2003). During nucleotide hydrolysis UvrA converts ATP to ADP and Pi (Seeberg and 
Steinum, 1982). A substrate level phosphorylation reaction in which PK transferred a 
phosphate group from phosphoenolpyruvate (PEP) onto ADP to form ATP and pyruvate 
enabled the level of ATP within the system to remain constant. The pyruvate was then 
reduced by NADH in a LDH catalysed reaction to form lactate and NAD. The loss of 
NADH from the reaction was monitored as a decrease in absorbance at 340 nm. Every 
time one molecule of ATP was converted to ADP one molecule of NADH reduced 
pyruvate and was thus lost. The loss of NADH from the system was plotted over time and 
the rate of ATP hydrolysis determined (Figure 5.5A). 
Characterisation of nucleotide hydrolysis activity of wild-type UvrA 
ATPase activity of wild-type UvrA 
The ATPase activity of wild-type UvrA (purified as described in chapter four) was 
measured by nucleotide hydrolysis assays to confirm that its ATPase activity conformed to 
published data. Each nucleotide hydrolysis reaction consisted of 50 nM UvrA, between 0 
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Figure 5.4 Principle of the PK/LDH nucleotide hydrolysis assay. 
UvrA is an ATPase that hydrolyses ATP to ADP and free phosphate (Pi). In a substrate level 
phosphorylation reaction PK transfers a phosphate group from PEP onto ADP to generate ATP and pyruvate. 
Pyruvate is reduced by NADH in the LDH catalysed reaction resulting in the production of lactate and NAD. 
The amount of NADH present within a reaction can be detected in a spectrophotometer at a wavelength of 
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Figure 5.5 ATPase activity of wild-type UvrA. 
(A) An example of raw data from a nucleotide hydrolysis assay. Nucleotide hydrolysis assays had 
absorbance readings recorded every 15 seconds over one hour (plain line). The rate of nucleotide hydrolysis 
was determined by fitting a line (dotted) over the steepest consecutive 30 minute period (calculated by 
SOFTmax PRO software) and then converting Absorbance over Atime into nM ATP hydrolysed sec'. (B) 
The rates of nucleotide hydrolysis calculated from the raw data were adjusted for background levels of 
NADH degradation (no UvrA). The results were then averaged (at least three independent experiments) and 
plotted onto graphs with standard deviation. A Michaelis-Menten curve was fitted to the data using GraFit 
software. 
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and 2 mM ATP and the reagents required for the PK/LDH reaction in a final volume of 
200 µl. As a control the reactions were repeated without UvrA. Very little background 
degradation of NADH was detected from the control reactions and what background was 
detected was subsequently subtracted from the UvrA assay results. Analysis of the raw 
data for the ATPase activity of UvrA revealed that the rate of hydrolysis slightly increased 
during the first 20 to 30 minutes before reaching a steady state for the last 30 minutes 
(Figure 5.5A). The rate of ATP hydrolysis for each ATP concentration tested was 
calculated from the steepest consecutive 30 minute period of the curve (identified by 
SOFTmax PRO software). The rate was then adjusted for background degradation (no 
UvrA). Average rates (from at least three independent experiments) were plotted against 
ATP concentration, a Michaelis-Menten curve fitted and the Km, Vmax and kcat values 
calculated (Figure 5.5B and wild-type ATPase values in Table 5.1). 
The ATPase K. value of UvrA measured under these conditions (23.4 µM ATP) closely 
resembled that measured by Sancar's lab who reported a Km value of 29.6 µM ATP (Myles 
and Sancar, 1991). However it differed from the range of Km values (103 gM to 210 gM 
ATP) measured by Grossman's lab (Caron and Grossman, 1988) (Oh et al., 1989) 
(Thiagalingam and Grossman, 1991) (Wang et al., 1994). The ATPase kcat value of UvrA 
measured under these conditions (48.5 miri 1) was similar to that measured by Sancar's lab 
(32.5 miri 1) and was close to the lower end of reported values from Grossman's lab 
(between 56 and 171 miri 1) (Myles and Sancar, 1991) (Caron and Grossman, 1988) (Oh et 
al., 1989) (Thiagalingam and Grossman, 1991) (Wang et al., 1994). The data confirmed 
that my purified histidine-tagged UvrA had similar ATPase activity to some previously 
published work. 
Effect of UvrB on the nucleotide hydrolysis activity of UvrA 
Under certain conditions the binding of UvrB to UvrA causes an effect on the overall 
nucleotide hydrolysis activity (Caron and Grossman, 1988). In the UvrA-UvrB complex 
there are five nucleotide hydrolysis regions. Of these, four are within UvrA. UvrA can 
hydrolyse ATP and can also hydrolyse GTP (Caron and Grossman, 1988). The fifth site is 
activated within UvrB upon binding to UvrA. This UvrB site will only hydrolyse ATP, it 
can not hydrolyse GTP (Caron and Grossman, 1988). 
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Wild-type 23.4 40.4 48.5 33.5 58.5 70.2 
RL023 288 10.7 12.8 737 10.2 12.2 
SA038 106 5.62 6.75 48.6 2.70 3.24 
FS064 18.6 54.2 65.0 28.7 64.5 77.4 
LQ065 63.2 37.5 45.0 107 40.5 48.6 
VD073 190 14.7 17.6 426 10.1 12.2 
SY080 290 23.8 28.6 820 24.1 28.9 
QL087 97.5 20.1 24.2 229 23.2 27.8 
LH151 30.6 42.4 50.9 45.9 48.3 57.9 
LP151 70.5 31.1 37.3 106 31.5 37.8 
KE159 24.6 49.2 59.0 41.4 58.2 69.9 
GD173 18.2 51.3 61.6 24.2 58.3 69.9 
YC174 22.4 51.8 62.1 30.5 58.6 70.4 
EV201 27.5 35.8 42.9 36.4 38.6 46.3 
VE202 139 18.9 22.7 179 16.7 20.0 
DG205 23.0 49.5 59.4 30.9 56.2 67.4 
Table 5.1 ATPase and GTPase Km, Vm.,, and kq, values for UvrA and UvrA mutants. 
Km, V. and k,. t values were calculated from the data in Figure 5.5, Figure 5.6, Figure 5.10 and Figure 5.11. 
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The effect on overall ATPase activity when UvrB is mixed with UvrA depends on the 
conditions used. Under conditions in which the UvrA concentration was less than 5 nM 
and ATP was saturating the presence of 225 nM UvrB caused the stimulation of ATPase 
activity (Caron and Grossman, 1988). Under conditions in which UvrA concentration 
exceeded 5 nM the presence of UvrB inhibited ATPase activity (Caron and Grossman, 
1988). The stimulation/inhibition effect on the ATPase activity of UvrA by UvrB would be 
complicated to interpret due to the activation of the UvrB ATPase activity upon the 
formation of the UvrA-UvrB complex (Caron and Grossman, 1988). Therefore ATP would 
not be a suitable substrate to analyses the effect of UvrB on the nucleotide hydrolysis 
activity of UvrA. 
If GTP was used instead of ATP the interpretation of the effect of UvrB on the nucleotide 
hydrolysis activity of UvrA would be simplified. This is because UvrB (within the 
UvrA-UvrB complex) can not hydrolyse GTP whereas UvrA can (Caron and Grossman, 
1988). Any change in GTPase activity upon addition of UvrB to UvrA would therefore be 
a direct result of a change in the UvrA GTPase activity. The effect of UvrB on UvrA can 
therefore be analysed by GTPase assays (Truglio et al., 2004). 
GTPase activity of wild-type UvrA 
In order to analyse the effect of UvrB on the GTPase activity of UvrA it was important to 
establish the GTPase properties of my UvrA preparation. This was done using the ATPase 
assay conditions except that ATP had been substituted by GTP. The results from the 
GTPase assay were similar to the ATPase results (Figure 5.6 and wild-type GTPase data in 
Table 5.1). The GTPase K. value (33.5 µM GTP) differed from the only previously 
reported value of 910 µM GTP (Caron and Grossman, 1988). The GTPase kcat value (70.2 
miri t) was within two-fold of the 114 miri 1 value previously reported (Caron and 
Grossman, 1988). My preparation of purified UvrA was confirmed to be a GTPase with a 
suitable level of activity for use in inhibition experiments. 
Effect of UvrB on the GTPase activity of wild-type UvrA 
The addition of UvrB to the UvrA GTPase assay described above should result in the 
measurable reduction of GTP hydrolysis (Claassen and Grossman, 1991). This would be a 
useful tool in characterisation studies of the UvrA mutant proteins. Therefore the effect of 
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Figure 5.6 GTPase activity of wild-type UvrA. 
GTP hydrolysis rates were calculated from data generated from nucleotide hydrolysis assays. Each assay 
contained the PK/LDH reagents, 50 nM UvrA and the indicated concentration of GTP in a final volume of 
200 µl. The reactions were incubated at 37°C for one hour with readings taken every 15 seconds. The rates 
were calculated by measuring the steepest consecutive 30 minute period of the curve and then background 
degradation was subtracted. The rates shown are an average of at least three independent experiments (with 
standard deviation). A Michaelis-Menten curve was fitted to the data using GraFit software. 
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wild-type UvrB on wild-type UvrA needed to be determined for my proteins. On its own 
UvrB was, as expected, unable to hydrolyse GTP (data not shown) whilst UvrA could (see 
above). 
The data obtained from reactions when both UvrA and UvrB were present did not fit the 
Michaelis-Menten equation and thus K,,, and V,,, a,, values could not be calculated (Figure 
5.7). The addition of UvrB to the UvrA nucleotide hydrolysis reactions caused a reduction 
in GTPase activity at saturating levels of GTP. As the UvrB concentration increased so did 
the level of GTPase inhibition. However at UvrB concentrations greater than 50 to 100 nM 
UvrB the level of inhibition was saturated and additional UvrB had no further detectable 
effect. This assay thus provided a way to detect the UvrA-UvrB interaction. 
The stoichiometry of the UvrA-UvrB complex is believed to consist of a dimer of UvrA 
and either a monomer or dimer of UvrB (Orren and Sancar, 1989) (Verhoeven et al., 
2002). If it is assumed that the preparation of UvrA and UvrB had the same specific 
activity then the stoichiometry of the UvrA-UvrB complex can be calculated from the 
above inhibition data. If the UvrA-UvrB complex consisted of two molecules of UvrA and 
one molecule of UvrB then 25 nM UvrB would be sufficient to inhibit the GTPase activity 
of 50 nM UvrA. If the UvrA-UvrB complex consisted of two molecules of UvrA and two 
molecules of UvrB then 50 nM of UvrB would be required to inhibit the GTPase activity 
of 50 nM UvrA. The inhibition data indicated that between 50 and 100 nM UvrB was 
required to obtain inhibition saturation of 50 nM UvrA. This suggests that the UvrA-UvrB 
ratio in the UvrA-UvrB complex was at least one molecule of UvrB for each molecule of 
UvrA. 
Effect of amino acid substitutions in UvrB on the GTPase activity of UvrA 
An amino acid substitution within either UvrA or UvrB that prevented the formation of the 
UvrA-UvrB complex should prevent the inhibition of the UvrA GTPase activity by UvrB. 
UvrBREI83, which was unable to interact with UvrA in pull-down assays (Truglio et al., 
2004), was therefore tested within this system as a control (Figure 5.8). At the same time 
UvrBRA213 was also tested (Figure 5.8). UvrBRE183 did not inhibit the GTPase activity of 
UvrA. UvrBRm13 slightly inhibited the GTPase activity of UvrA but not to the level that 
wild-type UvrB could. The results indicated that the loss of the UvrA-UvrB interaction 
resulted in the loss of the UvrB inhibitory effect on the GTPase activity of UvrA. The 
169 
Chapter 5 -In vitro Analysis of UvrA Mutant Proteins 








0.0 nM UvrB 
12.5 nM UvrB 
25.0 nM UvrB 
50.0 nM UvrB 
100.0 nM UvrB 
200.0 nM UvrB 
Figure 5.7 Effect of UvrB on the GTPase activity of UvrA. 
GTP hydrolysis rates were calculated from data generated from nucleotide hydrolysis assays. Each assay 
contained the PK/LDH reagents, 50 nM UvrA, the indicated concentration of GTP and the indicated 
concentration of UvrB. The reactions were incubated at 37°C for one hour with readings taken every 15 
seconds. The rates were calculated by measuring the steepest consecutive 30 minute period of the curve and 
then background degradation subtracted. The rates shown are an average of at least three independent 
experiments (with standard deviation). 
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Figure 5.8 Effect of amino acid substitutions in UvrB mutants on the GTPase activity of UvrA. 
GTP hydrolysis rates were calculated from data generated from nucleotide hydrolysis assays. Each assay 
contained the PK/LDH reagents, 50 nM UvrA, the indicated concentration of GTP and either 0 nM UvrB 
(black circles), 50 nM UvrB (black triangles), 50 nM UvrBRE183 (white circles) or 50 nM UvrB1 13 (white 
triangles) in a final volume of 200 µl. The reactions were incubated at 37°C for one hour with readings taken 
every 15 seconds. The rates were calculated by measuring the steepest consecutive 30 minute period of the 
curve and then background degradation subtracted. The rates shown are an average of at least three 
independent experiments (with standard deviation). 
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assay could therefore be used to determine which UvrA mutants were unable to form the 
UvrA-UvrB complex. 
Effect of Mfd on the GTPase activity of wild-type UvrA 
UvrB and Mfd share a region of sequence and structural homology that is believed to 
contain the UvrA interaction domain (Selby and Sancar, 1993) (Deaconescu et al., 2006). 
It has been suggested that the same region of UvrA is involved in the UvrA-UvrB and the 
UvrA-Mfd interaction (Selby and Sancar, 1993). If this is true the GTPase activity of 
UvrA that was inhibited by UvrB may also be inhibited by Mfd. 
Controls were carried out to confirm that Mfd could not hydrolyse GTP on its own. The 
nucleotide hydrolysis assay was carried out with and without Mfd in the presence of GTP. 
200 nM Mfd was unable to hydrolyse GTP under these conditions (data not shown). This 
agreed with previous data in which Mfd was unable to utilise GTP to displace stalled 
elongation complexes which it could displace in the presence of ATP (Chambers, 2005). 
Mfd (200 nM) was added to a nucleotide hydrolysis assay containing UvrA and GTP 
(Figure 5.9). The data generated was fitted to the Michaelis-Menten equation and Km and 
Vmax values calculated. The Km values with and without Mfd were 47.0 and 46.6 µM GTP 
respectively. The Vmax values with and without Mfd were 43.2 and 50.9 nM GTP sect 
respectively. Despite the concentration of Mfd being four-fold in excess of the 
concentration of UvrB required for saturation the inhibition effect of Mfd on the GTPase 
activity of UvrA was small. Under the nucleotide hydrolysis conditions tested UvrB and 
Mfd did not have the same effect on UvrA. 
The combined effect of UvrB and Mfd on the GTPase activity of UvrA 
To understand the process of UvrA and UvrB recruitment within TCR it would be useful 
to know if UvrB and Mfd compete for the same site on UvrA. One way to investigate this 
is to determine if Mfd can alleviate the inhibitory effect caused by UvrB on the GTPase 
activity of UvrA. 
At a fixed 2 mM GTP concentration combinations of UvrA, UvrB and Mfd were analysed 
for GTPase activity under the nucleotide hydrolysis assays conditions used previously 
(Table 5.2). As expected, UvrB inhibited the GTPase activity of UvrA whilst Mfd had 
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Figure 5.9 Effect of Mfd on the GTPase activity of UvrA. 
GTP hydrolysis rates were calculated from data generated from nucleotide hydrolysis assays. Each PK/LDH 
reaction contained the PK/LDH reagents, 50 nM UvrA, the indicated concentration of GTP and either 0 nM 
Mfd (black circles) or 200 nM Mid (white circles) in a final volume of 200 µl. The reactions were incubated 
at 37°C for one hour with readings taken every 15 seconds. The rates were calculated by measuring the 
steepest consecutive 30 minute period of the curve and then background degradation subtracted. The rates 
shown are an average of at least three independent experiments (with standard deviation). A 
Michaelis-Menten curve was fitted to the data using Grafit. 
173 
Chapter 5 -In vitro Analysis of UvrA Mutant Proteins 
0nMUvrB 50nMUvrB 










0 nM Mfd 73.1 2.53 20.7 1.82 
50 nM Mfd 69.2 1.59 21.0 0.183 
500 nM Mfd 69.8 1.28 21.8 1.23 
Table 5.2 Effect of Mfd and UvrB on the GTPase activity of UvrA. 
GTP hydrolysis rates were calculated from data generated from nucleotide hydrolysis assays. Each assay 
contained the PK/LDH reagents, 50 nM UvrA, 2 mM GTP, the indicated concentration of Mfd and the 
indicated concentration of UvrB in a final volume of 200 pl. The reactions were incubated at 37°C for one 
hour with readings taken every 15 seconds. The rates were calculated by measuring the steepest consecutive 
30 minute period of the curve and then background degradation subtracted. The rates shown are an average 
of at least three independent experiments. 
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relatively little effect. When all three proteins were present the rate of GTPase activity was 
comparable to the rate detected at the UvrA-UvrB inhibition level. Increasing the Mfd 
concentration to 500 nM did not alter this result despite being 10-fold in excess of the 
UvrB concentration. We conclude that under these conditions Mfd did not compete with 
UvrB for the UvrB binding site on UvrA. This may mean that Mfd binds UvrA at a distinct 
site or that under these conditions Mfd does not bind at all. 
Characterisation of nucleotide hydrolysis activity of UvrA mutants 
To determine if any of the identified UvrA amino acid substitutions affected nucleotide 
hydrolysis activity, ATPase, GTPase and GTPase inhibition experiments were repeated 
using the 15 UvrA mutants. Each experiment was carried out in triplicate, background 
rates deducted, the results averaged, Michaelis-Menten curves plotted and Km and Vmax 
values calculated where relevant. 
Effect of amino acid substitutions in UvrA on ATPase activity 
To determine if any of the 15 mutants were deficient in ATPase activity the ATPase 
nucleotide hydrolysis assays were used with each mutant replacing wild-type UvrA 
(Figure 5.10 and Table 5.1). The UvrA mutants can be split into those that have wild-type 
ATPase activity and those that have deficient (reduced) ATPase activity. ATPase Kn, and 
Vmax values for UvrAFS064, UvrALH1SI, UVrAKE159, UvrAGD1739 UvrAyC174, UvrAEV201 and 
UvrADG205 were within two-fold of the wild-type UvrA values. The ATPase K. values for 
UvrALQ065 and UvrALPl51 were between two and four-fold of the wild-type value whilst 
their Vmax values were comparable to wild-type (less than two-fold different). UvrARLO23, 
UvrASAO38, UvrAVD073, UvrASYOSO, UvrAQLOS7 and UvrAvE2o2 had ATPase Km values at 
least four-fold in excess of the wild-type value and their VmaX values were at least two-fold 
different from wild-type except for UvrASY08o. As expected the N-terminal Walker A 
mutant, UvrAsAO3s, was very poor at hydrolysing ATP. The ATPase kcat value of 6.75 
min" of UvrAsA038 was two-fold lower than the reported kcat value (15 min') for the 
neighbouring Walker A mutant UvrA, o37 (Myles and Sancar, 1991). It is not known if the 
amino acid substitutions in mutants that had reduced ATPase activity directly affected 
ATP binding, ATP hydrolysis, release of ADP or an upstream process such as UvrA 
dimerization. 
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Figure 5.10 Effect of amino acid substitutions in UvrA on the ATPase activity of UvrA. 
ATP hydrolysis rates were calculated from data generated from nucleotide hydrolysis assays. Each assay 
contained 50 nM of the indicated UvrA mutant (black circles), the PK/LDH reagents and the indicated 
concentration of ATP in a final volume of 200 W. The reactions were incubated at 37°C for one hour with 
readings taken every 15 seconds. The rates were calculated by measuring the steepest consecutive 30 minute 
period of the curve and then background degradation subtracted. The rates shown are an average of at least 
three independent experiments (with standard deviation). A Michaelis-Menten curve was fitted to the data 
using GraFit. The wild-type UvrA result (from Figure 5.5B) is on all mutant graphs for comparison (white 
circles). 
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Effect of amino acid substitutions in UvrA on GTPase activity 
To ascertain the effect of the 15 substitutions on GTPase activity the GTPase nucleotide 
hydrolysis activity was assessed. The majority of the 15 UvrA mutants showed the same 
general trend as they had when tested for ATPase activity (Figure 5.11 and Table 5.1). 
Only UvrASAo38 showed any difference. Its GTPase Km value was comparable to wild-type 
unlike its ATPase Km value, which was four-fold different. However the very low level of 
ATPase and GTPase activity seen with this mutant makes this observation unreliable. 
Effect of UvrB on the GTPase activity of UvrA mutants 
An interaction between UvrA and UvrB is necessary for the inhibition of the UvrA 
GTPase. Any mutant of UvrA that is unable to interact with UvrB should therefore 
maintain its GTPase activity upon addition of UvrB. The 15 UvrA mutants were therefore 
tested to determine which if any were able to maintain their GTPase activity when UvrB 
was present. 
Each UvrA mutant was characterised using the nucleotide hydrolysis assay at 2 mM GTP 
with or without 100 nM UvrB (a concentration that saw maximum inhibition of 50 nM 
wild-type UvrA) (Table 5.3). Repression by UvrB on the GTPase activity of UvrASAO38, 
UvrAFS064, UvrAQLO87, UvrALH151, UvrAKE159 and UvrAEV201 was comparable to the 
repression by UvrB on the GTPase activity of wild-type UvrA. The GTPase activity of 
UvrARL023, UVrALQ065, UvrAVD073, UvrASY08o, UVrALP151, UvrAGD173, UvrAyc174, 
UvrAvE2o2 and UvrADG205 was repressed less than wild-type UvrA upon addition of UvrB. 
However the effect of UvrB on the GTPase activity of UvrALQ065 and UvrAYC174 was only 
marginally different from the effect of UvrB on wild-type UvrA and the GTPase Vmax 
values without UvrB of UvrARLo23, UvrAvDo73, UvrAsyo8o and UvrAvE2o2 were more than 
two-fold lower than that of wild-type UvrA (Table 5.1). 
The experiment was repeated for UvrALH151, UvrALP151, UVrAGD173 and UVrADG205 with 
different concentrations of UvrB (Figure 5.12). The results confirmed that UvrALPI5I, 
UvrAGDI73 and UvrADG205 maintained a significant amount of GTPase activity when UvrB 
was added. The level of inhibition for UvrAGD173 and UvrADo2os had not appeared to reach 
saturation at the highest concentration (100 nM) of UvrB tested. UvrALP151 was almost 
unaffected by the addition of UvrB unlike UvrALHI5I, which acted as wild-type UvrA. 
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Figure 5.11 Effect of amino acid substitutions in UvrA on the GTPase activity of UvrA. 
GTP hydrolysis rates were calculated from data generated from nucleotide hydrolysis assays. Each assay 
contained 50 nM of the indicated UvrA mutant (black circles), the PK/LDH reagents and the indicated 
concentration of GTP in a final volume of 200 W. The reactions were incubated at 37°C for one hour with 
readings taken every 15 seconds. The rates were calculated by measuring the steepest consecutive 30 minute 
period of the curve and then background degradation subtracted. The rates shown are an average of at least 
three independent experiments (with standard deviation). A Michaelis-Menten curve was fitted to the data 
using GraFit. The wild-type UvrA result (from Figure 5.6) is on all mutant graphs for comparison (white 
circles). 
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Wt 54.6 12.1 12.1 2.76 4.51 7.13 2.86 
RL023 5.49 0.05 3.86 0.61 1.42 1.71 1.22 
SA038 2.63 0.80 2.63 1.63 1.00 3.41 0.43 
FS064 56.7 2.80 16.4 0.79 3.45 3.81 3.13 
LQ065 33.6 1.48 13.3 0.94 2.54 2.85 2.27 
VD073 7.54 0.52 6.22 0.42 1.21 1.39 1.06 
SY080 14.1 1.26 8.69 0.76 1.62 1.94 1.36 
QL087 18.1 0.79 5.00 0.68 3.61 4.36 3.05 
LH151 48.2 1.53 13.8 0.10 3.49 3.63 3.36 
LP151 25.1 0.58 22.2 4.61 1.13 1.46 0.92 
KE159 51.1 1.21 13.3 0.42 3.83 4.04 3.62 
GD173 54.9 7.29 37.6 7.40 1.46 2.06 1.06 
YC174 56.5 0.55 21.1 0.85 2.68 2.82 2.55 
EV201 37.1 0.14 13.0 0.57 2.86 3.00 2.73 
VE202 13.3 1.12 11.7 1.16 1.14 1.37 0.95 
DG205 55.5 3.27 27.5 2.74 2.02 2.37 1.73 
Table 5.3 Effect of UvrB on the GTPase activity of UvrA mutants. 
GTP hydrolysis rates were calculated from data generated from nucleotide hydrolysis assays. Each assay 
contained 50 nM UvrA or the indicated UvrA mutant, 2 mM GTP and either 0 nM or 100 nM UvrB in a final 
volume of 200 µl. The reactions were incubated at 37°C for one hour with readings taken every 15 seconds. 
The rates were calculated by measuring the steepest consecutive 30 minute period of the curve and then 
background degradation subtracted. The rates shown are an average of at least three independent experiments 
(with standard deviation). 
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Figure 5.12 Effect of UvrB concentration on the GTPase activity of UvrA mutants. 
GTP hydrolysis rates were calculated from data generated from nucleotide hydrolysis assays. Each assay 
contained the PK/LDH reagents, 2 mM GTP, the indicated concentration of UvrB and 50 nM of either UvrA 
(black square), UvrA. msl (white triangle), UvrALP1s1 (black triangle), UvrA0D173 (black circle), or UvrADa2os 
(white circle) in a final Volume of 200 µl. The reactions were incubated at 37°C for one hour with readings 
taken every 15 seconds. The rates were calculated by measuring the steepest consecutive 30 minute period of 
the curve and then background degradation subtracted. The rates shown are an average of at least three 
independent experiments (with standard deviation). 
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It can be concluded that the GTPase activity of UvrAsA038, UvrAFS064, UvrAQLO87, 
UVrALH151, UvrAKE159 and UvrAEV2o1 was inhibited by UvrB and therefore the UvrA-UvrB 
complex must presumably still form. However these mutants may have subtle changes in 
UvrB binding affinity that would not have been detected under this one set of conditions 
used to analyse them. The data indicated that the UvrA mutants UvrAGD173 and UvrADG2O5 
were still able to bind to UvrB as some inhibition was still detected. However it is not 
known if: the binding affinity has been reduced; the inhibitory effect of UvrB on UvrA has 
been affected; or whether both had. It would be beneficial to extend the experiment to 
include data points at higher UvrB concentrations to determine if the inhibitory effect 
would eventually reach that of wild-type UvrA. UvrALH151 and UvrALPISI had different 
characteristics within this assay. UvrALH151 acted as wild-type and as such is presumably 
able to interact with, and be affected by, UvrB. The results indicated that UvrALPISI was 
unable to bind UvrB or that once bound UvrB was unable to cause an effect on the GTPase 
activity. The replacement of leucine with the structurally altering proline residue within the 
mutant could have affected the UvrA structure and thus might affect many UvrA 
properties including its ability to bind and be affected by UvrB. 
DNA binding activity of UvrA 
Various complexes involving DNA are formed as part of the NER process. UvrA 
recognises and binds (psoralen) damaged DNA 103-fold more efficiently than undamaged 
DNA (Van Houten et al., 1987). ATP is not essential for the UvrA-DNA complex 
formation (Mazur and Grossman, 1991). However ATP binding is required for the 
formation of a UvrA-UvrB-DNA complex which resolves to a UvrB-DNA complex upon 
ATP hydrolysis (Offen and Sancar, 1990). To further characterise the 15 UvrA mutants 
conditions needed to be established in which a UvrA-DNA complex could be detected. 
DNA binding activity of wild-type UvrA 
Many different substrates have been used to study the DNA binding properties of the NER 
proteins. These include oligonucleotides containing lesions such as cisplatin (Visse et al., 
1991), pyrimidine dimers (Reardon et al., 1993) and fluorescein (DellaVecchia et al., 
2004). 
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A 50 base oligonucleotide was used in the DNA binding experiments. This oligonucleotide 
was designed to contain a single fluorescein molecule covalently attached to a thymine 
(Fld-dT) residue 29 bases from the 5' end (Figure 5.13). The DNA sequence of the 
oligonucleotide was designed so that it would not homodimerize or form secondary 
structures such as hairpins. 
To ascertain the effect of UvrA concentration on formation of a UvrA-DNA complex 
EMSAs were carried out with different concentrations of UvrA (Figure 5.14 (wild-type)). 
As expected the addition of UvrA shifted the DNA from the high mobility DNA-only band 
(band D) into the low mobility UvrA-DNA complex (band A). Increasing the 
concentration of UvrA resulted in the amount of the UvrA-DNA complex increasing 
whilst the amount of free DNA decreased. At the highest concentration of UvrA tested 
(100 nM) the majority of DNA had been shifted from the DNA-only band. A second and 
very faint third complex (band A+ and A++) were also detected in reactions with high 
concentrations of UvrA. These bands had lower mobility than the UvrA-DNA complex 
and were believed to represent two or more dimers of UvrA bound to one molecule of 
DNA. A UvrA-DNA complex had therefore been identified that could act as a control in 
the characterisation of the UvrA mutants. 
Effect of amino acid substitutions in UvrA on the formation of a 
UvrA-DNA complex 
The effect that the 15 amino acid substitutions in UvrA had on formation of a UvrA-DNA 
complex was characterised. The EMSA was repeated using the UvrA mutants instead of 
wild-type UvrA (Figure 5.14). Of the 15 mutants UvrAsA038, UvrAFS064, UvrALQ065, 
UvrAQLO87 and UvrAKE159 were all able to form a stable UvrA-DNA complex comparable 
to wild-type. In each of these cases the second UvrA-DNA complex (A+) was also detected 
at the higher protein concentrations. UvrAKE159 and to a lesser extent UvrAQLO87 formed the 
third complex (A++) more predominantly than the second (A). UvrARLO23, UvrAVD073, 
UvrAsyoso, UvrALH151, UvrALp151, UvrAGD173, UvrAYC174, UvrAEV201, UvrAVE202 and 
UvrADG2os did not form a stable UvrA-DNA complex. In each of these cases the 
DNA-only band reduced as the concentration of the UvrA mutant increased. In some cases 
either one or both of the lower mobility bands (A+/A++) were detected, although in most 
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5' CTAGGATCGG ATAGCGCATG ACAGTGACTG GATCGACAGC GTCGTATGAG 3' 
3' GATCCTAGCC TATCGCGTAC TGTCACTGAC CTAGCTGTCG CAGCATACTC 5' 
Figure 5.13 Fluorescein-dT. 
(A) The chemical structure of fluorescein covalently attached to thymine. (B) The DNA sequence of the 
oligonucleotide used in the EMSA experiments. The red letter indicates the base to which fluorescein had 
been covalently attached. 
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Figure 5.14 Effect of amino acid substitutions in UvrA on the formation of a UvrA-DNA complex. 
UvrA (or the indicated mutant) was added to 1 nM Fld-dT DNA in the presence of 1 mM ATPyS. The 
reactions were incubated at 37°C for 30 minutes. Each reaction was loaded onto a 6% acrylamide, 1x TBE 
gel and run at 40 mA (200 V) for approximately three hours at 4°C. The above gels are representatives of at 
least two independent experiments. Lanes 1,2,3,4,5,6 and 7 contain 0,3.1,6.3,12.5,25,50 or 100 nM 
UvrA respectively. The bands represent: D, DNA; A, UvrA-DNA complex; AA and A++, complexes 
involving more than one dimer of UvrA. 
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cases a smear was present at this position on the gel indicating some unstable specific or 
non-specific DNA binding. 
The UvrA mutants fell into two main categories: those that bound DNA like wild-type; 
and those that were unable to form stable complexes under these conditions. It is not 
known if the UvrA mutants unable to form the UvrA-DNA complex were deficient in 
DNA binding or if they were deficient in an earlier step of the process such as UvrA 
dimerization. The formation of the higher order complexes (A+/A++) with mutants that 
were unable to form a stable UvrA-DNA complex is puzzling. It had been assumed that 
these complexes had formed by the addition of a UvrA dimer to the preformed UvrA-DNA 
complex. This may still be true if a second dimer is needed to stabilise the DNA binding 
activity of the first dimer. 
UvrB binding activity of UvrA 
Effect of UvrB on UvrA-DNA complexes 
UvrA-DNA, UvrA-UvrB-DNA and UvrB-DNA complexes have previously been detected 
under various EMSA conditions (Moolenaar et al., 2005) (Truglio et al., 2004). During 
DNA binding, different steps in nucleotide hydrolysis must be completed to form the 
various protein-DNA complexes (Figure 5.15). UvrA can initially bind DNA in the 
presence or absence of ATP. However a UvrA-UvrB-DNA complex will only form upon 
ATP binding. The hydrolysis of ATP within this complex results in the loading of UvrB 
onto the damaged DNA by UvrA to form a UvrB-DNA complex. 
The conditions in which I could detect a UvrA-UvrB-DNA complex and a UvrB-DNA 
complex needed to be identified (Figure 5.16). EMSAs were therefore carried out. On a 
6% acrylamide gel in the absence of UvrA and UvrB the DNA formed a single band (lane 
1). As seen previously upon addition of UvrA a band (band A) of lower mobility was 
detected (a UvrA-DNA complex) whilst the DNA-only band (band D) reduced in intensity 
(lanes 2 to 4 compared to lane 1). UvrB had no direct effect on the mobility of the DNA in 
the absence of UvrA (lanes 8 to 10 compared to lane 1). The combined effect of UvrA and 
UvrB depended on the cofactor added. In the absence or presence of ATP a band 
corresponding in position to the UvrA-DNA complex was detected (band A lanes 5 and 6). 
In the presence of ATPyS, a poorly hydrolysable analogue of ATP, a band with lower 
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Figure 5.15 Nucleotide binding and hydrolysis requirements within NEIL 
Formation of the UvrA-DNA (A), UvrA-UvrB-DNA (AB) and the UvrB-DNA (B) complexes. Each 
complex indicates the furthest position in the NER cycle (Figure 5.1) that can be reached with the indicated 
proteins in the presence of no nucleotide, ATPyS or ATP. (D) indicates DNA. 
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Figure 5.16 DNA binding properties of wild-type UvrA and tJvrB proteins. 
(A) Hach reaction contained I nM Fld-dT annealed oligonucleotide and where indicated 100 nM UvrA, 100 
nM Uvrl3 and I mM ATP or ATPyS. The reactions were incubated at 37°C tier 30 minutes. Each reaction 
was loaded onto a 6% acrylamide, Ix TBE gel and run at 40 mA (200 V) for approximately three hours at 
4°C. (B) Each reaction contained I nM Fld-dT annealed oligonucleotide and where indicated 50 nM UvrA, 
200 nM Uvr6 and 1 mM ATP or ATPyS. The reactions were incubated at 37°C for 30 minutes. Each 
reaction was loaded onto a 4% acrylamide, 0.5 x THE, 10 mM MgCl2 gel and run at 40 mA (200 V) for 
approximately two hours at 4°C. Lanes II to 14 are from different parts a single gel. The hands in A and B 
represent: D, DNA; A, UvrA-DNA complex; AB, UvrA-UvrB-DNA complex; A', complexes involving 
more than one dimer of UvrA; and B, UvrB-DNA complexes. 
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mobility than the UvrA-DNA complex was detected (band AB in lane 7). This was thought 
to be the UvrA-UvrB-DNA complex. Therefore the conditions for UvrA-UvrB-DNA 
complex formation had been identified. 
Under the above conditions a UvrB-DNA complex was not detected. Previous groups had 
detected UvrB DNA complexes on 4% acrylamide gels containing Mg 2+ and ATP 
(Moolenaar et al., 2005). EMSA were therefore resolved on 4% acrylamide gels 
containing Mg 2+ to try and detect a UvrB-DNA complex (Figure 5.16). Different 
complexes were present when compared to those seen on the gel without Mg 2+ (compare 
gel A with gel B in Figure 5.16). In the absence of UvrA and UvrB a single DNA-only 
band was detected (lane 11). Again upon addition of UvrA, a UvrA-DNA complex was 
formed (lane 12). The effect of UvrA and UvrB again depended on the cofactor. In the 
presence of ATPyS a UvrA-UvrB-DNA complex was detected (band AB lane 14) that had 
marginally less mobility than the UvrA-DNA complex (band A lane 12). In the presence of 
ATP two additional bands were detected along with the UvrA-UvrB-DNA complex (lane 
13). Both bands had a higher mobility than the UvrA-DNA complex and were believed to 
be a UvrB-DNA and a UvrB2-DNA complex. These complexes were only seen when 
UvrA, UvrB and ATP were all present in the reaction. This combination was known to 
lead to UvrB-DNA complex formation (Moolenaar et al., 2005). The intensity of the 
UvrA-UvrB-DNA complex under these conditions was comparable to the same complex in 
the reaction containing ATPyS (band AB in lane 13 compared to lane 14) whilst the 
amount of free DNA had reduced. Under these conditions it would appear that once UvrA 
had loaded UvrB onto the DNA it was released. This enabled UvrA to restart the loading 
process. If further incubation had occurred it would be expected that all of the DNA would 
be within the UvrB-DNA complex. Therefore the conditions for UvrB-DNA complex 
formation had been identified. 
The two different UvrB-DNA complexes were only formed when MgC12 was present 
within the gel (as well as in the reaction mix) indicating a requirement for Mg 2+ to stabilise 
the UvrB-DNA complexes. The two UvrB complexes had only been previously detected in 
separate reactions that were run on acrylamide gels containing ATP (Moolenaar et al., 
2005) (Malta et al., 2006). 
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Effect of UvrB concentration on the formation of a UvrA-UvrB-DNA 
complex 
To enable differences in UvrA-UvrB binding affinity to be detected amongst the UvrA 
mutants the effect of UvrB concentration on the formation of the UvrA-UvrB-DNA 
complex was analysed. EMSA with different concentrations of UvrB were carried out in 
the presence of UvrA and ATPyS which would enable the formation of the 
UvrA-UvrB-DNA complex. As seen previously the addition of UvrB in the absence of 
UvrA had no effect on the mobility of the DNA (no UvrA gel Figure 5.17). As UvrB was 
titrated into reactions containing UvrA and ATPyS the amount of the UvrA-DNA complex 
(band A) reduced as the UvrA-UvrB-DNA complex (band AB) formed (wild-type gel 
Figure 5.17). Under the conditions used, 4 nM UvrB was sufficient to shift the majority of 
the UvrA-DNA complex into the UvrA-UvrB-DNA complex. 
Effect of UvrA amino acid substitutions in UvrA on the formation of a 
UvrA-UvrB-DNA complex 
If the UvrA mutants were unable to interact with UvrB then they would be unable to form 
a stable UvrA-UvrB-DNA complex. The above EMSA was repeated with each of the 15 
UvrA mutants replacing wild-type UvrA (Figure 5.17). UvrASAO38, UvrAFS064, UvrALQO65, 
UvrAQL087 and UvrAKEI59 all formed a UvrA-UvrB-DNA complex. UvrAsyogo, UvrALH151, 
UvrAYC174, UvrAEV201 and UvrADG2O5 also all formed a UvrA-UvrB-DNA complex despite 
the absence of a stable UvrA-DNA complex. UvrA>u, o23, UvrAVDO73, UvrALP151, UvrAGD173 
and UvrAvE2o2 all failed to form a stable UvrA-UvrB-DNA complex although some 
smearing near the top of the gel could be detected for some of these mutants. 
UvrAFS064, UvrALQO65, UvrAQLO87 and UvrAuE159 appear to interact with UvrB as wild-type 
under the conditions tested. UvrAsyoso, UvrALx151, UvrAyc174, UvrAEV2o1 and UvrADG205 
also appear to interact with UvrB despite their inability to form a stable UvrA-DNA 
complex. The ability of UvrARLO23, UvrAVDO73, UvrALP151, UvrAGD173 and UVrAVE2o2 to 
interact with UvrB can not be confirmed in this assay due to the absence of both the 
UvrA-DNA and the UvrA-UvrB-DNA complexes. 
UvrAsAo38 was confirmed to interact with UvrB as a UvrA-UvrB-DNA complex was 
detected. However quantification of the UvrA-DNA and the UvrA-UvrB-DNA complexes 
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Figure 5.17 Effect of amino acid substitutions in UvrA on the formation of a UvrA-UvrB-DNA 
complex. 
Each reaction contained 1 mM ATPyS, 10 nM UvrA or the indicated UvrA mutant and UvrB (concentration 
indicated below). The reactions were incubated at 37°C for 15 minutes, 1 nM Fld-dT annealed 
oligonucleotide was added, and the reactions then incubated for a further 15 minutes. Each reaction was 
loaded onto a 6% acrylamide, 1x TBE gel and run at 40 mA (200 V) for approximately three hours at 4°C. 
The above gels are representatives of at least two independent experiments. Lanes 1,2,3,4,5,6 and 7 
contain 0,0.5,1,2,4,8 or 16 nM UvrB respectively. The bands represent: D, DNA; A, UvrA-DNA 
complex; and AB, UvrA-UvrB-DNA complex. 
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indicated that a maximum of 65% of the UvrA-DNA complex could be converted into the 
UvrA-UvrB-DNA complex. When the wild-type data was analysed almost 100% of the 
UvrA-DNA complex could be converted under the same conditions (Figure 5.18). The 
reasons for this are unclear but could indicate the presence of two species of UvrA-DNA 
complex. If this is the case the UvrASAo38 amino acid substitution could prevent UvrB from 
interacting with one but not the other UvrA-DNA complex during the formation of a 
UvrA-UvrB-DNA complex. 
Discussion 
15 of the 20 amino acid substitutions of UvrA identified from the two screening 
procedures reported in chapter three have been successfully expressed and purified as 
N-terminal hexa-histidine tagged full-length UvrA mutants. Each of the UvrA mutants 
have been characterised in vivo and in vitro to understand the effect of each substitution on 
the properties of UvrA (summarised in Table 5.4). 
UvrA is involved in the initial stages of NER and needs to: form homodimers; bind and 
hydrolyse ATP; bind DNA; bind UvrB and load UvrB onto damaged DNA. Its last step in 
the process is its dissociation from the UvrB-DNA complex to enable UvrC to bind UvrB 
and incise the DNA. Therefore within NER the role of UvrA is completed before the 
incision reactions occur. Each step preceding the 5' cleavage, which includes all steps in 
which UvrA is involved, must be completed to allow the cleavage reaction to take place. 
UvrA mutants that are completely deficient in any essential NER property would therefore 
be unable to facilitate successful incision. 
In combination wild-type UvrA, UvrB and UvrC proteins were able to incise biotinylated 
DNA eight and 15 phosphodiester bonds from the biotin site. Each of these wild-type 
proteins contained a histidine-tag at their N-terminus. The NER properties of my 
histidine-tagged wild-type NER proteins were comparable to previously published data for 
untagged NER proteins indicating that the histidine-tag did not appear to have any 
detectable effect on the initial stages of NER (up to and including incision). 
Of the 15 UvrA mutants, 11 enabled the incision of the DNA to take place. UvrARLO23, 
UvrAVDO73, UvrALPl5l, and UvrAVE2O2 were unable to act as wild-type and enable incision 
of the DNA. At this stage it was not known if these four mutants were specifically 
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Figure 5.18 Effect of UvrA amino acid substitution SA038 on UvrA-UvrB-DNA complex formation. 
ImageQuant software was used to quantify the UvrA-DNA and the UvrA-UvrB-DNA complexes from the 
UvrA (white circles) and UvrAsao3s (black circles) gels (an example of each in Figure 5.17). The proportion 
of the UvrA-UvrB-DNA complex (of the combined UvrA-DNA and UvrA-UvrB-DNA complex) was plotted 
on the graph. At least three individual experiments were quantified in this way and standard deviations are 
shown. A Michaelis-Menten curve fitting the data has been plotted. 
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Table 5.4 Summary of the properties of UvrA mutants. 
Red boxes indicates a difference from wild-type, Yellow boxes indicates similarity to wild-type. N/D Not 
measured. The star indicates that some UvrA-DNA complex always remained. 
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deficient in a particular NER step, reflecting an essential requirement for the amino acid 
that had been substituted, or if the amino acid substitutions had significantly altered the 
tertiary structure. Interestingly some of the 11 mutants that were able to facilitate the first 
5' incision were unable to support the second 5' incision 15 phosphodiester bonds from the 
biotin site. This second 5' incision reaction had previously been shown to require the 
nicked primary 5' incision site, UvrB and UvrC, but not UvrA (Moolenaar et al., 1998a). 
Therefore mutations within UvrA were not expected to have affected this secondary 
incision process. It is possible that the lack of incision at this site is due to changes in 
affinity or stability of protein-protein, protein-nucleotide or protein-DNA interactions and 
with more time the second incision would be detected. However the intensity of the band 
representing the first 5' cleavage was comparable between mutants that do and do not have 
the second cleavage band. Another possibility is that UvrA normally stimulates this extra 
incision activity but this would contradict evidence that indicated that UvrA actually 
inhibited this reaction (Moolenaar et al., 1998a). Finally it is possible that some of the 
UvrA mutants could not completely dissociate from the UvrB-DNA complex, and thus 
interfered with secondary incision. However the mutant would have to remain bound in 
such a way as to not interfere with UvrC binding and the initial incision events. The UvrA 
protein interacts with both the N- and C-terminal regions of UvrB whilst UvrC interacts 
with the C-terminal region (Hsu et al., 1995). If the UvrA mutants were unable to 
dissociate from the N-terminal region of UvrB but were able to dissociate from the 
C-terminal region, UvrC would potentially be able to be bound to UvrB at the same time 
as UvrA. However UvrC would still need to cleave at the primary 3' and 5' incision sites 
and could be prevented by UvrA from cleaving at the secondary incision site if this theory 
is correct. It would be of interest to see if any of the UvrA mutants were able to inhibit the 
incision of the 15`h phosphodiester bond when added to reactions containing UvrB, UvrC 
and a substrate prenicked at the eighth phosphodiester bond 5' of the lesion (this assay was 
used by Moolenaar et al. (Moolenaar et al., 1998a)). 
Mutants that had subtle effects on the affinity of. UvrA dimerization; ATP binding; DNA 
binding; or UvrB binding could still be able to function within the incision assay without 
any noticeable defect. This was due to the incision reaction being analysed at a single time 
point. Stopping the assay at different time points would enable more information to be 
gained. However even when a defect was detected it was not possible to identify at which 
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stage the mutant was unable to function like wild-type. The individual steps of NER were 
assayed individually in order to identify steps in which amino acid substitutions in UvrA 
caused a noticeable defect. 
Histidine-tagged wild-type UvrA was confirmed as both an ATPase and a GTPase in a 
series of nucleotide hydrolysis assays. The ATPase activity corresponded closely to the 
values reported from Sancar's lab however it differed from those reported from 
Grossman's lab (Myles et al., 1991) (Caron and Grossman, 1988). The GTPase activity 
more closely resembled ATPase activity than previously published GTPase data (Caron 
and Grossman, 1988). The reaction conditions between the different labs differed in salt 
and magnesium concentration, temperature and UvrA concentration. It was therefore 
unsurprising that different Km and kcat values were measured. 
Some of the amino acid substitutions within UvrA affected both the ATPase and GTPase 
activity. These mutants generally had an increased Km and a decreased Vmax values. The 
direct effect of the amino acid substitutions could be in: UvrA dimerization; NTP binding; 
NTP hydrolysis; or NDP release. Gel filtration or analytical ultracentrifugation (AUC) 
experiments would determine if these mutants were still able to dimerize. This would 
further localise the precise step in which these nucleotide hydrolysis deficient mutants 
were affected. 
Under high UvrA concentrations UvrB was confirmed to inhibit the GTPase activity of 
UvrA, presumably via a direct UvrA-UvrB interaction. Interestingly the inhibition data 
also showed that in reactions where UvrA and UvrB were present high concentrations of 
GTP enhanced inhibition. This enhanced inhibition was more pronounced at the higher 
UvrB concentrations (Figure 5.7). This could indicate that under these conditions GTP was 
required for the formation of both the UvrA dimer and the UvrA-UvrB complex. If this is 
correct low GTP concentrations would stimulate the UvrA dimerization event but would 
be unable to promote the formation of the UvrA-UvrB complex. Thus the majority of 
UvrA would be in the dimerization state that can hydrolyse GTP. At high GTP 
concentrations there would be sufficient GTP to stimulate the formation of the UvrA-UvrB 
complex. The UvrA-UvrB complex is unable to hydrolyse GTP at the same rate as the 
UvrA dimer and thus the GTP hydrolysis rate would decrease. As the proportion of UvrA 
that was in a UvrA-UvrB complex increased the rate of hydrolysis would decrease. 
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The inhibition data indicated that at least one molecule of UvrB was present for each 
molecule of UvrA in the UvrA-UvrB complex. This agreed with scanning force 
microscopy (SFM) data from which a UvrA2UvrB2 complex was proposed (Verhoeven et 
al., 2002). Damage is proposed to be recognised by the successful flipping of the 
nucleotide adjacent to the damaged site (whose stacking interactions within the double 
helix are reduced due to the neighbouring damage) (Malta et al., 2006). If, as the inhibition 
data and published data suggested, there are two molecules of UvrB in the UvrA-UvrB 
complex then both strands could be scanned without the need for complex dissociation and 
rebinding which would help aid the overall repair rate within the cell (Verhoeven et al., 
2002). 
Previous studies using GTPase assays to detect the UvrA-UvrB interactions indicated that 
the addition of UvrB had no effect on the overall GTPase activity (Truglio et al., 2004). 
However the GTP concentration (100 µM) used in that assay was below the UvrA and the 
UvrA-UvrB K,,, values for GTP (910 µM and 190 µM respectively) (Caron and Grossman, 
1988). At 100 µM GTP the predicted GTP hydrolysis rates of UvrA and UvrA-UvrB were 
less than 1.3-fold different and thus it was not surprising that a difference in GTPase 
activity was not detected. At the 2 mM GTP concentration that I used the difference in 
GTPase activity was predicted to be 3.3-fold different and therefore a decrease in GTPase 
activity when UvrB was present would and is detected. 
The repression of the GTPase activity of the majority of UvrA mutants by UvrB was 
investigated at a single UvrB concentration (100 nM). The assay was used for the detection 
of UvrA-UvrB contact mutants as the UvrB mutant UvrBRE183 that was known to be 
deficient in the UvrA-UvrB interaction did not inhibit UvrA under these conditions. This 
mutant had previously been shown to slightly stimulate GTPase activity (Truglio et al., 
2004). UvrALP151, UvrAGD173 and UvrADG2O5 were not affected by UvrB like wild-type 
UvrA was, and therefore were potentially UvrA-UvrB interaction mutants. UvrALPI51 was 
completely unaffected by UvrB whilst UvrAGD173 and UvrADG205 appeared to have a 
reduced UvrA-UvrB interaction affinity. Further experiments at higher UvrB 
concentrations are needed to determine if wild-type levels of inhibition can be achieved for 
these two mutants. The other UvrA mutants were either inhibited by UvrB under these 
conditions or were deficient in GTPase activity to begin with. However mutants that only 
slightly altered the UvrA-UvrB binding affinity would not have been detected in this assay 
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as the protein concentrations used were much higher than the 5 nM Kd value previously 
reported. 
In TCR the NER proteins have been reported to be recruited to the damaged DNA via 
interactions with Mfd. The crystal structure of Mfd contained a region of structural 
similarity (amino acids 1 to 340) to UvrB (Assenmacher et al., 2006) (Deaconescu et al., 
2006). This region extended beyond the region of sequence homology initially identified 
(amino acids 82 to 219) (Selby and Sancar, 1993). The corresponding region within UvrB 
has been linked with the interaction it makes with UvrA (Hsu et al., 1995). Therefore it 
was suggested that this region of Mfd was involved in the Mfd-UvrA interaction (Selby 
and Sancar, 1993). UvrA has been shown to interact with Mfd bound to an affinity column 
(Selby and Sancar, 1993). Furthermore in pull-down assays UvrA interacted with the 
N-terminal region of Mfd (amino acids 1 to 378) (Selby and Sancar, 1995a). 
If Mfd interacts with UvrA at the UvrB binding site it would be expected to compete with 
UvrB to bind UvrA, and might have a similar effect on GTPase activity. Despite 
predictions that Mfd interacts with UvrA in a similar manner to UvrB, Mfd was unable to 
inhibit the GTPase activity of UvrA under the conditions in which UvrB could. Mfd did 
not appear to compete with UvrB for the UvrA binding site as it was unable to alleviate the 
inhibition caused by the addition of UvrB to UvrA. However it could be possible that 
UvrB and Mfd bind different molecules of the same UvrA dimer to form a 
Mfd-UvrA2-UvrB complex. A Mfd-UvrA2-UvrB complex would help to explain the 
increased rate of repair in TCR compared to global NER as two of the six proteins required 
for complete NER (in vitro) would be localised to the damaged site without the need to 
scan the DNA for damage. However binding assays, in which UvrA and a UvrA-UvrB mix 
were placed on Mfd affinity columns, indicated that Mfd and UvrB were unable to bind 
UvrA at the same time (Selby and Sancar, 1993). 
The results of the GTPase assays involving Mfd could indicate several things. Firstly it 
could indicate that Mfd interacts with a different region of UvrA than UvrB does. A 
Mfd-UvrA interaction away from the UvrB binding site would be unlikely to cause the 
same inhibitory effect as caused by the UvrA-UvrB interaction. Secondly it could indicate 
that the binding of Mfd to the UvrB interaction domain of UvrA does not have the same 
effect on GTPase activity. Thirdly it could indicate that the presence of the histidine-tag on 
UvrA could affect binding by Mfd. Although small the tag is located at the N-terminus 
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which is the region proposed to interact with Mfd. The tag did not affect the UvrA-UvrB 
interaction but could potentially affect the Mfd-UvrA interaction. Finally it could indicate 
that under the conditions used in these experiments Mfd was unable to interact with UvrA 
(with or without the histidine-tag). 
The crystal structure of Mfd indicated that the UvrA interaction region of Mfd may be 
blocked by domain 7 (Figure 1.12B) (Deaconescu et al., 2006). Within the UvrB crystal 
structure the UvrA interaction domain was clearly visible and not blocked by any other 
part of the protein (Truglio et al., 2004). If the UvrA interaction domain of Mfd was 
blocked this would prevent an interaction between UvrA and Mfd and thus no GTPase 
inhibition would be detected. It has been proposed that due to conformational changes 
associated with the interaction Mfd makes with RNAP, domain 7 of Mfd moves 
(Deaconescu et al., 2006). This movement was suggested to expose the UvrA interaction 
domain and thus enable a Mfd-UvrA interaction to form. It would be of interest to 
determine if the deletion of domain 7 would enable Mfd to interact and inhibit the GTPase 
activity of UvrA. 
The DNA binding properties of the UvrA mutants varied with five able to bind DNA and 
nine unable to form the main complex that was seen with wild-type UvrA. Surprisingly 
some mutants that were unable to form the main UvrA-DNA complex were able to form a 
complex with lower mobility. This complex was originally assumed to be multiple dimers 
of UvrA bound to the same DNA molecule. Its appearance in lanes in which the original 
UvrA-DNA complex was not detected leads to the theory that some level of cooperation is 
required between dimers of UvrA for this complex to form. Alternatively it is possible that 
a higher order complex of UvrA such as a tetramer binds the DNA although no evidence 
for the formation of UvrA complexes greater than dimers has previously been published. 
All of the UvrA mutants that bound DNA could also form a UvrA-UvrB-DNA complex. 
However, only 65% of the UvrAsAo3s-DNA complex could potentially be converted to the 
UvrA-UvrB-DNA complex upon addition of any concentration of UvrB. This could 
indicate that two different UvrA-DNA complexes are formed. For example UvrA could 
bind specifically to the fluorescein section of the oligonucleotide or it could bind the DNA 
non-specifically away from the fluorescein site. The non-specific UvrA-DNA complex 
would not be a suitable target for UvrB loading and as such would be unstable and 
dissociate. The specific UvrA-DNA complex would be a suitable target for UvrB loading 
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and therefore a UvrA-UvrB-DNA complex would be formed. In this model any wild-type 
UvrA that bound non-specific DNA would dissociate and thus be able to rebind the DNA 
(either specifically or non-specifically). Once UvrA bound specifically UvrB would then 
bind. If UvrAsA038 was unable to dissociate from the non-specific DNA then UvrB would 
be unable to bind and the UvrAsAO38-DNA complex would always be detected. The 
UvrAsAO39 that bound specifically could bind UvrB to form the UvrA-UvrB-DNA 
complex. 
Some mutants that did not form the UvrA-DNA complex did form the UvrA-UvrB-DNA 
complex. Previous studies have indicated that the UvrA-UvrB-DNA complex is much 
more stable than the UvrA-DNA complex (Yeung et al., 1983). Therefore the addition of 
UvrB could lead to the stabilization of UvrA-DNA interaction which would be detected on 
the gel as the appearance of the UvrA-UvrB-DNA complex. Other mutants were unable to 
form either the UvrA-DNA complex or the UvrA-UvrB-DNA complex. 
Two UvrB mutants have been characterised. UvrBREI83 was unable to inhibit the UvrA 
GTPase activity or support significant levels of incision on damaged DNA. UvrBRA213 was 
unable to inhibit the GTPase activity of UvrA but was able to facilitate incision of the 
damaged DNA. This data reflected published date in which UvrBRE183 was defective in a 
variety of in vitro assays including UvrA-UvrB interaction assays (Truglio et al., 2004). 
In summary, the UvrA mutants isolated in this work can be segregated into different 
groups depending on their in vitro and in vivo properties. 
UvrARLo23 and UvrAvD073 were both identified from the UV sensitivity screen. In AuvrA 
cells both mutants were able to offer some UV resistance but not to the level seen when 
wild-type UvrA was present. Both mutants failed to display any wild-type in vitro property 
of those tested. This indicated that either the mutations have specifically affected the UvrA 
dimerization ability (the first step in NER) or the mutations have had a significant effect on 
the tertiary structure of the protein. 
UvrAvE2o2 was identified from the bacterial two-hybrid screen. It was able to complement 
AuvrA cells yet had no wild-type in vitro properties. It is likely that UvrAVE202 did not 
maintain its tertiary structure during the purification process. 
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In contrast the UvrA mutants UvrAFS064 and UVrAKE159 acted as wild-type UvrA in all 
in vitro assays despite cells carrying these mutations being UV sensitive. An explanation 
for this is that these residues could affect a function of UvrA that is required in vivo but not 
in vitro. For example the residues could be involved in the recruitment of UvrA, as part of 
a macromolecular complex, to the inner membrane of E. coli upon exposure to UV light 
(Lin et al., 1997). 
UvrAYC14 and UvrAEV201 were unable to bind DNA without the assistance of UvrB. 
However this characteristic did not affect their ability to complement AuvrA cells and did 
not affect the overall incision activity in vitro. UvrAy174 and UVrAE201 appear to be 
important for DNA binding but that this role is not essential for successful NER providing 
a UvrA-UvrB-DNA complex can be formed. 
UvrAsyoso had reduced nucleotide hydrolysis and DNA binding activity but was still able 
to form a UvrA-UvrB-DNA complex and enable incision of damaged DNA in vitro. The 
amount of the UvrA-UvrB-DNA complex formed was lower than that formed by wild-type 
UvrA. The reduced nucleotide hydrolysis rates could be the main cause of the UV 
sensitivity observed within cells expressing this protein. UvrAsoso therefore appears to be 
important for ATP and GTP binding and/or hydrolysis but other residues must also be 
involved in these reactions. 
UvrALQO65 and UvrAQLO87 both had poor nucleotide hydrolysis ability and were unable to 
complement AuvrA cells to the same extent as wild-type UvrA. However in vitro these 
mutants were able to bind DNA and UvrB and facilitate incision. Interestingly UvrAQLOS7 
was unable to enable the secondary incision reaction 15 phosphodiester bonds from the 
damage site. These results suggest that UvrAL065 and UvrAQOS7 are involved in nucleotide 
binding or hydrolysis. 
The two UvrAL151 mutants had been identified from different screens. UvrALP151 was 
identified from the UV sensitivity screen in which it was unable to complement AuvrA 
cells. UvrALHI51 was identified from the bacterial two-hybrid screen but unlike UvrALPl51 
could complement AuvrA cells. The difference in UV resistance phenotypes was reflected 
by the in vitro properties of these mutants. UvrALH151 was able to hydrolyse ATP and GTP 
whilst UvrALPISI had reduced Km values. Both were unable to bind DNA but whilst 
UvrALI151 could form a UvrA-UvrB-DNA complex UvrALPl51 was unable to do so. 
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Incision was detected when UvrALH15I was present but was not detected when UvrALP151 
was present. The replacement of UvrAL151 with proline or histidine appeared to have 
affected UvrA differently. Proline is often associated with large changes in tertiary 
structure due to the interaction of its side chain with the nitrogen residue of its backbone. 
Histidine is also dissimilar from leucine but would be unlikely to cause the same level of 
structural chaos as proline. UvrAL151 is likely to be involved in DNA binding. UvrB did 
not have any effect on the GTPase properties of UvrALP151 whilst it did affect UvrALH151. It 
is likely that structural changes in UvrALP15, have affected residues involved in the 
UvrA-UvrB interaction either by altering their position or by blocking their availability. 
When and if a crystal structure of UvrA is published it would be interesting to determine if 
any residues near to UvrAL151 could be involved in the UvrA-UvrB interaction. 
UvrAso38 is within the Walker A motif of UvrA. It was therefore predicted and 
subsequently proven that UvrASA038 would be deficient in nucleotide hydrolysis activity. 
This mutant was able to bind DNA which has previously been shown not to require 
nucleotide binding or hydrolysis (Caron and Grossman, 1988). It was also able to form a 
UvrA-UvrB-DNA complex. However not all the UvrA-DNA complex was converted into 
the UvrA-UvrB-DNA complex unlike it was with wild-type UvrA. It would appear that 
even at very high UvrB concentrations a maximum of 65% of the UvrA-DNA complex 
would be converted into the UvrA-UvrB-DNA complex whilst with the wild-type protein 
all would have been converted. The formation of a UvrA-UvrB-DNA complex requires 
ATP binding, not hydrolysis. As such it was expected that the UvrAsAO38 would be able to 
completely form the UvrA-UvrB-DNA complex which it did not. 
UvrAGD173 and UvrADC2o5 were both identified from the bacterial two-hybrid screens. Both 
were unable to interact with DNA. Both these mutants had normal nucleotide hydrolysis 
activities except that the addition of UvrB had a different effect compared to when it was 
added to wild-type UvrA. UvrB was unable to inhibit the GTPase activity of these UvrA 
mutant proteins to the same extent as it was able to inhibit the GTPase activity of 
wild-type UvrA. This strongly suggests that these residues play an important role in the 
UvrA-UvrB interaction. It would be of interest to see if the inhibition of these mutants by 
UvrB would eventually reflect the inhibition rate of wild-type UvrA if the protein 
concentration of UvrB was increased. Both mutants were able to support incision within 
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the DNA and both conferred UV resistance to AuvrA cells. UvrAG173 and UvrAD205 appear 
to be important for the UvrA-UvrB interaction. 
Some of the six UvrA mutants identified from the bacterial two-hybrid screen were not 
defective in the UvrA-UvrB interaction under the GTPase inhibition assay conditions. In 
the original bacterial two-hybrid model transcription was proposed to be stimulated if the 
aUvrAi. 252 and the ý, cIUvrB35.252 fusion proteins interacted. However in vivo full-length 
wild-type UvrB is proposed to interact with the dimeric form of UvrA. Thus the 
), cIUvrB35.252 truncation of UvrB may only interact with a dimeric form of aUvrAl-252. 
This alters the bacterial two-hybrid model with two interactions now being essential for 
transcription. Firstly aUvrAI-252 would have to dimerize and then XcIUvrB35-252 would 
have to bind UvrA, possibly in two positions (Figure 5.19B). The formation of the 
aUvrAl. 252 dimer would be required to form the correct interface for UvrB binding. Two 
types of UvrA mutants would therefore be identified from this assay. These would be 
UvrA dimerization mutants and UvrA-UvrB interaction mutants (Figure 5.19C). 
Previous work has identified that residues within UvrA1-605 are required for UvrA 
dimerization (Myles and Sancar, 1991) (Claassen and Grossman, 1991). UvrA1-230 was 
unable to dimerize (Claassen and Grossman, 1991). This indicates that at least one residue 
within UvrA231-605 is essential for dimerization. There is one complete ABC ATPase motif 
within UvrA1-680. In the absence of the complete ABC ATPase motif dimerization is likely 
to be compromised. However within the bacterial two-hybrid system the local 
concentration of UvrA1-252 will be greatly increased as two aUvrA1.252 molecules will be 
tethered to one RNAP molecule. This may enable a dimer to form without all the 
necessary components. 
If dimerization was required between the UvrA subunits in the bacterial two-hybrid screen 
then two aUvrAl_252 subunits would likely have to be part of the same RNAP complex. In 
Figure 3.9 it can be seen that levels of the endogenous full-length RNAPa subunit are 
greater then the levels of the aUvrAl-252. (mutants) fusion proteins and therefore the majority 
of the RNAP complexes will either be in the wild-type form or be a hybrid with one 
full-length RNAPa subunit and one aUvrA1.252 subunit. Neither of these complexes would 
be proposed to interact with XcIUvrB35-252 in this model. This would help to explain the 
low level of ß-galactosidase activity that was detected in comparison to other systems in 
which a and Xcl fusion proteins have been used (Dove et al., 1997). 
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ý ý 
Figure 5.19 Revised model of bacterial two-hybrid interactions. 
(A) The original model in which one molecule of UvrB interacted with one molecule of UvrA to recruit 
RNAP to the promoter to activate transcription. (B) The revised model in which UvrB will only bind to a 
UvrA dimer. The UvrA-UvrA and the UvrA-UvrB interaction are both necessary for the recruitment of 
RNAP to the promoter to activate transcription. The interactions necessary are indicated by thick black lines. 
(C) If UvrA is unable to dimerize then UvrB will not interact and RNAP will not be recruited to the 
promoter. 
A 
B ýý C 
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The system is proposed to identify UvrA dimerization mutants. Interestingly when all six 
bacterial two-hybrid mutants were expressed as full-length proteins they were unable to 
form a stable UvrA-DNA complex. UvrA binds DNA as a dimer and as such if the mutants 
effected dimerization they could also affect the stability of a UvrA-DNA complex. 
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Chapter 6- Conclusions 
In summary, two genetic screens have been established to identify important residues 
within UvrA. The bacterial two-hybrid screen was specifically designed to identify 
residues of UvrA that interrupted the UvrA-UvrB or the UvrA-Mfd interaction. Six 
residues were identified from this screen as being important in the UvrA1.252-UvrB35-252 
and the UvrA1-252-Mfd1-219 interaction. The second screen was designed to identify UvrA 
residues that were essential for any aspect of UvrA function that was essential for its 
in vivo function. 12 residues were identified from this screen of which one (UvrAL151) had 
been identified in the bacterial two-hybrid screen. 
Hexa-histidine N-terminally tagged wild-type and mutant UvrA proteins were purified 
from AuvrA cells using a one column purification procedure. The tagged wild-type UvrA 
protein functioned as expected in all assays associated with the NER pathway, indicating 
that the tag had no effect on these properties of UvrA. Further work is needed to determine 
if the histidine tag effects the interaction that UvrA makes with Mfd. 
Of the 20 identified UvrA mutants (17 residues), 15 (14 residues) were characterised 
in vitro. These mutants are deficient in a range of properties including ATP hydrolysis, 
DNA binding and overall support of incision activity. Of most interest to us are the two 
mutants that appear to affect the UvrA-UvrB interaction. UvrAGD173 and UvrADG205 were 
both identified from the bacterial two-hybrid screen and are able to facilitate UV survival 
in vivo. Both mutants are able to hydrolyse GTP but unlike wild-type UvrA this GTPase 
activity is not strongly repressed by the addition of UvrB. 
As part of this work a novel method of site-specifically introducing a lesion within a 
plasmid was used. SMILing DNA enabled a modification to be introduced within a large 
DNA fragment at a specific site on a specific strand. The introduced 6Baz modification 
contains a biotin molecule. Biotin had not previously been used a substrate for NER. The 
6Baz modification acts as a NER substrate with similar cleavage patterns to other lesions 
repaired by NER. 
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